{"system_instruction":{"parts":[{"text":"You are Syndi, a highly competent and helpful data assistant."}]},"contents":[{"parts":[{"text":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Default is the project PI and/or the user who created all files/records.\",\n        \"title\": \"Creator\",\n        \"type\": \"string\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate original data, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"title\": \"Measurement Technique\",\n        \"enum\": [\n          \"2D AlamarBlue absorbance\",\n          \"2D AlamarBlue fluorescence\",\n          \"3D confocal imaging\",\n          \"3D electron microscopy\",\n          \"3D imaging\",\n          \"3D microtissue viability\",\n          \"actigraphy\",\n          \"AlgometRx Nociometer\",\n          \"auditory brainstem response\",\n          \"ATAC-seq\",\n          \"ATPase activity assay\",\n          \"BrdU proliferation assay\",\n          \"CAPP-seq\",\n          \"CUT&RUN\",\n          \"ChIP-seq\",\n          \"Child Behavior Checklist for Ages 1.5-5\",\n          \"Child Behavior Checklist for Ages 6-18\",\n          \"CODEX\",\n          \"confocal microscopy\",\n          \"Corsi blocks\",\n          \"current clamp assay\",\n          \"diffusion MRI\",\n          \"distortion product otoacoustic emissions\",\n          \"DNA optical mapping\",\n          \"ELISA\",\n          \"ERR bisulfite sequencing\",\n          \"EdU proliferation assay\",\n          \"FIA-MSMS\",\n          \"FLIPR high-throughput cellular screening\",\n          \"Fluorescence In Situ Hybridization\",\n          \"Focus group\",\n          \"FTIR spectroscopy\",\n          \"HI-C\",\n          \"HPLC\",\n          \"Interview\",\n          \"ISO-seq\",\n          \"MIB/MS\",\n          \"Matrigel-based tumorigenesis assay\",\n          \"MudPIT\",\n          \"Migration Assay\",\n          \"NIH Toolbox\",\n          \"NOMe-seq\",\n          \"RNA array\",\n          \"RNA-seq\",\n          \"RPPA\",\n          \"Riccardi and Ablon scales\",\n          \"SNP array\",\n          \"SUSHI\",\n          \"Sanger sequencing\",\n          \"Social Responsiveness Scale\",\n          \"Social Responsiveness Scale, Second Edition\",\n          \"T cell receptor repertoire sequencing\",\n          \"TIDE\",\n          \"TMT quantitation\",\n          \"TriKinetics activity monitoring\",\n          \"Von Frey test\",\n          \"active avoidance learning behavior assay\",\n          \"array\",\n          \"atomic force microscopy\",\n          \"autoradiography\",\n          \"bisulfite sequencing\",\n          \"blood chemistry measurement\",\n          \"blue native PAGE\",\n          \"body size trait measurement\",\n          \"bone histomorphometry\",\n          \"brightfield microscopy\",\n          \"cAMP-Glo Max Assay\",\n          \"calcium retention capacity assay\",\n          \"cell competition\",\n          \"cell count\",\n          \"cell painting\",\n          \"cell proliferation\",\n          \"cell viability assay\",\n          \"clinical data\",\n          \"cNF-Skindex\",\n          \"cognitive assessment\",\n          \"combination library screen\",\n          \"combination screen\",\n          \"complex II enzyme activity assay\",\n          \"compound screen\",\n          \"contextual conditioning behavior assay\",\n          \"conventional MRI\",\n          \"Children's Dermatology Life Quality Index Questionnaire\",\n          \"differential scanning calorimetry\",\n          \"dynamic light scattering\",\n          \"electrochemiluminescence\",\n          \"electrophoretic light scattering\",\n          \"elevated plus maze test\",\n          \"FACE-Q Appearance-related Distress\",\n          \"flow cytometry\",\n          \"focus forming assay\",\n          \"functional MRI\",\n          \"gait measurement\",\n          \"gel filtration chromatography\",\n          \"gel permeation chromatography\",\n          \"genotyping\",\n          \"high content screen\",\n          \"high frequency ultrasound\",\n          \"high-performance liquid chromatography/tandem mass spectrometry\",\n          \"immunoassay\",\n          \"immunocytochemistry\",\n          \"immunofluorescence\",\n          \"immunohistochemistry\",\n          \"in silico synthesis\",\n          \"in vitro tumorigenesis\",\n          \"in vivo PDX viability\",\n          \"in vivo bioluminescence\",\n          \"in vivo tumor growth\",\n          \"jumping library\",\n          \"label free mass spectrometry\",\n          \"laser speckle imaging\",\n          \"light scattering assay\",\n          \"liquid chromatography-electrochemical detection\",\n          \"liquid chromatography/mass spectrometry\",\n          \"liquid chromatography/tandem mass spectrometry\",\n          \"lncRNA-seq\",\n          \"local field potential recording\",\n          \"long term potentiation assay\",\n          \"mRNA counts\",\n          \"magnetic resonance angiography\",\n          \"magnetic resonance spectroscopy\",\n          \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n          \"mass spectrometry\",\n          \"massively parallel reporter assay\",\n          \"metabolic screening\",\n          \"methylation array\",\n          \"miRNA array\",\n          \"miRNA-seq\",\n          \"microrheology\",\n          \"Skindex-16\",\n          \"multi-electrode array\",\n          \"nanoparticle tracking analysis\",\n          \"NanoString nCounter Analysis System\",\n          \"n-back task\",\n          \"neuropsychological assessment\",\n          \"next generation targeted sequencing\",\n          \"novelty response behavior assay\",\n          \"open field test\",\n          \"optical tomography\",\n          \"optical coherence tomography\",\n          \"optokinetic reflex assay\",\n          \"oscillatory rheology\",\n          \"oxBS-seq\",\n          \"oxygen consumption assay\",\n          \"pattern electroretinogram\",\n          \"perineurial cell thickness\",\n          \"pharmocokinetic ADME assay\",\n          \"phase-contrast microscopy\",\n          \"photograph\",\n          \"polymerase chain reaction\",\n          \"polysomnography\",\n          \"positron emission tomography\",\n          \"PROMIS Cognitive Function\",\n          \"proximity extension assay\",\n          \"pure tone average\",\n          \"quantitative PCR\",\n          \"questionnaire\",\n          \"reactive oxygen species assay\",\n          \"reporter gene assay\",\n          \"rheometry\",\n          \"ribo-seq\",\n          \"rotarod performance test\",\n          \"sandwich ELISA\",\n          \"scCGI-seq\",\n          \"scale\",\n          \"SaferSeqS\",\n          \"single molecule drug screen assay\",\n          \"single-cell RNA-seq\",\n          \"single cell ATAC-seq\",\n          \"single-nucleus RNA-seq\",\n          \"small molecule library screen\",\n          \"sorbitol dehydrogenase activity level assay\",\n          \"spatial frequency domain imaging\",\n          \"spatial transcriptomics\",\n          \"static histomorphometry\",\n          \"static light scattering\",\n          \"survival\",\n          \"targeted exome sequencing\",\n          \"traction force microscopy\",\n          \"transcranial doppler ultrasonography\",\n          \"twin spot assay\",\n          \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n          \"western blot\",\n          \"whole exome sequencing\",\n          \"whole genome sequencing\",\n          \"whole-cell patch clamp\",\n          \"word recognition score\",\n          \"STR profile\"\n        ],\n        \"type\": \"string\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn24875850\n\n\n# DNA methylation signatures in peripheral leukocytes of patients with Schwannomatosis or sporadic schwannoma\n\n## Opening the Data Drawers Initiative\n### Principal Investigator: Dr. Gelareh Zadeh\n### Institution: University Health Network of Toronto\n\n### Project Description: \nAberrant DNA methylation is associated with cancer development and progression. There are several types of specimens from which DNA methylation patterns can be measured and evaluated as an indicator of disease status (from normal biological process to pathologic condition) and even of pharmacologic response to therapy. Blood-based specimens such as cell-free circulating nucleic acid and DNA extracted from leukocytes in peripheral blood may be a potential source of non-invasive cancer biomarkers. As part of our synodos for schwannomatosis study we focused on multiplatform genomic analysis of schwannomatosis related schwannomas. We also performed DNA methylation profiling on whole genomic DNA isolated from peripheral blood leukocytes from 27 schwannomatosis patients and 22 patients with sporadic non-syndromic schwannomas. This analysis was outside the scope of the synodos for schwannomatosis study; however, we were interested in evaluating the proportion of immune cell types in the blood of patients with peripheral nerve sheath tumors including schwannomatosis patients. After performing QC analysis, we removed 5 schwannomatosis samples (failed QC: detp>0.05). We then Removed 176834 failed probes (detp>0.05), 12613 probes on the X and Y sex chromosomes, 23507 probes associated with SNPs at the CpG sites, and 24267 cross-reactive probes. Total 630553 probes were left for clustering analysis. We then performed cell deconvolution analysis using IDOLOptimizedCpGs method  to determine the proportion of immune cell types in blood of patients with schwannomatosis or non-syndromic sporadic schwannomas including neutrophils, monocytes, CD4 T cells, CD8 T cells, B cells and NK cells. We then clustered the samples based on immune cell proportions. We found that schwannomatosis samples clustered separate from sporadic schwannomas. Our results suggested that schwannomatosis patients harboured a higher neutrophil to lymphocyte ratio (NLR) compared to schwannomas. Further studies are required to determine the clinical implications of this result, in addition to continued work to uncover the biological underpinnings of these differences among these syndromic and non-syndromic disorders.\n\n### Quality Assurance of the Data:\n\nAll data was processed using appropriate DNA methylation analysis pipelines including minfi from Bioconductor. We performed in-depth QC analysis as described above. Samples that did not meet our QC threshold were removed. All failed probes and probes associated with SNPs, X/Y chromosomes, and cross-reactive probes were also removed. Detailed QC results and associated graphs are ready available for uploading upon request.\n\n\n## Tables for Curation\n1. ID: syn65467791\nName: DNA methylation signatures in peripheral leukocytes of patients with Schwannomatosis or sporadic schwannoma\nSummary:\n- Assays: methylation array, \n- Species: Homo sapiens, \n- Individual count: 54\n- Specimen count: 54\n- Diagnoses present: Sporadic Schwannoma, Schwannomatosis, \n- Tumor types present: Not Applicable, \n- Data types: chromatinActivity, \n- File formats present: idat, \n- Funders: CTF\n- Contains data created by: Sheila Mansouri, Robert Allaway\n- Example files present: 201536580019_R08C01_Grn.idat, 201536580019_R08C01_Red.idat, 201536580019_R07C01_Grn.idat, 201536580019_R07C01_Red.idat, 201536580019_R06C01_Grn.idat\n\n\n"}]}]}{"system_instruction":{"parts":[{"text":"You are Syndi, a highly competent and helpful data assistant."}]},"contents":[{"parts":[{"text":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Default is the project PI and/or the user who created all files/records.\",\n        \"title\": \"Creator\",\n        \"type\": \"string\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate original data, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"title\": \"Measurement Technique\",\n        \"enum\": [\n          \"2D AlamarBlue absorbance\",\n          \"2D AlamarBlue fluorescence\",\n          \"3D confocal imaging\",\n          \"3D electron microscopy\",\n          \"3D imaging\",\n          \"3D microtissue viability\",\n          \"actigraphy\",\n          \"AlgometRx Nociometer\",\n          \"auditory brainstem response\",\n          \"ATAC-seq\",\n          \"ATPase activity assay\",\n          \"BrdU proliferation assay\",\n          \"CAPP-seq\",\n          \"CUT&RUN\",\n          \"ChIP-seq\",\n          \"Child Behavior Checklist for Ages 1.5-5\",\n          \"Child Behavior Checklist for Ages 6-18\",\n          \"CODEX\",\n          \"confocal microscopy\",\n          \"Corsi blocks\",\n          \"current clamp assay\",\n          \"diffusion MRI\",\n          \"distortion product otoacoustic emissions\",\n          \"DNA optical mapping\",\n          \"ELISA\",\n          \"ERR bisulfite sequencing\",\n          \"EdU proliferation assay\",\n          \"FIA-MSMS\",\n          \"FLIPR high-throughput cellular screening\",\n          \"Fluorescence In Situ Hybridization\",\n          \"Focus group\",\n          \"FTIR spectroscopy\",\n          \"HI-C\",\n          \"HPLC\",\n          \"Interview\",\n          \"ISO-seq\",\n          \"MIB/MS\",\n          \"Matrigel-based tumorigenesis assay\",\n          \"MudPIT\",\n          \"Migration Assay\",\n          \"NIH Toolbox\",\n          \"NOMe-seq\",\n          \"RNA array\",\n          \"RNA-seq\",\n          \"RPPA\",\n          \"Riccardi and Ablon scales\",\n          \"SNP array\",\n          \"SUSHI\",\n          \"Sanger sequencing\",\n          \"Social Responsiveness Scale\",\n          \"Social Responsiveness Scale, Second Edition\",\n          \"T cell receptor repertoire sequencing\",\n          \"TIDE\",\n          \"TMT quantitation\",\n          \"TriKinetics activity monitoring\",\n          \"Von Frey test\",\n          \"active avoidance learning behavior assay\",\n          \"array\",\n          \"atomic force microscopy\",\n          \"autoradiography\",\n          \"bisulfite sequencing\",\n          \"blood chemistry measurement\",\n          \"blue native PAGE\",\n          \"body size trait measurement\",\n          \"bone histomorphometry\",\n          \"brightfield microscopy\",\n          \"cAMP-Glo Max Assay\",\n          \"calcium retention capacity assay\",\n          \"cell competition\",\n          \"cell count\",\n          \"cell painting\",\n          \"cell proliferation\",\n          \"cell viability assay\",\n          \"clinical data\",\n          \"cNF-Skindex\",\n          \"cognitive assessment\",\n          \"combination library screen\",\n          \"combination screen\",\n          \"complex II enzyme activity assay\",\n          \"compound screen\",\n          \"contextual conditioning behavior assay\",\n          \"conventional MRI\",\n          \"Children's Dermatology Life Quality Index Questionnaire\",\n          \"differential scanning calorimetry\",\n          \"dynamic light scattering\",\n          \"electrochemiluminescence\",\n          \"electrophoretic light scattering\",\n          \"elevated plus maze test\",\n          \"FACE-Q Appearance-related Distress\",\n          \"flow cytometry\",\n          \"focus forming assay\",\n          \"functional MRI\",\n          \"gait measurement\",\n          \"gel filtration chromatography\",\n          \"gel permeation chromatography\",\n          \"genotyping\",\n          \"high content screen\",\n          \"high frequency ultrasound\",\n          \"high-performance liquid chromatography/tandem mass spectrometry\",\n          \"immunoassay\",\n          \"immunocytochemistry\",\n          \"immunofluorescence\",\n          \"immunohistochemistry\",\n          \"in silico synthesis\",\n          \"in vitro tumorigenesis\",\n          \"in vivo PDX viability\",\n          \"in vivo bioluminescence\",\n          \"in vivo tumor growth\",\n          \"jumping library\",\n          \"label free mass spectrometry\",\n          \"laser speckle imaging\",\n          \"light scattering assay\",\n          \"liquid chromatography-electrochemical detection\",\n          \"liquid chromatography/mass spectrometry\",\n          \"liquid chromatography/tandem mass spectrometry\",\n          \"lncRNA-seq\",\n          \"local field potential recording\",\n          \"long term potentiation assay\",\n          \"mRNA counts\",\n          \"magnetic resonance angiography\",\n          \"magnetic resonance spectroscopy\",\n          \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n          \"mass spectrometry\",\n          \"massively parallel reporter assay\",\n          \"metabolic screening\",\n          \"methylation array\",\n          \"miRNA array\",\n          \"miRNA-seq\",\n          \"microrheology\",\n          \"Skindex-16\",\n          \"multi-electrode array\",\n          \"nanoparticle tracking analysis\",\n          \"NanoString nCounter Analysis System\",\n          \"n-back task\",\n          \"neuropsychological assessment\",\n          \"next generation targeted sequencing\",\n          \"novelty response behavior assay\",\n          \"open field test\",\n          \"optical tomography\",\n          \"optical coherence tomography\",\n          \"optokinetic reflex assay\",\n          \"oscillatory rheology\",\n          \"oxBS-seq\",\n          \"oxygen consumption assay\",\n          \"pattern electroretinogram\",\n          \"perineurial cell thickness\",\n          \"pharmocokinetic ADME assay\",\n          \"phase-contrast microscopy\",\n          \"photograph\",\n          \"polymerase chain reaction\",\n          \"polysomnography\",\n          \"positron emission tomography\",\n          \"PROMIS Cognitive Function\",\n          \"proximity extension assay\",\n          \"pure tone average\",\n          \"quantitative PCR\",\n          \"questionnaire\",\n          \"reactive oxygen species assay\",\n          \"reporter gene assay\",\n          \"rheometry\",\n          \"ribo-seq\",\n          \"rotarod performance test\",\n          \"sandwich ELISA\",\n          \"scCGI-seq\",\n          \"scale\",\n          \"SaferSeqS\",\n          \"single molecule drug screen assay\",\n          \"single-cell RNA-seq\",\n          \"single cell ATAC-seq\",\n          \"single-nucleus RNA-seq\",\n          \"small molecule library screen\",\n          \"sorbitol dehydrogenase activity level assay\",\n          \"spatial frequency domain imaging\",\n          \"spatial transcriptomics\",\n          \"static histomorphometry\",\n          \"static light scattering\",\n          \"survival\",\n          \"targeted exome sequencing\",\n          \"traction force microscopy\",\n          \"transcranial doppler ultrasonography\",\n          \"twin spot assay\",\n          \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n          \"western blot\",\n          \"whole exome sequencing\",\n          \"whole genome sequencing\",\n          \"whole-cell patch clamp\",\n          \"word recognition score\",\n          \"STR profile\"\n        ],\n        \"type\": \"string\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn21355225\n\n# Evaluation of the use of antisense oligonucleotides as a personalized therapy for Neurofibromatosis Type 2 patients\n## Children's Tumor Foundation DDI\n\n### Principal Investigator: Dr. Elisabeth Castellanos\n### Project Lead / Data Coordinator: TBD\n### Institution: Germans Trias I Pujol Research Institute (IGTP) & Hospital Universitari Germans Trias i Pujol (HUGTP)\n\n### Project Description: \nNeurofibromatosis type 2 (NF2) is a devastating genetic condition, characterized by the development of multiple tumors of the nervous system for which effective therapeutic options with no adverse consequences need to be developed. The clinical presentation of the disease is variable and related to the type of constitutional mutation in the _NF2_ gene inherited: patients affected with truncating mutations have a more severe form of the disease, while patients with missense, splicing or large deletions present a milder phenotype. \n\nIn this context, the development of personalized therapies based on the type of _NF2_ mutation constitutes an opportunity. One of the therapeutic approaches that are being successfully developed for different hereditary diseases are therapies that act at the RNA level. Currently, it is possible to design antisense oligonucleotides (AONs) able to correct the effect of deleterious DNA mutations at the protein level, or to create proteins that still retain partial function from loss-of-function mutated alleles. AONs could be used to force the skipping of exons carrying truncating mutations when the reading frame is maintained. In this way, mutations that are associated to severe phenotypes could potentially be modified to less deleterious forms, associated to milder phenotypes. The NF2 gene is made up of 17 exons, 9 of them being in frame. Taken together, approximately 45% of the mutations detected in the NF2 gene could be susceptible to be treated by antisense therapy.\n\nHere we propose to evaluate the use of AONs to reduce the severity of _NF2_ truncating and splicing mutations to milder hypomorphic forms _in vitro_. In addition, we hope to recover merlin function in cases where splicing mutation could be corrected. Based on our previous studies, we will induce skipping of in frame exons in primary fibroblasts derived from NF2 patients carrying truncating, splicing and missense mutations using specific AONs for each exon. The effect on merlin activity will be analyzed through different functional analysis. \n\nThis work will allow the evaluation of the use of AONs as a personalized therapy for NF2 patients _in vitro_. The demonstration that the use of AONs reduce the severity of the _NF2_ truncating and splicing mutations, could open up the possibility to further studies using _in vivo_ models, thereby enabling to take a major step towards an effective therapy for NF2 patients.\n\n${image?fileName=imatge%5F2RFA%2Epng&align=None&scale=100&responsive=true&altText=Schematic representation of the effect of different mutation types in merlin’s function and the resulting merlin protein after the treatment with antisense oligomers %28PMOs%29%2E }\n\n${previewattachment?fileName=imatge%5F2RFA%2Epng}\n\n\nBackground: Neurofibromatosis type 2 (NF2) is a genetic condition characterized by the development of multiple tumors of the nervous system. The clinical presentation of the disease is variable and related to the type of the inherited constitutional mutation variant in the NF2 gene. The use of antisense oligonucleotides (AONs), acting at RNA level, could be useful to correct the effect of deleterious DNA mutations at the protein level, or to create proteins that still retain partial function from loss-of-function mutated alleles. AONs They could be used to force the skipping of exons carrying truncating mutations when the reading frame is maintained. We have shown that a deep intronic mutation responsible for an aberrant NF2 splicing could be corrected by the use of PMOs and recover Merlin function. Here, we propose to evaluate the use of AONs PMOs to reduce the severity of NF2 truncating and splicing mutations to milder hypomorphic forms in vitro. \n\nMethods: Samples: primary fibroblasts cultures from NF2 patients. Phosphorodiamidate morpholino oligomers (PMOs)AONs: We designed specific phosphorodiamidate morpholino oligomers (PMOs) targeting four independent disease-causing splicing mutationsvariants, and a pair of PMOs to induce exon skipping of exons 4, 6&7, 8, and 11 of the NF2 gene. Primary fibroblasts carrying nonsense mutations variants were treated with the corresponding pair of PMOs. A dose-response and a time course study were performed to set-up conditions and confirmed the in-frame skipping of the target exons by RT-PCR and Sanger sequencing. Functional analysis: Functional studies were performed from fibroblast cultures untreated and treated at different PMOs concentrations. We measured: 1) Merlin, ERK and their phosphorylated forms by Western Blot; 2) actin cytoskeleton organization; 3) NF2 and YAP1 nuclear translocation capacity by immunofluorescence, and 4) proliferation capacity. \n\nResults: MutationVariant-specific PMOs for splicing mutations: our results showed the PMOs designed for splicing variants located at +/- 15 (or less) from the intron-exon boundary region, were not specific enough and interfered in the correct splicing signaling of both wild-type and mutated alleles. Exon-specific PMOs for truncating mutationsvariants: the effect of the exon skipping on both the mutated and the WT allele, although maintaining the NF2 gene reading frame at cDNA level, caused the complete loss of Merlin. Despite these results, complementary functional analysis are being performed to confirm the absence of Merlin at a cellular level.\n\nConclusions: PMOs might be optimal for inducing targeted exon skipping without altering gene transcription in cells carrying deep intronic variants, or for the modulation of alternative spliced exons. However, here we show that, in the case of NF2, PMOs may not be useful for correcting splicing when mutations are located in splicing canonical sites, neither for inducing semi-functional Merlin isoforms, since the use of these antisense molecules results in total Merlin los\n\n## Publication\nCatasús, N., Rosas, I., Bonache, S., Negro, A., Torres-Martin, M., Plana-Pla, A., ... & Castellanos, E. (2022). Antisense oligonucleotides targeting exon 11 are able to partially rescue the NF2-related schwannomatosis phenotype in vitro. Molecular Therapy-Nucleic Acids, 30, 493-505.\n\n## Acknowledgement Statements\nIn using this data, you promise to acknowledge the data contributors by including the following statement: \"Data was provided by: Catasús, N., Rosas, I., Bonache, S., Negro, A., Torres-Martin, M., Plana-Pla, A., ... & Castellanos, E. (2022). Antisense oligonucleotides targeting exon 11 are able to partially rescue the NF2-related schwannomatosis phenotype in vitro. Molecular Therapy-Nucleic Acids, 30, 493-505.\" \n\nIn addition, please acknowledge the NF Data Portal like so: \"The results published here are in whole or in part based on data obtained from the NF Data Portal (http://www.nf.synapse.org, RRID:SCR_021683) and made available through the NF Open Science Initiative.\n\n\n## Tables for Curation\n1. ID: syn65467790\nName: Patient Data\nSummary:\n- Assays: polymerase chain reaction, \n- Species: Homo sapiens, \n- Individual count: 15\n- Specimen count: ?\n- Diagnoses present: NF2-related schwannomatosis, \n- Tumor types present: NF2-Associated Tumor, \n- Data types: drugScreen, \n- File formats present: excel, \n- Funders: CTF\n- Contains data created by: Elisabeth Castellanos, James Moon\n- Example files present: Raw_Data_CTF_v4.xlsx, Exon4_Patient_07.xlsx, Exon4_Patient_335.xlsx, Exon6and7_Patient_416.xlsx, Exon8_Patient_009.xlsx\n\n\n"}]}]}{"system_instruction":{"parts":[{"text":"You are Syndi, a highly competent and helpful data assistant."}]},"contents":[{"parts":[{"text":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Default is the project PI and/or the user who created all files/records.\",\n        \"title\": \"Creator\",\n        \"type\": \"string\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate original data, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"title\": \"Measurement Technique\",\n        \"enum\": [\n          \"2D AlamarBlue absorbance\",\n          \"2D AlamarBlue fluorescence\",\n          \"3D confocal imaging\",\n          \"3D electron microscopy\",\n          \"3D imaging\",\n          \"3D microtissue viability\",\n          \"actigraphy\",\n          \"AlgometRx Nociometer\",\n          \"auditory brainstem response\",\n          \"ATAC-seq\",\n          \"ATPase activity assay\",\n          \"BrdU proliferation assay\",\n          \"CAPP-seq\",\n          \"CUT&RUN\",\n          \"ChIP-seq\",\n          \"Child Behavior Checklist for Ages 1.5-5\",\n          \"Child Behavior Checklist for Ages 6-18\",\n          \"CODEX\",\n          \"confocal microscopy\",\n          \"Corsi blocks\",\n          \"current clamp assay\",\n          \"diffusion MRI\",\n          \"distortion product otoacoustic emissions\",\n          \"DNA optical mapping\",\n          \"ELISA\",\n          \"ERR bisulfite sequencing\",\n          \"EdU proliferation assay\",\n          \"FIA-MSMS\",\n          \"FLIPR high-throughput cellular screening\",\n          \"Fluorescence In Situ Hybridization\",\n          \"Focus group\",\n          \"FTIR spectroscopy\",\n          \"HI-C\",\n          \"HPLC\",\n          \"Interview\",\n          \"ISO-seq\",\n          \"MIB/MS\",\n          \"Matrigel-based tumorigenesis assay\",\n          \"MudPIT\",\n          \"Migration Assay\",\n          \"NIH Toolbox\",\n          \"NOMe-seq\",\n          \"RNA array\",\n          \"RNA-seq\",\n          \"RPPA\",\n          \"Riccardi and Ablon scales\",\n          \"SNP array\",\n          \"SUSHI\",\n          \"Sanger sequencing\",\n          \"Social Responsiveness Scale\",\n          \"Social Responsiveness Scale, Second Edition\",\n          \"T cell receptor repertoire sequencing\",\n          \"TIDE\",\n          \"TMT quantitation\",\n          \"TriKinetics activity monitoring\",\n          \"Von Frey test\",\n          \"active avoidance learning behavior assay\",\n          \"array\",\n          \"atomic force microscopy\",\n          \"autoradiography\",\n          \"bisulfite sequencing\",\n          \"blood chemistry measurement\",\n          \"blue native PAGE\",\n          \"body size trait measurement\",\n          \"bone histomorphometry\",\n          \"brightfield microscopy\",\n          \"cAMP-Glo Max Assay\",\n          \"calcium retention capacity assay\",\n          \"cell competition\",\n          \"cell count\",\n          \"cell painting\",\n          \"cell proliferation\",\n          \"cell viability assay\",\n          \"clinical data\",\n          \"cNF-Skindex\",\n          \"cognitive assessment\",\n          \"combination library screen\",\n          \"combination screen\",\n          \"complex II enzyme activity assay\",\n          \"compound screen\",\n          \"contextual conditioning behavior assay\",\n          \"conventional MRI\",\n          \"Children's Dermatology Life Quality Index Questionnaire\",\n          \"differential scanning calorimetry\",\n          \"dynamic light scattering\",\n          \"electrochemiluminescence\",\n          \"electrophoretic light scattering\",\n          \"elevated plus maze test\",\n          \"FACE-Q Appearance-related Distress\",\n          \"flow cytometry\",\n          \"focus forming assay\",\n          \"functional MRI\",\n          \"gait measurement\",\n          \"gel filtration chromatography\",\n          \"gel permeation chromatography\",\n          \"genotyping\",\n          \"high content screen\",\n          \"high frequency ultrasound\",\n          \"high-performance liquid chromatography/tandem mass spectrometry\",\n          \"immunoassay\",\n          \"immunocytochemistry\",\n          \"immunofluorescence\",\n          \"immunohistochemistry\",\n          \"in silico synthesis\",\n          \"in vitro tumorigenesis\",\n          \"in vivo PDX viability\",\n          \"in vivo bioluminescence\",\n          \"in vivo tumor growth\",\n          \"jumping library\",\n          \"label free mass spectrometry\",\n          \"laser speckle imaging\",\n          \"light scattering assay\",\n          \"liquid chromatography-electrochemical detection\",\n          \"liquid chromatography/mass spectrometry\",\n          \"liquid chromatography/tandem mass spectrometry\",\n          \"lncRNA-seq\",\n          \"local field potential recording\",\n          \"long term potentiation assay\",\n          \"mRNA counts\",\n          \"magnetic resonance angiography\",\n          \"magnetic resonance spectroscopy\",\n          \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n          \"mass spectrometry\",\n          \"massively parallel reporter assay\",\n          \"metabolic screening\",\n          \"methylation array\",\n          \"miRNA array\",\n          \"miRNA-seq\",\n          \"microrheology\",\n          \"Skindex-16\",\n          \"multi-electrode array\",\n          \"nanoparticle tracking analysis\",\n          \"NanoString nCounter Analysis System\",\n          \"n-back task\",\n          \"neuropsychological assessment\",\n          \"next generation targeted sequencing\",\n          \"novelty response behavior assay\",\n          \"open field test\",\n          \"optical tomography\",\n          \"optical coherence tomography\",\n          \"optokinetic reflex assay\",\n          \"oscillatory rheology\",\n          \"oxBS-seq\",\n          \"oxygen consumption assay\",\n          \"pattern electroretinogram\",\n          \"perineurial cell thickness\",\n          \"pharmocokinetic ADME assay\",\n          \"phase-contrast microscopy\",\n          \"photograph\",\n          \"polymerase chain reaction\",\n          \"polysomnography\",\n          \"positron emission tomography\",\n          \"PROMIS Cognitive Function\",\n          \"proximity extension assay\",\n          \"pure tone average\",\n          \"quantitative PCR\",\n          \"questionnaire\",\n          \"reactive oxygen species assay\",\n          \"reporter gene assay\",\n          \"rheometry\",\n          \"ribo-seq\",\n          \"rotarod performance test\",\n          \"sandwich ELISA\",\n          \"scCGI-seq\",\n          \"scale\",\n          \"SaferSeqS\",\n          \"single molecule drug screen assay\",\n          \"single-cell RNA-seq\",\n          \"single cell ATAC-seq\",\n          \"single-nucleus RNA-seq\",\n          \"small molecule library screen\",\n          \"sorbitol dehydrogenase activity level assay\",\n          \"spatial frequency domain imaging\",\n          \"spatial transcriptomics\",\n          \"static histomorphometry\",\n          \"static light scattering\",\n          \"survival\",\n          \"targeted exome sequencing\",\n          \"traction force microscopy\",\n          \"transcranial doppler ultrasonography\",\n          \"twin spot assay\",\n          \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n          \"western blot\",\n          \"whole exome sequencing\",\n          \"whole genome sequencing\",\n          \"whole-cell patch clamp\",\n          \"word recognition score\",\n          \"STR profile\"\n        ],\n        \"type\": \"string\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn4984604\n\n${image?fileName=CTF Synodos Data Site Headers2%2Ejpg&align=Center&scale=100&responsive=true}\n#The CTF Biobank\nIn 2013, CTF began a neurofibromatosis biobank to collect NF samples to better study the disease. With all samples being collected under the same protocol, the biobank enables comprehensive analysis of diverse NF samples.\n---\n##Cutaneous Neurofibromas\nTo showcase the value the biobank, **CTF** has kicked off a pilot project designed to characterize the molecular landscape of cutaneous neurofibromas (NF) that grow in NF1 patients, sponsored by the Children's Tumor Foundation. This project includes high-throughput data from 11 different patient tumors and matched blood samples.  These data are then compared with one another to assess the distinct landscape of cutaneous NF for each patient.  A manuscript describing this resource can be found [here](https://www.nature.com/articles/sdata201745)\n---\n\nThe project represents a collaborative effort between physicians, scientists and CTF to collect high-quality data from a diverse panel of cutaneous neurofibromas.\n${image?fileName=newFig1%2Epng&align=Center&responsive=true}\n---\n##Data Release\nThe data can be downloaded directly from Synapse.  For details on how to get access to the data, navigate to the [data access wiki page](https://www.synapse.org/#!Synapse:syn4984604/wiki/400545). \n\n## Tables for Curation\n1. ID: syn64954691\nName: Immunohistochemistry\nSummary:\n- Assays: ?\n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: Neurofibromatosis type 1\n- Tumor types present: ?\n- Data types: ?\n- File formats present: txt\n- Funders: CTF\n- Contains data created by: Robert Allaway\n- Example files present: Carroll_cNF_IHC.txt\n\n\n\n2. ID: syn52128513\nName: NFOSI to process 2023-07-21\nSummary:\n- Assays: ?\n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: ?\n- File formats present: ?\n- Funders: ?\n- Contains data created by: Thomas Yu\n- Example files present: C6E8YANXX_s8_1_GSLv3-7_02_SL106285.fastq.gz, C6E8YANXX_s8_1_GSLv3-7_01_SL106284.fastq.gz, C6E8YANXX_s8_1_GSLv3-7_03_SL106286.fastq.gz, C6E8YANXX_s8_1_GSLv3-7_04_SL106287.fastq.gz, C6E8YANXX_s8_1_GSLv3-7_05_SL106288.fastq.gz\n\n\n\n3. ID: syn64954692\nName: Proteomics\nSummary:\n- Assays: MudPIT\n- Species: Homo sapiens\n- Individual count: 11\n- Specimen count: 40\n- Diagnoses present: Neurofibromatosis type 1\n- Tumor types present: Cutaneous Neurofibroma\n- Data types: proteomics\n- File formats present: txt, raw, msf\n- Funders: CTF\n- Contains data created by: Sara Gosline,  \n- Example files present: dermalNF_proteomics_sample_EMPTY_Normalized_P_SC__NP_SC_.txt, dermalNF_proteomics_sample_X45_Normalized_P_SC__NP_SC_.txt, dermalNF_proteomics_sample_X47_Normalized_P_SC__NP_SC_.txt, dermalNF_proteomics_sample_X49_Normalized_P_SC__NP_SC_.txt, dermalNF_proteomics_sample_X51_Normalized_P_SC__NP_SC_.txt\n\n\n\n4. ID: syn64954693\nName: RNA-Seq\nSummary:\n- Assays: RNA-seq, \n- Species: Homo sapiens, \n- Individual count: 44\n- Specimen count: 33\n- Diagnoses present: Neurofibromatosis type 1\n- Tumor types present: Cutaneous Neurofibroma, \n- Data types: geneExpression, \n- File formats present: bam, bai, txt, gtf, png, tsv, fastq, sf\n- Funders: CTF\n- Contains data created by: Thomas Yu, Sara Gosline, Robert Allaway\n- Example files present: accepted_hits_SL106284.bam, accepted_hits_SL106284.bam.bai, accepted_hits_SL106285.bam, accepted_hits_SL106285.bam.bai, accepted_hits_SL106286.bam\n\n\n\n5. ID: syn40134517\nName: Raw cNF RNAseq Files\nSummary:\n- Assays: RNA-seq\n- Species: Homo sapiens\n- Individual count: 11\n- Specimen count: 33\n- Diagnoses present: Neurofibromatosis type 1\n- Tumor types present: Cutaneous Neurofibroma\n- Data types: geneExpression\n- File formats present: fastq\n- Funders: CTF\n- Contains data created by: ?\n- Example files present: SL106284_1.fastq.gz, SL106284_2.fastq.gz, SL106285_1.fastq.gz, SL106285_2.fastq.gz, SL106286_1.fastq.gz\n\n\n\n6. ID: syn63126358\nName: Raw cNF RNAseq Files (unmerged)\nSummary:\n- Assays: RNA-seq\n- Species: Homo sapiens\n- Individual count: 11\n- Specimen count: 33\n- Diagnoses present: Neurofibromatosis type 1\n- Tumor types present: Cutaneous Neurofibroma\n- Data types: geneExpression\n- File formats present: fastq\n- Funders: CTF\n- Contains data created by: ?\n- Example files present: C6E8YANXX_s8_1_GSLv3-7_02_SL106285.fastq.gz, C6E8YANXX_s8_1_GSLv3-7_01_SL106284.fastq.gz, C6E8YANXX_s8_1_GSLv3-7_03_SL106286.fastq.gz, C6E8YANXX_s8_1_GSLv3-7_04_SL106287.fastq.gz, C6E8YANXX_s8_1_GSLv3-7_05_SL106288.fastq.gz\n\n\n\n7. ID: syn64954694\nName: SNP\nSummary:\n- Assays: SNP array\n- Species: Homo sapiens\n- Individual count: 11\n- Specimen count: 48\n- Diagnoses present: Neurofibromatosis type 1\n- Tumor types present: , Cutaneous Neurofibroma\n- Data types: genomicVariants\n- File formats present: txt, csv\n- Funders: CTF\n- Contains data created by: Sara Gosline\n- Example files present: 3096-PBK_FinalReport.txt, 3096-PBK-0047_Final.csv, 3096-PBK-0049_Final.csv, 3096-PBK-0051_Final.csv, 3096-PBK-0053_Final.csv\n\n\n\n8. ID: syn64954695\nName: Sample Information\nSummary:\n- Assays: whole genome sequencing, RNA-seq, , MudPIT, questionnaire, SNP array\n- Species: Homo sapiens\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: Neurofibromatosis type 1\n- Tumor types present: , Cutaneous Neurofibroma\n- Data types: genomicVariants,proteomics, geneExpression, , proteomics, clinical, geneExpression,genomicVariants, genomicVariants\n- File formats present: txt, pdf, doc, csv\n- Funders: CTF\n- Contains data created by: Sara Gosline\n- Example files present: Sample manifest_DNA_Protein_experiments.txt, Sample manifest_RNA-seq.txt, CTF CRF version 1 0 Final 04June2013.pdf, NF_Methods_Proteomics.docx, dermalNFPatientData.txt\n\n\n\n9. ID: syn64954696\nName: WGS\nSummary:\n- Assays: whole genome sequencing\n- Species: Homo sapiens\n- Individual count: 15\n- Specimen count: 62\n- Diagnoses present: Neurofibromatosis type 1\n- Tumor types present: Cutaneous Neurofibroma, \n- Data types: genomicVariants\n- File formats present: vcf, maf, bam\n- Funders: CTF\n- Contains data created by: Thomas Yu, Sara Gosline\n- Example files present: SL102344.vcf, SL102345.vcf, SL102346.vcf, SL102347.vcf, SL102348.vcf\n\n\n\n10. ID: syn62667549\nName: cNF RNA-seq quantification files (salmon)\nSummary:\n- Assays: \n- Species: \n- Individual count: 0\n- Specimen count: ?\n- Diagnoses present: \n- Tumor types present: \n- Data types: \n- File formats present: \n- Funders: CTF\n- Contains data created by: ?\n- Example files present: quant.sf, quant.genes.sf, quant.genes.sf, quant.sf, quant.genes.sf\n\n\n"}]}]}{"system_instruction":{"parts":[{"text":"You are Syndi, a highly competent and helpful data assistant."}]},"contents":[{"parts":[{"text":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Default is the project PI and/or the user who created all files/records.\",\n        \"title\": \"Creator\",\n        \"type\": \"string\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate original data, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"title\": \"Measurement Technique\",\n        \"enum\": [\n          \"2D AlamarBlue absorbance\",\n          \"2D AlamarBlue fluorescence\",\n          \"3D confocal imaging\",\n          \"3D electron microscopy\",\n          \"3D imaging\",\n          \"3D microtissue viability\",\n          \"actigraphy\",\n          \"AlgometRx Nociometer\",\n          \"auditory brainstem response\",\n          \"ATAC-seq\",\n          \"ATPase activity assay\",\n          \"BrdU proliferation assay\",\n          \"CAPP-seq\",\n          \"CUT&RUN\",\n          \"ChIP-seq\",\n          \"Child Behavior Checklist for Ages 1.5-5\",\n          \"Child Behavior Checklist for Ages 6-18\",\n          \"CODEX\",\n          \"confocal microscopy\",\n          \"Corsi blocks\",\n          \"current clamp assay\",\n          \"diffusion MRI\",\n          \"distortion product otoacoustic emissions\",\n          \"DNA optical mapping\",\n          \"ELISA\",\n          \"ERR bisulfite sequencing\",\n          \"EdU proliferation assay\",\n          \"FIA-MSMS\",\n          \"FLIPR high-throughput cellular screening\",\n          \"Fluorescence In Situ Hybridization\",\n          \"Focus group\",\n          \"FTIR spectroscopy\",\n          \"HI-C\",\n          \"HPLC\",\n          \"Interview\",\n          \"ISO-seq\",\n          \"MIB/MS\",\n          \"Matrigel-based tumorigenesis assay\",\n          \"MudPIT\",\n          \"Migration Assay\",\n          \"NIH Toolbox\",\n          \"NOMe-seq\",\n          \"RNA array\",\n          \"RNA-seq\",\n          \"RPPA\",\n          \"Riccardi and Ablon scales\",\n          \"SNP array\",\n          \"SUSHI\",\n          \"Sanger sequencing\",\n          \"Social Responsiveness Scale\",\n          \"Social Responsiveness Scale, Second Edition\",\n          \"T cell receptor repertoire sequencing\",\n          \"TIDE\",\n          \"TMT quantitation\",\n          \"TriKinetics activity monitoring\",\n          \"Von Frey test\",\n          \"active avoidance learning behavior assay\",\n          \"array\",\n          \"atomic force microscopy\",\n          \"autoradiography\",\n          \"bisulfite sequencing\",\n          \"blood chemistry measurement\",\n          \"blue native PAGE\",\n          \"body size trait measurement\",\n          \"bone histomorphometry\",\n          \"brightfield microscopy\",\n          \"cAMP-Glo Max Assay\",\n          \"calcium retention capacity assay\",\n          \"cell competition\",\n          \"cell count\",\n          \"cell painting\",\n          \"cell proliferation\",\n          \"cell viability assay\",\n          \"clinical data\",\n          \"cNF-Skindex\",\n          \"cognitive assessment\",\n          \"combination library screen\",\n          \"combination screen\",\n          \"complex II enzyme activity assay\",\n          \"compound screen\",\n          \"contextual conditioning behavior assay\",\n          \"conventional MRI\",\n          \"Children's Dermatology Life Quality Index Questionnaire\",\n          \"differential scanning calorimetry\",\n          \"dynamic light scattering\",\n          \"electrochemiluminescence\",\n          \"electrophoretic light scattering\",\n          \"elevated plus maze test\",\n          \"FACE-Q Appearance-related Distress\",\n          \"flow cytometry\",\n          \"focus forming assay\",\n          \"functional MRI\",\n          \"gait measurement\",\n          \"gel filtration chromatography\",\n          \"gel permeation chromatography\",\n          \"genotyping\",\n          \"high content screen\",\n          \"high frequency ultrasound\",\n          \"high-performance liquid chromatography/tandem mass spectrometry\",\n          \"immunoassay\",\n          \"immunocytochemistry\",\n          \"immunofluorescence\",\n          \"immunohistochemistry\",\n          \"in silico synthesis\",\n          \"in vitro tumorigenesis\",\n          \"in vivo PDX viability\",\n          \"in vivo bioluminescence\",\n          \"in vivo tumor growth\",\n          \"jumping library\",\n          \"label free mass spectrometry\",\n          \"laser speckle imaging\",\n          \"light scattering assay\",\n          \"liquid chromatography-electrochemical detection\",\n          \"liquid chromatography/mass spectrometry\",\n          \"liquid chromatography/tandem mass spectrometry\",\n          \"lncRNA-seq\",\n          \"local field potential recording\",\n          \"long term potentiation assay\",\n          \"mRNA counts\",\n          \"magnetic resonance angiography\",\n          \"magnetic resonance spectroscopy\",\n          \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n          \"mass spectrometry\",\n          \"massively parallel reporter assay\",\n          \"metabolic screening\",\n          \"methylation array\",\n          \"miRNA array\",\n          \"miRNA-seq\",\n          \"microrheology\",\n          \"Skindex-16\",\n          \"multi-electrode array\",\n          \"nanoparticle tracking analysis\",\n          \"NanoString nCounter Analysis System\",\n          \"n-back task\",\n          \"neuropsychological assessment\",\n          \"next generation targeted sequencing\",\n          \"novelty response behavior assay\",\n          \"open field test\",\n          \"optical tomography\",\n          \"optical coherence tomography\",\n          \"optokinetic reflex assay\",\n          \"oscillatory rheology\",\n          \"oxBS-seq\",\n          \"oxygen consumption assay\",\n          \"pattern electroretinogram\",\n          \"perineurial cell thickness\",\n          \"pharmocokinetic ADME assay\",\n          \"phase-contrast microscopy\",\n          \"photograph\",\n          \"polymerase chain reaction\",\n          \"polysomnography\",\n          \"positron emission tomography\",\n          \"PROMIS Cognitive Function\",\n          \"proximity extension assay\",\n          \"pure tone average\",\n          \"quantitative PCR\",\n          \"questionnaire\",\n          \"reactive oxygen species assay\",\n          \"reporter gene assay\",\n          \"rheometry\",\n          \"ribo-seq\",\n          \"rotarod performance test\",\n          \"sandwich ELISA\",\n          \"scCGI-seq\",\n          \"scale\",\n          \"SaferSeqS\",\n          \"single molecule drug screen assay\",\n          \"single-cell RNA-seq\",\n          \"single cell ATAC-seq\",\n          \"single-nucleus RNA-seq\",\n          \"small molecule library screen\",\n          \"sorbitol dehydrogenase activity level assay\",\n          \"spatial frequency domain imaging\",\n          \"spatial transcriptomics\",\n          \"static histomorphometry\",\n          \"static light scattering\",\n          \"survival\",\n          \"targeted exome sequencing\",\n          \"traction force microscopy\",\n          \"transcranial doppler ultrasonography\",\n          \"twin spot assay\",\n          \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n          \"western blot\",\n          \"whole exome sequencing\",\n          \"whole genome sequencing\",\n          \"whole-cell patch clamp\",\n          \"word recognition score\",\n          \"STR profile\"\n        ],\n        \"type\": \"string\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn6633069\n\n${image?fileName=CTF Synodos Data Site Headers%2Ejpg&align=Center&scale=100&responsive=true}\n###**Welcome to the Columbia University NF1 Glioma Project**\n\nThis site is the central place for all data from the NF1 Glioma grant awarded by CTF to Dr. Antonio Iavarone at Columbia University. The wiki area and specific folders can be accessed by all members of the group from the menu on the left.\n\n->${buttonlink?text=Back to NF Data Portal&url=https://nf.synapse.org/}<-\n\n\n\n\n## Tables for Curation\n1. ID: syn51915976\nName: Copy Number Variation from the Columbia University NF1 Glioma Project\nSummary:\n- Assays: whole exome sequencing\n- Species: Homo sapiens\n- Individual count: 56\n- Specimen count: 59\n- Diagnoses present: Neurofibromatosis type 1\n- Tumor types present: Low-Grade Glioma NOS, High-Grade Glioma NOS\n- Data types: genomicVariants\n- File formats present: txt\n- Funders: CTF\n- Contains data created by: Fulvio D'Angelo\n- Example files present: AI_DT_10.seg.txt.gz, AI_DT_11.seg.txt.gz, AI_DT_12.seg.txt.gz, AI_DT_13.seg.txt.gz, AI_DT_16.seg.txt.gz\n\n\n\n2. ID: syn64954697\nName: CopyNumberVariation\nSummary:\n- Assays: whole exome sequencing\n- Species: Homo sapiens\n- Individual count: 56\n- Specimen count: 59\n- Diagnoses present: Neurofibromatosis type 1\n- Tumor types present: Low-Grade Glioma NOS, High-Grade Glioma NOS\n- Data types: genomicVariants\n- File formats present: txt\n- Funders: CTF\n- Contains data created by: Fulvio D'Angelo\n- Example files present: AI_DT_10.seg.txt.gz, AI_DT_11.seg.txt.gz, AI_DT_12.seg.txt.gz, AI_DT_13.seg.txt.gz, AI_DT_16.seg.txt.gz\n\n\n\n3. ID: syn64954698\nName: GeneExpression\nSummary:\n- Assays: RNA-seq\n- Species: Homo sapiens\n- Individual count: 29\n- Specimen count: 32\n- Diagnoses present: Neurofibromatosis type 1\n- Tumor types present: Low-Grade Glioma NOS, High-Grade Glioma NOS\n- Data types: geneExpression\n- File formats present: txt\n- Funders: CTF\n- Contains data created by: Fulvio D'Angelo\n- Example files present: AI_RT_10.counts.txt.gz, AI_RT_11.counts.txt.gz, AI_RT_12.counts.txt.gz, AI_RT_15.counts.txt.gz, AI_RT_16.counts.txt.gz\n\n\n\n4. ID: syn64954699\nName: Methylation\nSummary:\n- Assays: methylation array\n- Species: Homo sapiens\n- Individual count: 31\n- Specimen count: 31\n- Diagnoses present: Neurofibromatosis type 1\n- Tumor types present: Low-Grade Glioma NOS, High-Grade Glioma NOS\n- Data types: chromatinActivity\n- File formats present: gz, txt\n- Funders: CTF\n- Contains data created by: Fulvio D'Angelo\n- Example files present: AI_DT_10.beta.txt.gz, AI_DT_11.beta.txt.gz, AI_DT_12.beta.txt.gz, AI_DT_13.beta.txt.gz, AI_DT_16.beta.txt.gz\n\n\n\n5. ID: syn64954700\nName: NucleotideVariation\nSummary:\n- Assays: whole exome sequencing\n- Species: Homo sapiens\n- Individual count: 56\n- Specimen count: 102\n- Diagnoses present: Neurofibromatosis type 1\n- Tumor types present: High-Grade Glioma NOS, Low-Grade Glioma NOS\n- Data types: genomicVariants\n- File formats present: txt\n- Funders: CTF\n- Contains data created by: Fulvio D'Angelo\n- Example files present: AI_DN_43.variants.txt.gz, AI_DN_44.variants.txt.gz, AI_DN_45.variants.txt.gz, AI_DN_46.variants.txt.gz, AI_DN_47.variants.txt.gz\n\n\n\n6. ID: syn64954701\nName: WholeGenomeVariants\nSummary:\n- Assays: whole genome sequencing\n- Species: Homo sapiens\n- Individual count: 11\n- Specimen count: 22\n- Diagnoses present: Neurofibromatosis type 1\n- Tumor types present: Low-Grade Glioma NOS, High-Grade Glioma NOS\n- Data types: genomicVariants\n- File formats present: vcf\n- Funders: CTF\n- Contains data created by: Fulvio D'Angelo\n- Example files present: A1.indel.vcf.gz, H1.snp.vcf.gz, G4.snp.vcf.gz, G1.snp.vcf.gz, F1.snp.vcf.gz\n\n\n"}]}]}{"system_instruction":{"parts":[{"text":"You are Syndi, a highly competent and helpful data assistant."}]},"contents":[{"parts":[{"text":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Default is the project PI and/or the user who created all files/records.\",\n        \"title\": \"Creator\",\n        \"type\": \"string\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate original data, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"title\": \"Measurement Technique\",\n        \"enum\": [\n          \"2D AlamarBlue absorbance\",\n          \"2D AlamarBlue fluorescence\",\n          \"3D confocal imaging\",\n          \"3D electron microscopy\",\n          \"3D imaging\",\n          \"3D microtissue viability\",\n          \"actigraphy\",\n          \"AlgometRx Nociometer\",\n          \"auditory brainstem response\",\n          \"ATAC-seq\",\n          \"ATPase activity assay\",\n          \"BrdU proliferation assay\",\n          \"CAPP-seq\",\n          \"CUT&RUN\",\n          \"ChIP-seq\",\n          \"Child Behavior Checklist for Ages 1.5-5\",\n          \"Child Behavior Checklist for Ages 6-18\",\n          \"CODEX\",\n          \"confocal microscopy\",\n          \"Corsi blocks\",\n          \"current clamp assay\",\n          \"diffusion MRI\",\n          \"distortion product otoacoustic emissions\",\n          \"DNA optical mapping\",\n          \"ELISA\",\n          \"ERR bisulfite sequencing\",\n          \"EdU proliferation assay\",\n          \"FIA-MSMS\",\n          \"FLIPR high-throughput cellular screening\",\n          \"Fluorescence In Situ Hybridization\",\n          \"Focus group\",\n          \"FTIR spectroscopy\",\n          \"HI-C\",\n          \"HPLC\",\n          \"Interview\",\n          \"ISO-seq\",\n          \"MIB/MS\",\n          \"Matrigel-based tumorigenesis assay\",\n          \"MudPIT\",\n          \"Migration Assay\",\n          \"NIH Toolbox\",\n          \"NOMe-seq\",\n          \"RNA array\",\n          \"RNA-seq\",\n          \"RPPA\",\n          \"Riccardi and Ablon scales\",\n          \"SNP array\",\n          \"SUSHI\",\n          \"Sanger sequencing\",\n          \"Social Responsiveness Scale\",\n          \"Social Responsiveness Scale, Second Edition\",\n          \"T cell receptor repertoire sequencing\",\n          \"TIDE\",\n          \"TMT quantitation\",\n          \"TriKinetics activity monitoring\",\n          \"Von Frey test\",\n          \"active avoidance learning behavior assay\",\n          \"array\",\n          \"atomic force microscopy\",\n          \"autoradiography\",\n          \"bisulfite sequencing\",\n          \"blood chemistry measurement\",\n          \"blue native PAGE\",\n          \"body size trait measurement\",\n          \"bone histomorphometry\",\n          \"brightfield microscopy\",\n          \"cAMP-Glo Max Assay\",\n          \"calcium retention capacity assay\",\n          \"cell competition\",\n          \"cell count\",\n          \"cell painting\",\n          \"cell proliferation\",\n          \"cell viability assay\",\n          \"clinical data\",\n          \"cNF-Skindex\",\n          \"cognitive assessment\",\n          \"combination library screen\",\n          \"combination screen\",\n          \"complex II enzyme activity assay\",\n          \"compound screen\",\n          \"contextual conditioning behavior assay\",\n          \"conventional MRI\",\n          \"Children's Dermatology Life Quality Index Questionnaire\",\n          \"differential scanning calorimetry\",\n          \"dynamic light scattering\",\n          \"electrochemiluminescence\",\n          \"electrophoretic light scattering\",\n          \"elevated plus maze test\",\n          \"FACE-Q Appearance-related Distress\",\n          \"flow cytometry\",\n          \"focus forming assay\",\n          \"functional MRI\",\n          \"gait measurement\",\n          \"gel filtration chromatography\",\n          \"gel permeation chromatography\",\n          \"genotyping\",\n          \"high content screen\",\n          \"high frequency ultrasound\",\n          \"high-performance liquid chromatography/tandem mass spectrometry\",\n          \"immunoassay\",\n          \"immunocytochemistry\",\n          \"immunofluorescence\",\n          \"immunohistochemistry\",\n          \"in silico synthesis\",\n          \"in vitro tumorigenesis\",\n          \"in vivo PDX viability\",\n          \"in vivo bioluminescence\",\n          \"in vivo tumor growth\",\n          \"jumping library\",\n          \"label free mass spectrometry\",\n          \"laser speckle imaging\",\n          \"light scattering assay\",\n          \"liquid chromatography-electrochemical detection\",\n          \"liquid chromatography/mass spectrometry\",\n          \"liquid chromatography/tandem mass spectrometry\",\n          \"lncRNA-seq\",\n          \"local field potential recording\",\n          \"long term potentiation assay\",\n          \"mRNA counts\",\n          \"magnetic resonance angiography\",\n          \"magnetic resonance spectroscopy\",\n          \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n          \"mass spectrometry\",\n          \"massively parallel reporter assay\",\n          \"metabolic screening\",\n          \"methylation array\",\n          \"miRNA array\",\n          \"miRNA-seq\",\n          \"microrheology\",\n          \"Skindex-16\",\n          \"multi-electrode array\",\n          \"nanoparticle tracking analysis\",\n          \"NanoString nCounter Analysis System\",\n          \"n-back task\",\n          \"neuropsychological assessment\",\n          \"next generation targeted sequencing\",\n          \"novelty response behavior assay\",\n          \"open field test\",\n          \"optical tomography\",\n          \"optical coherence tomography\",\n          \"optokinetic reflex assay\",\n          \"oscillatory rheology\",\n          \"oxBS-seq\",\n          \"oxygen consumption assay\",\n          \"pattern electroretinogram\",\n          \"perineurial cell thickness\",\n          \"pharmocokinetic ADME assay\",\n          \"phase-contrast microscopy\",\n          \"photograph\",\n          \"polymerase chain reaction\",\n          \"polysomnography\",\n          \"positron emission tomography\",\n          \"PROMIS Cognitive Function\",\n          \"proximity extension assay\",\n          \"pure tone average\",\n          \"quantitative PCR\",\n          \"questionnaire\",\n          \"reactive oxygen species assay\",\n          \"reporter gene assay\",\n          \"rheometry\",\n          \"ribo-seq\",\n          \"rotarod performance test\",\n          \"sandwich ELISA\",\n          \"scCGI-seq\",\n          \"scale\",\n          \"SaferSeqS\",\n          \"single molecule drug screen assay\",\n          \"single-cell RNA-seq\",\n          \"single cell ATAC-seq\",\n          \"single-nucleus RNA-seq\",\n          \"small molecule library screen\",\n          \"sorbitol dehydrogenase activity level assay\",\n          \"spatial frequency domain imaging\",\n          \"spatial transcriptomics\",\n          \"static histomorphometry\",\n          \"static light scattering\",\n          \"survival\",\n          \"targeted exome sequencing\",\n          \"traction force microscopy\",\n          \"transcranial doppler ultrasonography\",\n          \"twin spot assay\",\n          \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n          \"western blot\",\n          \"whole exome sequencing\",\n          \"whole genome sequencing\",\n          \"whole-cell patch clamp\",\n          \"word recognition score\",\n          \"STR profile\"\n        ],\n        \"type\": \"string\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn26347297\n\n# The effects of RAS signaling pathway inhibitors on tumor cells and the tumor immune microenvironment in malignant peripheral nerve sheath tumors\n## CTF Young Investigator Award\n\n### Principal Investigator: Lindy Zhang\n### Project Lead / Data Coordinator: Lindy Zhang, Christine Pratilas, Nicolas Llosa\n### Institution: Johns Hopkins University\n\n### Project Description: \nNF1-associated MPNSTs are resistant to MEK inhibition monotherapy because of activation of alternate cancer signaling pathways. This study will test combinations of MEK inhibitors, SHP2 inhibitors, and CDK inhibitors, which target different signaling pathways, to treat MPNSTs. Additionally, we will also investigate the role of the tumor microenvironment and the impact of various inhibitors on immune cells to design trials of immunotherapy drugs plus targeted drugs for MPNST.\n\n## Tables for Curation\n1. ID: syn64954915\nName: Flow Cytometry\nSummary:\n- Assays: ?\n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: ?\n- File formats present: ?\n- Funders: CTF\n- Contains data created by: Lindy Zhang\n- Example files present: Human PNST_FACS data.xlsx\n\n\n\n2. ID: syn64954916\nName: Immunohistochemistry\nSummary:\n- Assays: ?\n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: ?\n- File formats present: ?\n- Funders: CTF\n- Contains data created by: Lindy Zhang\n- Example files present: Human PNST_IHC data.xlsx\n\n\n"}]}]}{"system_instruction":{"parts":[{"text":"You are Syndi, a highly competent and helpful data assistant."}]},"contents":[{"parts":[{"text":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Default is the project PI and/or the user who created all files/records.\",\n        \"title\": \"Creator\",\n        \"type\": \"string\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate original data, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"title\": \"Measurement Technique\",\n        \"enum\": [\n          \"2D AlamarBlue absorbance\",\n          \"2D AlamarBlue fluorescence\",\n          \"3D confocal imaging\",\n          \"3D electron microscopy\",\n          \"3D imaging\",\n          \"3D microtissue viability\",\n          \"actigraphy\",\n          \"AlgometRx Nociometer\",\n          \"auditory brainstem response\",\n          \"ATAC-seq\",\n          \"ATPase activity assay\",\n          \"BrdU proliferation assay\",\n          \"CAPP-seq\",\n          \"CUT&RUN\",\n          \"ChIP-seq\",\n          \"Child Behavior Checklist for Ages 1.5-5\",\n          \"Child Behavior Checklist for Ages 6-18\",\n          \"CODEX\",\n          \"confocal microscopy\",\n          \"Corsi blocks\",\n          \"current clamp assay\",\n          \"diffusion MRI\",\n          \"distortion product otoacoustic emissions\",\n          \"DNA optical mapping\",\n          \"ELISA\",\n          \"ERR bisulfite sequencing\",\n          \"EdU proliferation assay\",\n          \"FIA-MSMS\",\n          \"FLIPR high-throughput cellular screening\",\n          \"Fluorescence In Situ Hybridization\",\n          \"Focus group\",\n          \"FTIR spectroscopy\",\n          \"HI-C\",\n          \"HPLC\",\n          \"Interview\",\n          \"ISO-seq\",\n          \"MIB/MS\",\n          \"Matrigel-based tumorigenesis assay\",\n          \"MudPIT\",\n          \"Migration Assay\",\n          \"NIH Toolbox\",\n          \"NOMe-seq\",\n          \"RNA array\",\n          \"RNA-seq\",\n          \"RPPA\",\n          \"Riccardi and Ablon scales\",\n          \"SNP array\",\n          \"SUSHI\",\n          \"Sanger sequencing\",\n          \"Social Responsiveness Scale\",\n          \"Social Responsiveness Scale, Second Edition\",\n          \"T cell receptor repertoire sequencing\",\n          \"TIDE\",\n          \"TMT quantitation\",\n          \"TriKinetics activity monitoring\",\n          \"Von Frey test\",\n          \"active avoidance learning behavior assay\",\n          \"array\",\n          \"atomic force microscopy\",\n          \"autoradiography\",\n          \"bisulfite sequencing\",\n          \"blood chemistry measurement\",\n          \"blue native PAGE\",\n          \"body size trait measurement\",\n          \"bone histomorphometry\",\n          \"brightfield microscopy\",\n          \"cAMP-Glo Max Assay\",\n          \"calcium retention capacity assay\",\n          \"cell competition\",\n          \"cell count\",\n          \"cell painting\",\n          \"cell proliferation\",\n          \"cell viability assay\",\n          \"clinical data\",\n          \"cNF-Skindex\",\n          \"cognitive assessment\",\n          \"combination library screen\",\n          \"combination screen\",\n          \"complex II enzyme activity assay\",\n          \"compound screen\",\n          \"contextual conditioning behavior assay\",\n          \"conventional MRI\",\n          \"Children's Dermatology Life Quality Index Questionnaire\",\n          \"differential scanning calorimetry\",\n          \"dynamic light scattering\",\n          \"electrochemiluminescence\",\n          \"electrophoretic light scattering\",\n          \"elevated plus maze test\",\n          \"FACE-Q Appearance-related Distress\",\n          \"flow cytometry\",\n          \"focus forming assay\",\n          \"functional MRI\",\n          \"gait measurement\",\n          \"gel filtration chromatography\",\n          \"gel permeation chromatography\",\n          \"genotyping\",\n          \"high content screen\",\n          \"high frequency ultrasound\",\n          \"high-performance liquid chromatography/tandem mass spectrometry\",\n          \"immunoassay\",\n          \"immunocytochemistry\",\n          \"immunofluorescence\",\n          \"immunohistochemistry\",\n          \"in silico synthesis\",\n          \"in vitro tumorigenesis\",\n          \"in vivo PDX viability\",\n          \"in vivo bioluminescence\",\n          \"in vivo tumor growth\",\n          \"jumping library\",\n          \"label free mass spectrometry\",\n          \"laser speckle imaging\",\n          \"light scattering assay\",\n          \"liquid chromatography-electrochemical detection\",\n          \"liquid chromatography/mass spectrometry\",\n          \"liquid chromatography/tandem mass spectrometry\",\n          \"lncRNA-seq\",\n          \"local field potential recording\",\n          \"long term potentiation assay\",\n          \"mRNA counts\",\n          \"magnetic resonance angiography\",\n          \"magnetic resonance spectroscopy\",\n          \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n          \"mass spectrometry\",\n          \"massively parallel reporter assay\",\n          \"metabolic screening\",\n          \"methylation array\",\n          \"miRNA array\",\n          \"miRNA-seq\",\n          \"microrheology\",\n          \"Skindex-16\",\n          \"multi-electrode array\",\n          \"nanoparticle tracking analysis\",\n          \"NanoString nCounter Analysis System\",\n          \"n-back task\",\n          \"neuropsychological assessment\",\n          \"next generation targeted sequencing\",\n          \"novelty response behavior assay\",\n          \"open field test\",\n          \"optical tomography\",\n          \"optical coherence tomography\",\n          \"optokinetic reflex assay\",\n          \"oscillatory rheology\",\n          \"oxBS-seq\",\n          \"oxygen consumption assay\",\n          \"pattern electroretinogram\",\n          \"perineurial cell thickness\",\n          \"pharmocokinetic ADME assay\",\n          \"phase-contrast microscopy\",\n          \"photograph\",\n          \"polymerase chain reaction\",\n          \"polysomnography\",\n          \"positron emission tomography\",\n          \"PROMIS Cognitive Function\",\n          \"proximity extension assay\",\n          \"pure tone average\",\n          \"quantitative PCR\",\n          \"questionnaire\",\n          \"reactive oxygen species assay\",\n          \"reporter gene assay\",\n          \"rheometry\",\n          \"ribo-seq\",\n          \"rotarod performance test\",\n          \"sandwich ELISA\",\n          \"scCGI-seq\",\n          \"scale\",\n          \"SaferSeqS\",\n          \"single molecule drug screen assay\",\n          \"single-cell RNA-seq\",\n          \"single cell ATAC-seq\",\n          \"single-nucleus RNA-seq\",\n          \"small molecule library screen\",\n          \"sorbitol dehydrogenase activity level assay\",\n          \"spatial frequency domain imaging\",\n          \"spatial transcriptomics\",\n          \"static histomorphometry\",\n          \"static light scattering\",\n          \"survival\",\n          \"targeted exome sequencing\",\n          \"traction force microscopy\",\n          \"transcranial doppler ultrasonography\",\n          \"twin spot assay\",\n          \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n          \"western blot\",\n          \"whole exome sequencing\",\n          \"whole genome sequencing\",\n          \"whole-cell patch clamp\",\n          \"word recognition score\",\n          \"STR profile\"\n        ],\n        \"type\": \"string\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn11817821\n\nThe newly developed massively parallel technologies have enabled the simultaneous analysis of many pathways. There are several large scale international efforts to probe the genetics and drug sensitivity of cancer cell lines. However, there are some rare cancers that have not been analyzed in depth. One of these rare cancers is malignant peripheral nerve sheet tumors (MPNST). MPNST, although a rare cancer, are common in patients with neurofibromatosis type 1. We obtained funding from the Children’s Tumor Foundation to fill this gap, in a novel way by enlisting students in a hybrid research/education model through what is likely to be the first course in high throughput screening. In the course, students will take part in a high throughput discovery effort in two phases. \n\n###Phase 1\nPhase 1 is a training phase, which will consist of quantitative profiling the sensitivity of MPNST cell lines to a library of 130 common and experimental cancer drugs. These will be conducted in the UPenn High Throughput Screening Core with [Dr. David Schultz](http://www.med.upenn.edu/cores/High-ThroughputScreeningCore.shtml). While we call this a training phase, the data from this will be subject to rigorous quality control for eventual publication and development of a public database for rare tumors. Phase 1 will also include an introductory synthesis in the [Upenn/Merck High Throughput Experimentation Laboratory](https://www.chem.upenn.edu/facilities/penn-chemistry-high-throughput-experimentation-center).  \n\n###Phase 2\nPhase 2 is an independent research project. Examples of projects include, but are not limited to: Combinatorial screens (synthetic lethal); siRNA screens; novel compound screens; determining mechanisms of cell death; developing tools for data analysis and database development. During phase 2, students can also modify compounds of interest using the Penn Chemistry: Upenn/Merck High Throughput Experimentation Laboratory, and then retest them for activity to determine structure activity relationships. We will sponsor phase 2 projects relevant to neurofibromatosis. However, in phase 2 students can also perform experiments in other areas if they develop sponsorships from professors. We expect the course to be a hypothesis engine that generates ideas for further research.\n\n## Tables for Curation\n1. ID: syn64954768\nName: Exp008_analyzed Data\nSummary:\n- Assays: cell viability assay, immunofluorescence, \n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: drugScreen, image, \n- File formats present: excel, pzfx, jpg, txt, powerpoint, csv, pdf\n- Funders: CTF\n- Contains data created by: Jeffrey Field, yang yang\n- Example files present: Exp008_01_analysis.xlsx, Exp008_01_normalized_template.pzfx, Exp002_Analysis template_ST88-14_ATPLite_plates1-3.xlsx, Exp002_Analysis template_ST88-14_DAPI_plates4-6.xlsx, Exp002_ST88-14_ATPlite_48hr_Corrected IC50s.xlsx\n\n\n\n2. ID: syn64954770\nName: Raw Data and logs\nSummary:\n- Assays: \n- Species: \n- Individual count: ?\n- Specimen count: 27\n- Diagnoses present: [\"Neurofibromatosis type 1\"], [\"Neurofibromatosis type 2\"], , [\"Neurofibromatosis type 1\", \"Neurofibromatosis type 2\"]\n- Tumor types present: [\"Malignant Peripheral Nerve Sheath Tumor\"], [\"Schwannoma\", \"Fibrosarcoma\", \"Colorectal Carcinoma\", \"Malignant Peripheral Nerve Sheath Tumor\"], [\"NF2\"], , [\"NF1\"], [\"Colorectal Carcinoma\"], [\"NF1\", \"NF2\"]\n- Data types: drugScreen\n- File formats present: csv, excel\n- Funders: CTF\n- Contains data created by: Jeffrey Field, yang yang\n- Example files present: 259_USLUM_384_20151123.csv, 267_USLUM_384_20151204.csv, 280_US_LUM_384_20151214.csv, 321_USLUM_384_20160118.csv, 322_USLUM_384_20160118.csv\n\n\n\n3. ID: syn64954773\nName: exome sequencing\nSummary:\n- Assays: \n- Species: \n- Individual count: 13\n- Specimen count: ?\n- Diagnoses present: , Neurofibromatosis type 1, Cancer, Neurofibromatosis type 2\n- Tumor types present: , Malignant Peripheral Nerve Sheath Tumor, Schwannoma\n- Data types: , genomicVariants\n- File formats present: tsv, excel, pdf, txt, vcf, fastq, , maf\n- Funders: CTF\n- Contains data created by: Jeffrey Field, Robert Allaway\n- Example files present: 2213_JF_01_VCF_v1_c648_2016-09-20-13-21-912-2016-09-20-18-23-30699.tsv, 2213_JF_01_VCF_v1_c648_2016-09-20-13-21-912-2016-09-20-18-23-30699.xlsx, 2213_JF_01.xlsx, 2214_JF_02 nf1.xlsx, 2214_JF_02.xlsx\n\n\n"}]}]}{"system_instruction":{"parts":[{"text":"You are Syndi, a highly competent and helpful data assistant."}]},"contents":[{"parts":[{"text":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Default is the project PI and/or the user who created all files/records.\",\n        \"title\": \"Creator\",\n        \"type\": \"string\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate original data, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"title\": \"Measurement Technique\",\n        \"enum\": [\n          \"2D AlamarBlue absorbance\",\n          \"2D AlamarBlue fluorescence\",\n          \"3D confocal imaging\",\n          \"3D electron microscopy\",\n          \"3D imaging\",\n          \"3D microtissue viability\",\n          \"actigraphy\",\n          \"AlgometRx Nociometer\",\n          \"auditory brainstem response\",\n          \"ATAC-seq\",\n          \"ATPase activity assay\",\n          \"BrdU proliferation assay\",\n          \"CAPP-seq\",\n          \"CUT&RUN\",\n          \"ChIP-seq\",\n          \"Child Behavior Checklist for Ages 1.5-5\",\n          \"Child Behavior Checklist for Ages 6-18\",\n          \"CODEX\",\n          \"confocal microscopy\",\n          \"Corsi blocks\",\n          \"current clamp assay\",\n          \"diffusion MRI\",\n          \"distortion product otoacoustic emissions\",\n          \"DNA optical mapping\",\n          \"ELISA\",\n          \"ERR bisulfite sequencing\",\n          \"EdU proliferation assay\",\n          \"FIA-MSMS\",\n          \"FLIPR high-throughput cellular screening\",\n          \"Fluorescence In Situ Hybridization\",\n          \"Focus group\",\n          \"FTIR spectroscopy\",\n          \"HI-C\",\n          \"HPLC\",\n          \"Interview\",\n          \"ISO-seq\",\n          \"MIB/MS\",\n          \"Matrigel-based tumorigenesis assay\",\n          \"MudPIT\",\n          \"Migration Assay\",\n          \"NIH Toolbox\",\n          \"NOMe-seq\",\n          \"RNA array\",\n          \"RNA-seq\",\n          \"RPPA\",\n          \"Riccardi and Ablon scales\",\n          \"SNP array\",\n          \"SUSHI\",\n          \"Sanger sequencing\",\n          \"Social Responsiveness Scale\",\n          \"Social Responsiveness Scale, Second Edition\",\n          \"T cell receptor repertoire sequencing\",\n          \"TIDE\",\n          \"TMT quantitation\",\n          \"TriKinetics activity monitoring\",\n          \"Von Frey test\",\n          \"active avoidance learning behavior assay\",\n          \"array\",\n          \"atomic force microscopy\",\n          \"autoradiography\",\n          \"bisulfite sequencing\",\n          \"blood chemistry measurement\",\n          \"blue native PAGE\",\n          \"body size trait measurement\",\n          \"bone histomorphometry\",\n          \"brightfield microscopy\",\n          \"cAMP-Glo Max Assay\",\n          \"calcium retention capacity assay\",\n          \"cell competition\",\n          \"cell count\",\n          \"cell painting\",\n          \"cell proliferation\",\n          \"cell viability assay\",\n          \"clinical data\",\n          \"cNF-Skindex\",\n          \"cognitive assessment\",\n          \"combination library screen\",\n          \"combination screen\",\n          \"complex II enzyme activity assay\",\n          \"compound screen\",\n          \"contextual conditioning behavior assay\",\n          \"conventional MRI\",\n          \"Children's Dermatology Life Quality Index Questionnaire\",\n          \"differential scanning calorimetry\",\n          \"dynamic light scattering\",\n          \"electrochemiluminescence\",\n          \"electrophoretic light scattering\",\n          \"elevated plus maze test\",\n          \"FACE-Q Appearance-related Distress\",\n          \"flow cytometry\",\n          \"focus forming assay\",\n          \"functional MRI\",\n          \"gait measurement\",\n          \"gel filtration chromatography\",\n          \"gel permeation chromatography\",\n          \"genotyping\",\n          \"high content screen\",\n          \"high frequency ultrasound\",\n          \"high-performance liquid chromatography/tandem mass spectrometry\",\n          \"immunoassay\",\n          \"immunocytochemistry\",\n          \"immunofluorescence\",\n          \"immunohistochemistry\",\n          \"in silico synthesis\",\n          \"in vitro tumorigenesis\",\n          \"in vivo PDX viability\",\n          \"in vivo bioluminescence\",\n          \"in vivo tumor growth\",\n          \"jumping library\",\n          \"label free mass spectrometry\",\n          \"laser speckle imaging\",\n          \"light scattering assay\",\n          \"liquid chromatography-electrochemical detection\",\n          \"liquid chromatography/mass spectrometry\",\n          \"liquid chromatography/tandem mass spectrometry\",\n          \"lncRNA-seq\",\n          \"local field potential recording\",\n          \"long term potentiation assay\",\n          \"mRNA counts\",\n          \"magnetic resonance angiography\",\n          \"magnetic resonance spectroscopy\",\n          \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n          \"mass spectrometry\",\n          \"massively parallel reporter assay\",\n          \"metabolic screening\",\n          \"methylation array\",\n          \"miRNA array\",\n          \"miRNA-seq\",\n          \"microrheology\",\n          \"Skindex-16\",\n          \"multi-electrode array\",\n          \"nanoparticle tracking analysis\",\n          \"NanoString nCounter Analysis System\",\n          \"n-back task\",\n          \"neuropsychological assessment\",\n          \"next generation targeted sequencing\",\n          \"novelty response behavior assay\",\n          \"open field test\",\n          \"optical tomography\",\n          \"optical coherence tomography\",\n          \"optokinetic reflex assay\",\n          \"oscillatory rheology\",\n          \"oxBS-seq\",\n          \"oxygen consumption assay\",\n          \"pattern electroretinogram\",\n          \"perineurial cell thickness\",\n          \"pharmocokinetic ADME assay\",\n          \"phase-contrast microscopy\",\n          \"photograph\",\n          \"polymerase chain reaction\",\n          \"polysomnography\",\n          \"positron emission tomography\",\n          \"PROMIS Cognitive Function\",\n          \"proximity extension assay\",\n          \"pure tone average\",\n          \"quantitative PCR\",\n          \"questionnaire\",\n          \"reactive oxygen species assay\",\n          \"reporter gene assay\",\n          \"rheometry\",\n          \"ribo-seq\",\n          \"rotarod performance test\",\n          \"sandwich ELISA\",\n          \"scCGI-seq\",\n          \"scale\",\n          \"SaferSeqS\",\n          \"single molecule drug screen assay\",\n          \"single-cell RNA-seq\",\n          \"single cell ATAC-seq\",\n          \"single-nucleus RNA-seq\",\n          \"small molecule library screen\",\n          \"sorbitol dehydrogenase activity level assay\",\n          \"spatial frequency domain imaging\",\n          \"spatial transcriptomics\",\n          \"static histomorphometry\",\n          \"static light scattering\",\n          \"survival\",\n          \"targeted exome sequencing\",\n          \"traction force microscopy\",\n          \"transcranial doppler ultrasonography\",\n          \"twin spot assay\",\n          \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n          \"western blot\",\n          \"whole exome sequencing\",\n          \"whole genome sequencing\",\n          \"whole-cell patch clamp\",\n          \"word recognition score\",\n          \"STR profile\"\n        ],\n        \"type\": \"string\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn4939876\n\n##Combination Index Validation Studies (2 drug combinations)\n**Initiative:** Cell Culture\n&nbsp;\n**Name:** D. Wade Clapp, M.D. \n**Contact Email:** dclapp@iupui.edu\n**Dates:** 7-15-15 to 12-31-15\n**Tumor Focus:** Plexiform Neurofibroma\n**Application:** Validation Translational Model\n&nbsp;\n**Background:** Preliminary High-throughput screening (HTS) data generated at National Center for Advancing Translational Sciences (NCATS) implicated a number of different compounds as potential candidates and combinations suitable for moving forward to preclinical testing, with nine combinations prioritized for validation in murine primary embryonic Schwann cell lines and/or immortalized cell lines. \n&nbsp;\n**Goals of Project:** The goal of these experiments was to validate the results of preliminary HTS at NIH/NCATS by Dr. Ferrer.  \n&nbsp;\n**Specific Aims:** \n1. Test the first two prioritized combinations in primary embryonic Schwann cell lines and murine plexiform-derived cell line (MTC): Rapamycin & Ganetespib and Selumetinib & Panobinostat.  \n2. Compare the results of the Caspase-Glo and CellTiter-Glo reagents with those obtained by mouse tumor tissue (MTT) (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) in simultan\n3. Compare the response of these two drug combinations in three different cell lines: 2 human derived NF1-/- cell lines (ipNF 95.6 and ipNF 05.5) and mouse pheochromocytoma (MPC)'s\n&nbsp;\n${buttonlink?text=Back to the NTAP Data Portal&url=https%3A%2F%2Fwww%2Esynapse%2Eorg%2F%23%21Synapse%3Asyn4939478}\n\n## Tables for Curation\n1. ID: syn64954677\nName: Spreadsheets\nSummary:\n- Assays: \n- Species: \n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: Neurofibromatosis type 1\n- Tumor types present: Plexiform Neurofibroma\n- Data types: drugScreen\n- File formats present: excel, csv\n- Funders: NTAP\n- Contains data created by: Heather Daniel, Xindi Guo\n- Example files present: NCATS SP RG in vitro data July 2015 - primary murine eSCs.xlsx, November 2015 3 cell line in vitro studies - Rapa+Gane and Selu+Pano-Clapp.xlsx, November 2015 NCATS MTT vs caspase-celltiterglo validation data-Clapp.xlsx, NCATS SP RG in vitro data July 2015 - primary murine eSCs_R+G apoptosis (16h).csv, NCATS SP RG in vitro data July 2015 - primary murine eSCs_R+G apoptosis (24h).csv\n\n\n"}]}]}{"system_instruction":{"parts":[{"text":"You are Syndi, a highly competent and helpful data assistant."}]},"contents":[{"parts":[{"text":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Default is the project PI and/or the user who created all files/records.\",\n        \"title\": \"Creator\",\n        \"type\": \"string\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate original data, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"title\": \"Measurement Technique\",\n        \"enum\": [\n          \"2D AlamarBlue absorbance\",\n          \"2D AlamarBlue fluorescence\",\n          \"3D confocal imaging\",\n          \"3D electron microscopy\",\n          \"3D imaging\",\n          \"3D microtissue viability\",\n          \"actigraphy\",\n          \"AlgometRx Nociometer\",\n          \"auditory brainstem response\",\n          \"ATAC-seq\",\n          \"ATPase activity assay\",\n          \"BrdU proliferation assay\",\n          \"CAPP-seq\",\n          \"CUT&RUN\",\n          \"ChIP-seq\",\n          \"Child Behavior Checklist for Ages 1.5-5\",\n          \"Child Behavior Checklist for Ages 6-18\",\n          \"CODEX\",\n          \"confocal microscopy\",\n          \"Corsi blocks\",\n          \"current clamp assay\",\n          \"diffusion MRI\",\n          \"distortion product otoacoustic emissions\",\n          \"DNA optical mapping\",\n          \"ELISA\",\n          \"ERR bisulfite sequencing\",\n          \"EdU proliferation assay\",\n          \"FIA-MSMS\",\n          \"FLIPR high-throughput cellular screening\",\n          \"Fluorescence In Situ Hybridization\",\n          \"Focus group\",\n          \"FTIR spectroscopy\",\n          \"HI-C\",\n          \"HPLC\",\n          \"Interview\",\n          \"ISO-seq\",\n          \"MIB/MS\",\n          \"Matrigel-based tumorigenesis assay\",\n          \"MudPIT\",\n          \"Migration Assay\",\n          \"NIH Toolbox\",\n          \"NOMe-seq\",\n          \"RNA array\",\n          \"RNA-seq\",\n          \"RPPA\",\n          \"Riccardi and Ablon scales\",\n          \"SNP array\",\n          \"SUSHI\",\n          \"Sanger sequencing\",\n          \"Social Responsiveness Scale\",\n          \"Social Responsiveness Scale, Second Edition\",\n          \"T cell receptor repertoire sequencing\",\n          \"TIDE\",\n          \"TMT quantitation\",\n          \"TriKinetics activity monitoring\",\n          \"Von Frey test\",\n          \"active avoidance learning behavior assay\",\n          \"array\",\n          \"atomic force microscopy\",\n          \"autoradiography\",\n          \"bisulfite sequencing\",\n          \"blood chemistry measurement\",\n          \"blue native PAGE\",\n          \"body size trait measurement\",\n          \"bone histomorphometry\",\n          \"brightfield microscopy\",\n          \"cAMP-Glo Max Assay\",\n          \"calcium retention capacity assay\",\n          \"cell competition\",\n          \"cell count\",\n          \"cell painting\",\n          \"cell proliferation\",\n          \"cell viability assay\",\n          \"clinical data\",\n          \"cNF-Skindex\",\n          \"cognitive assessment\",\n          \"combination library screen\",\n          \"combination screen\",\n          \"complex II enzyme activity assay\",\n          \"compound screen\",\n          \"contextual conditioning behavior assay\",\n          \"conventional MRI\",\n          \"Children's Dermatology Life Quality Index Questionnaire\",\n          \"differential scanning calorimetry\",\n          \"dynamic light scattering\",\n          \"electrochemiluminescence\",\n          \"electrophoretic light scattering\",\n          \"elevated plus maze test\",\n          \"FACE-Q Appearance-related Distress\",\n          \"flow cytometry\",\n          \"focus forming assay\",\n          \"functional MRI\",\n          \"gait measurement\",\n          \"gel filtration chromatography\",\n          \"gel permeation chromatography\",\n          \"genotyping\",\n          \"high content screen\",\n          \"high frequency ultrasound\",\n          \"high-performance liquid chromatography/tandem mass spectrometry\",\n          \"immunoassay\",\n          \"immunocytochemistry\",\n          \"immunofluorescence\",\n          \"immunohistochemistry\",\n          \"in silico synthesis\",\n          \"in vitro tumorigenesis\",\n          \"in vivo PDX viability\",\n          \"in vivo bioluminescence\",\n          \"in vivo tumor growth\",\n          \"jumping library\",\n          \"label free mass spectrometry\",\n          \"laser speckle imaging\",\n          \"light scattering assay\",\n          \"liquid chromatography-electrochemical detection\",\n          \"liquid chromatography/mass spectrometry\",\n          \"liquid chromatography/tandem mass spectrometry\",\n          \"lncRNA-seq\",\n          \"local field potential recording\",\n          \"long term potentiation assay\",\n          \"mRNA counts\",\n          \"magnetic resonance angiography\",\n          \"magnetic resonance spectroscopy\",\n          \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n          \"mass spectrometry\",\n          \"massively parallel reporter assay\",\n          \"metabolic screening\",\n          \"methylation array\",\n          \"miRNA array\",\n          \"miRNA-seq\",\n          \"microrheology\",\n          \"Skindex-16\",\n          \"multi-electrode array\",\n          \"nanoparticle tracking analysis\",\n          \"NanoString nCounter Analysis System\",\n          \"n-back task\",\n          \"neuropsychological assessment\",\n          \"next generation targeted sequencing\",\n          \"novelty response behavior assay\",\n          \"open field test\",\n          \"optical tomography\",\n          \"optical coherence tomography\",\n          \"optokinetic reflex assay\",\n          \"oscillatory rheology\",\n          \"oxBS-seq\",\n          \"oxygen consumption assay\",\n          \"pattern electroretinogram\",\n          \"perineurial cell thickness\",\n          \"pharmocokinetic ADME assay\",\n          \"phase-contrast microscopy\",\n          \"photograph\",\n          \"polymerase chain reaction\",\n          \"polysomnography\",\n          \"positron emission tomography\",\n          \"PROMIS Cognitive Function\",\n          \"proximity extension assay\",\n          \"pure tone average\",\n          \"quantitative PCR\",\n          \"questionnaire\",\n          \"reactive oxygen species assay\",\n          \"reporter gene assay\",\n          \"rheometry\",\n          \"ribo-seq\",\n          \"rotarod performance test\",\n          \"sandwich ELISA\",\n          \"scCGI-seq\",\n          \"scale\",\n          \"SaferSeqS\",\n          \"single molecule drug screen assay\",\n          \"single-cell RNA-seq\",\n          \"single cell ATAC-seq\",\n          \"single-nucleus RNA-seq\",\n          \"small molecule library screen\",\n          \"sorbitol dehydrogenase activity level assay\",\n          \"spatial frequency domain imaging\",\n          \"spatial transcriptomics\",\n          \"static histomorphometry\",\n          \"static light scattering\",\n          \"survival\",\n          \"targeted exome sequencing\",\n          \"traction force microscopy\",\n          \"transcranial doppler ultrasonography\",\n          \"twin spot assay\",\n          \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n          \"western blot\",\n          \"whole exome sequencing\",\n          \"whole genome sequencing\",\n          \"whole-cell patch clamp\",\n          \"word recognition score\",\n          \"STR profile\"\n        ],\n        \"type\": \"string\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn22267330\n\n## **Malignant Peripheral Nerve Sheath Tumors Achilles Heel: Combinatorial Targeting of ERBB3 and Calcium Signaling**\n\n### CTF Young Investigator:\n#### Laurel Black\n\n### Investigator Institution:\nMedical University of South Carolina\n\n### Abstract:\nThis proposal will investigate the role that ErbB3 and calcium-mediated signaling pathways play in regulating cellular proliferation and survival by in malignant peripheral sheath tumors (MPNSTs). At present, there are no effective treatments for MPNSTs other than radical surgical resection. After resection, recurrence typically occurs and so patients with MPNSTs have abysmal survival rates. The pathogenesis of MPNSTs is driven by Ras hyperactivation, a result of NF1 loss, and the loss of other tumor suppressor genes such as p53, PTEN and CDKN2A that negatively regulate cell proliferation/survival. Clinically targeting hyperactive Ras and its effector molecules has failed and so there is a desperate need to identify new therapeutic targets. We have focused on identifying Ras- independent and -dependent signaling pathways necessary for MPNST proliferation and survival using comprehensive genomic analyses, kinase phospho-arrays, pharmacological screens and several animal models. Our efforts have identified ErbB3 (a receptor tyrosine kinase/RTK) and calmodulin (CaM) as potential therapeutic targets in MPNSTs. Although there is conflicting evidence that other RTKs can drive Ras hyperactivation in MPNSTs, the role of ErbB3 has not yet been investigated in MPNSTs. Interestingly, our transcriptomic analyses of NRG1? (an ErbB3 ligand) stimulated Schwann cells and our global shRNA screens implicate ErbB3 and calmodulin-mediated calcium signaling as key biological pathways driving MPNST proliferation. With the cumulative support of our screens and functional analyses, we hypothesize that simultaneous inhibition of NRG1? activated effector molecules and calmodulin regulated signaling pathways will cooperatively inhibit MPNST cellular proliferation and survival. In Aim 1, I will test the hypothesis that NRG1? activation of ErbB3 directly modulates calmodulin regulated signaling in MPNSTs to promote cellular proliferation and survival. In Aim 2, I will test the hypothesis that dual inhibition of the NRG1? effector, ErbB3, and calmodulin effector molecules induces a cytotoxic effect in MPNSTs. This work will yield novel information about MPNST tumorigenesis by investigating the role(s) of ErbB3 (an upstream activator of Ras) and calcium signaling pathways (which can be dependent or independent of Ras). My ultimate goal is to identify a novel combinatorial treatment for MPNSTs using FDA approved drugs or drugs that are already in clinical trials that can rapidly advance to clinical trials.\n\n### Acknowledgement:\nData was provided by:\n\n**Black, L. E., Longo, J. F., Anderson, J. C., & Carroll, S. L. (2023). Inhibition of erb-B2 receptor tyrosine kinase 3 and associated regulatory pathways potently impairs Malignant peripheral nerve sheath tumor proliferation and survival. The American Journal of Pathology, 193(9), 1298-1318.**\n\nThe results published here are in whole or in part based on data obtained from the NF Data Portal (http://www.nf.synapse.org, RRID:SCR_021683) and made available through the NF Open Science Initiative.\n**Accessing the data from this study requires a Synapse account.**\n\n## Tables for Curation\n1. ID: syn64954868\nName: Cell Viability Celigo Assays\nSummary:\n- Assays: cell viability assay, \n- Species: Homo sapiens, \n- Individual count: 1\n- Specimen count: ?\n- Diagnoses present: Not Applicable, \n- Tumor types present: Malignant Peripheral Nerve Sheath Tumor, \n- Data types: image, geneExpression, drugScreen, drugCombinationScreen, \n- File formats present: tif, excel, pzfx, \n- Funders: CTF\n- Contains data created by: Laurel Black, James Moon\n- Example files present: S462NT+TFP_Day9.tif, S462sh1+TFP_Day9.tif, STS-26T_Src_72hr.tif, STS-26T_Src+TFP_72hr.tif, STS-26T_Veh_72hr.tif\n\n\n\n2. ID: syn64954871\nName: Imaging\nSummary:\n- Assays: immunocytochemistry, \n- Species: Homo sapiens, \n- Individual count: 1\n- Specimen count: ?\n- Diagnoses present: Not Applicable, \n- Tumor types present: Malignant Peripheral Nerve Sheath Tumor, \n- Data types: image, \n- File formats present: tif, \n- Funders: CTF\n- Contains data created by: Laurel Black, James Moon\n- Example files present: Image_749_erbb3sc285.tif, Image_750_Neg.tif, Image_748_erbb3sc81455.tif, Image_746_erbb3sc285.tif, Image_747_Neg.tif\n\n\n\n3. ID: syn64954872\nName: Kinomics\nSummary:\n- Assays: immunoassay, \n- Species: Homo sapiens, \n- Individual count: 1\n- Specimen count: ?\n- Diagnoses present: Not Applicable, \n- Tumor types present: Malignant Peripheral Nerve Sheath Tumor, \n- Data types: kinomics, \n- File formats present: excel, powerpoint, \n- Funders: CTF\n- Contains data created by: Laurel Black, James Moon\n- Example files present: 7.9.22CarrollTMXMFS15GG.xls, 8.12.22Carroll.pptx, 7.5.22CarrolUpKin.xlsx, 7.9.22CarrollTFZMFS15GG.xls, synapse_storage_manifest_imagingassaytemplate.csv\n\n\n\n4. ID: syn64954873\nName: Microarray\nSummary:\n- Assays: array, \n- Species: Rattus norvegicus, \n- Individual count: 1\n- Specimen count: 1\n- Diagnoses present: Not Applicable, \n- Tumor types present: Malignant Peripheral Nerve Sheath Tumor, \n- Data types: geneExpression, \n- File formats present: excel, \n- Funders: CTF\n- Contains data created by: Laurel Black, James Moon\n- Example files present: NRG1 Beta Regulated Genes in Adult Schwann CellsJF.xlsx, synapse_storage_manifest_rnaseqtemplate.csv\n\n\n"}]}]}{"system_instruction":{"parts":[{"text":"You are Syndi, a highly competent and helpful data assistant."}]},"contents":[{"parts":[{"text":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Default is the project PI and/or the user who created all files/records.\",\n        \"title\": \"Creator\",\n        \"type\": \"string\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate original data, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"title\": \"Measurement Technique\",\n        \"enum\": [\n          \"2D AlamarBlue absorbance\",\n          \"2D AlamarBlue fluorescence\",\n          \"3D confocal imaging\",\n          \"3D electron microscopy\",\n          \"3D imaging\",\n          \"3D microtissue viability\",\n          \"actigraphy\",\n          \"AlgometRx Nociometer\",\n          \"auditory brainstem response\",\n          \"ATAC-seq\",\n          \"ATPase activity assay\",\n          \"BrdU proliferation assay\",\n          \"CAPP-seq\",\n          \"CUT&RUN\",\n          \"ChIP-seq\",\n          \"Child Behavior Checklist for Ages 1.5-5\",\n          \"Child Behavior Checklist for Ages 6-18\",\n          \"CODEX\",\n          \"confocal microscopy\",\n          \"Corsi blocks\",\n          \"current clamp assay\",\n          \"diffusion MRI\",\n          \"distortion product otoacoustic emissions\",\n          \"DNA optical mapping\",\n          \"ELISA\",\n          \"ERR bisulfite sequencing\",\n          \"EdU proliferation assay\",\n          \"FIA-MSMS\",\n          \"FLIPR high-throughput cellular screening\",\n          \"Fluorescence In Situ Hybridization\",\n          \"Focus group\",\n          \"FTIR spectroscopy\",\n          \"HI-C\",\n          \"HPLC\",\n          \"Interview\",\n          \"ISO-seq\",\n          \"MIB/MS\",\n          \"Matrigel-based tumorigenesis assay\",\n          \"MudPIT\",\n          \"Migration Assay\",\n          \"NIH Toolbox\",\n          \"NOMe-seq\",\n          \"RNA array\",\n          \"RNA-seq\",\n          \"RPPA\",\n          \"Riccardi and Ablon scales\",\n          \"SNP array\",\n          \"SUSHI\",\n          \"Sanger sequencing\",\n          \"Social Responsiveness Scale\",\n          \"Social Responsiveness Scale, Second Edition\",\n          \"T cell receptor repertoire sequencing\",\n          \"TIDE\",\n          \"TMT quantitation\",\n          \"TriKinetics activity monitoring\",\n          \"Von Frey test\",\n          \"active avoidance learning behavior assay\",\n          \"array\",\n          \"atomic force microscopy\",\n          \"autoradiography\",\n          \"bisulfite sequencing\",\n          \"blood chemistry measurement\",\n          \"blue native PAGE\",\n          \"body size trait measurement\",\n          \"bone histomorphometry\",\n          \"brightfield microscopy\",\n          \"cAMP-Glo Max Assay\",\n          \"calcium retention capacity assay\",\n          \"cell competition\",\n          \"cell count\",\n          \"cell painting\",\n          \"cell proliferation\",\n          \"cell viability assay\",\n          \"clinical data\",\n          \"cNF-Skindex\",\n          \"cognitive assessment\",\n          \"combination library screen\",\n          \"combination screen\",\n          \"complex II enzyme activity assay\",\n          \"compound screen\",\n          \"contextual conditioning behavior assay\",\n          \"conventional MRI\",\n          \"Children's Dermatology Life Quality Index Questionnaire\",\n          \"differential scanning calorimetry\",\n          \"dynamic light scattering\",\n          \"electrochemiluminescence\",\n          \"electrophoretic light scattering\",\n          \"elevated plus maze test\",\n          \"FACE-Q Appearance-related Distress\",\n          \"flow cytometry\",\n          \"focus forming assay\",\n          \"functional MRI\",\n          \"gait measurement\",\n          \"gel filtration chromatography\",\n          \"gel permeation chromatography\",\n          \"genotyping\",\n          \"high content screen\",\n          \"high frequency ultrasound\",\n          \"high-performance liquid chromatography/tandem mass spectrometry\",\n          \"immunoassay\",\n          \"immunocytochemistry\",\n          \"immunofluorescence\",\n          \"immunohistochemistry\",\n          \"in silico synthesis\",\n          \"in vitro tumorigenesis\",\n          \"in vivo PDX viability\",\n          \"in vivo bioluminescence\",\n          \"in vivo tumor growth\",\n          \"jumping library\",\n          \"label free mass spectrometry\",\n          \"laser speckle imaging\",\n          \"light scattering assay\",\n          \"liquid chromatography-electrochemical detection\",\n          \"liquid chromatography/mass spectrometry\",\n          \"liquid chromatography/tandem mass spectrometry\",\n          \"lncRNA-seq\",\n          \"local field potential recording\",\n          \"long term potentiation assay\",\n          \"mRNA counts\",\n          \"magnetic resonance angiography\",\n          \"magnetic resonance spectroscopy\",\n          \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n          \"mass spectrometry\",\n          \"massively parallel reporter assay\",\n          \"metabolic screening\",\n          \"methylation array\",\n          \"miRNA array\",\n          \"miRNA-seq\",\n          \"microrheology\",\n          \"Skindex-16\",\n          \"multi-electrode array\",\n          \"nanoparticle tracking analysis\",\n          \"NanoString nCounter Analysis System\",\n          \"n-back task\",\n          \"neuropsychological assessment\",\n          \"next generation targeted sequencing\",\n          \"novelty response behavior assay\",\n          \"open field test\",\n          \"optical tomography\",\n          \"optical coherence tomography\",\n          \"optokinetic reflex assay\",\n          \"oscillatory rheology\",\n          \"oxBS-seq\",\n          \"oxygen consumption assay\",\n          \"pattern electroretinogram\",\n          \"perineurial cell thickness\",\n          \"pharmocokinetic ADME assay\",\n          \"phase-contrast microscopy\",\n          \"photograph\",\n          \"polymerase chain reaction\",\n          \"polysomnography\",\n          \"positron emission tomography\",\n          \"PROMIS Cognitive Function\",\n          \"proximity extension assay\",\n          \"pure tone average\",\n          \"quantitative PCR\",\n          \"questionnaire\",\n          \"reactive oxygen species assay\",\n          \"reporter gene assay\",\n          \"rheometry\",\n          \"ribo-seq\",\n          \"rotarod performance test\",\n          \"sandwich ELISA\",\n          \"scCGI-seq\",\n          \"scale\",\n          \"SaferSeqS\",\n          \"single molecule drug screen assay\",\n          \"single-cell RNA-seq\",\n          \"single cell ATAC-seq\",\n          \"single-nucleus RNA-seq\",\n          \"small molecule library screen\",\n          \"sorbitol dehydrogenase activity level assay\",\n          \"spatial frequency domain imaging\",\n          \"spatial transcriptomics\",\n          \"static histomorphometry\",\n          \"static light scattering\",\n          \"survival\",\n          \"targeted exome sequencing\",\n          \"traction force microscopy\",\n          \"transcranial doppler ultrasonography\",\n          \"twin spot assay\",\n          \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n          \"western blot\",\n          \"whole exome sequencing\",\n          \"whole genome sequencing\",\n          \"whole-cell patch clamp\",\n          \"word recognition score\",\n          \"STR profile\"\n        ],\n        \"type\": \"string\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn31619419\n\n# Early treatment of cutaneous neurofibromas type 1 (cNF) to markedly improve patient's quality of life\n## NTAP - DHART SPORE Developmental Research Program\n### Principal Investigator: Thomas E. Milner\n### Project Lead / Data Coordinator: Wangcun Jia\n### Institution: University of California, Irvine\n### Project Description:\nThe most common complication for neurofibromatosis 1 (NF1) patients is the appearance of cutaneous neurofibromas (cNF), which is considered as the most significant life burden of NF1. Current management of the tumors is eradication often with significant morbidity.\n\nThe goals of project are to improve the quality of life of NF1 patients through the identification of a biomarker to locate and evaluate cNF and through the development of a laser therapy solution. The proposed research has two aims. Aim 1 is to demonstrate an optical biomarker and validate using histology, and Aim 2 is to identify and demonstrate laser treatment mechanism of action. In Aim 1, two optical imaging modalities are utilized, Spatial Frequency Domain Imaging (SFDI) and optical coherence tomography (OCT) to first detect and then image tissue microstructure of cNF tumors. In Aim 2, two laser treatment modalities will be tested. The first treatment approach utilizes laser light to target the tumor vasculature to induce local hyperthermia and eradicate the tumor. The second treatment alternative utilizes near-infrared laser radiation to spatially target water and collagen to induce local hyperthermia and eradicate the tumor. \n\n\n## Tables for Curation\n1. ID: syn64954917\nName: Analysis\nSummary:\n- Assays: spatial frequency domain imaging, optical coherence tomography, \n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: image, \n- File formats present: tif, powerpoint, \n- Funders: NTAP,NIH-NCI\n- Contains data created by: Wangcun Jia, Junsoo Lee, Christina Parry\n- Example files present: back_2022.10.12.13.33.01-2_musp-SCALED-Marked-conc.tif, Chest_2022.10.12.13.24.20-0_musp-scaled-marked.gif, OCT_on_Chest_and_Back.pptx, Back-2_2022.10.20.14.44.48-1_musp-scaled-marked-conc.tif, chest_2022.10.20.14.28.00-0_musp-scaled-marked-conc.tif\n\n\n\n2. ID: syn64954918\nName: Histology\nSummary:\n- Assays: brightfield microscopy, \n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: image, metadata\n- File formats present: ?\n- Funders: NTAP,NIH-NCI\n- Contains data created by: Wangcun Jia\n- Example files present: Suspect_Invisible-cNF.jpg, Uninvolved-skin.jpg, Visible-cNF.jpg, Suspect_Invisible-cNF-deep.jpg, Suspect_Invisible-cNF.jpg\n\n\n\n3. ID: syn64954919\nName: OCT data\nSummary:\n- Assays: optical coherence tomography, \n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: image, \n- File formats present: ?\n- Funders: NTAP,NIH-NCI\n- Contains data created by: Junsoo Lee, Christina Parry\n- Example files present: Atten_Visible1.tif, Atten_Visible2.tif, Atten_Visible3.tif, Atten.tif, CDV.tiff\n\n\n\n4. ID: syn64954920\nName: Photos\nSummary:\n- Assays: photograph, \n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: image, metadata\n- File formats present: ?\n- Funders: NTAP,NIH-NCI\n- Contains data created by: Wangcun Jia\n- Example files present: DSC05394.JPG, DSC05402.JPG, DSC05414.JPG, DSC05423.JPG, DSC05427.JPG\n\n\n\n5. ID: syn64954921\nName: SFDI data\nSummary:\n- Assays: spatial frequency domain imaging, \n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: image, metadata\n- File formats present: ?\n- Funders: NTAP,NIH-NCI\n- Contains data created by: Wangcun Jia\n- Example files present: Chest_2022.10.12.13.24.20-0_ab, Chest_2022.10.12.13.24.20-0_ab.xml, Chest_2022.10.12.13.24.20-0_calibrated_position, Chest_2022.10.12.13.24.20-0_calibrated_rd, Chest_2022.10.12.13.24.20-0_calibrated_rd.xml\n\n\n"}]}]}{"system_instruction":{"parts":[{"text":"You are Syndi, a highly competent and helpful data assistant."}]},"contents":[{"parts":[{"text":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Default is the project PI and/or the user who created all files/records.\",\n        \"title\": \"Creator\",\n        \"type\": \"string\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate original data, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"title\": \"Measurement Technique\",\n        \"enum\": [\n          \"2D AlamarBlue absorbance\",\n          \"2D AlamarBlue fluorescence\",\n          \"3D confocal imaging\",\n          \"3D electron microscopy\",\n          \"3D imaging\",\n          \"3D microtissue viability\",\n          \"actigraphy\",\n          \"AlgometRx Nociometer\",\n          \"auditory brainstem response\",\n          \"ATAC-seq\",\n          \"ATPase activity assay\",\n          \"BrdU proliferation assay\",\n          \"CAPP-seq\",\n          \"CUT&RUN\",\n          \"ChIP-seq\",\n          \"Child Behavior Checklist for Ages 1.5-5\",\n          \"Child Behavior Checklist for Ages 6-18\",\n          \"CODEX\",\n          \"confocal microscopy\",\n          \"Corsi blocks\",\n          \"current clamp assay\",\n          \"diffusion MRI\",\n          \"distortion product otoacoustic emissions\",\n          \"DNA optical mapping\",\n          \"ELISA\",\n          \"ERR bisulfite sequencing\",\n          \"EdU proliferation assay\",\n          \"FIA-MSMS\",\n          \"FLIPR high-throughput cellular screening\",\n          \"Fluorescence In Situ Hybridization\",\n          \"Focus group\",\n          \"FTIR spectroscopy\",\n          \"HI-C\",\n          \"HPLC\",\n          \"Interview\",\n          \"ISO-seq\",\n          \"MIB/MS\",\n          \"Matrigel-based tumorigenesis assay\",\n          \"MudPIT\",\n          \"Migration Assay\",\n          \"NIH Toolbox\",\n          \"NOMe-seq\",\n          \"RNA array\",\n          \"RNA-seq\",\n          \"RPPA\",\n          \"Riccardi and Ablon scales\",\n          \"SNP array\",\n          \"SUSHI\",\n          \"Sanger sequencing\",\n          \"Social Responsiveness Scale\",\n          \"Social Responsiveness Scale, Second Edition\",\n          \"T cell receptor repertoire sequencing\",\n          \"TIDE\",\n          \"TMT quantitation\",\n          \"TriKinetics activity monitoring\",\n          \"Von Frey test\",\n          \"active avoidance learning behavior assay\",\n          \"array\",\n          \"atomic force microscopy\",\n          \"autoradiography\",\n          \"bisulfite sequencing\",\n          \"blood chemistry measurement\",\n          \"blue native PAGE\",\n          \"body size trait measurement\",\n          \"bone histomorphometry\",\n          \"brightfield microscopy\",\n          \"cAMP-Glo Max Assay\",\n          \"calcium retention capacity assay\",\n          \"cell competition\",\n          \"cell count\",\n          \"cell painting\",\n          \"cell proliferation\",\n          \"cell viability assay\",\n          \"clinical data\",\n          \"cNF-Skindex\",\n          \"cognitive assessment\",\n          \"combination library screen\",\n          \"combination screen\",\n          \"complex II enzyme activity assay\",\n          \"compound screen\",\n          \"contextual conditioning behavior assay\",\n          \"conventional MRI\",\n          \"Children's Dermatology Life Quality Index Questionnaire\",\n          \"differential scanning calorimetry\",\n          \"dynamic light scattering\",\n          \"electrochemiluminescence\",\n          \"electrophoretic light scattering\",\n          \"elevated plus maze test\",\n          \"FACE-Q Appearance-related Distress\",\n          \"flow cytometry\",\n          \"focus forming assay\",\n          \"functional MRI\",\n          \"gait measurement\",\n          \"gel filtration chromatography\",\n          \"gel permeation chromatography\",\n          \"genotyping\",\n          \"high content screen\",\n          \"high frequency ultrasound\",\n          \"high-performance liquid chromatography/tandem mass spectrometry\",\n          \"immunoassay\",\n          \"immunocytochemistry\",\n          \"immunofluorescence\",\n          \"immunohistochemistry\",\n          \"in silico synthesis\",\n          \"in vitro tumorigenesis\",\n          \"in vivo PDX viability\",\n          \"in vivo bioluminescence\",\n          \"in vivo tumor growth\",\n          \"jumping library\",\n          \"label free mass spectrometry\",\n          \"laser speckle imaging\",\n          \"light scattering assay\",\n          \"liquid chromatography-electrochemical detection\",\n          \"liquid chromatography/mass spectrometry\",\n          \"liquid chromatography/tandem mass spectrometry\",\n          \"lncRNA-seq\",\n          \"local field potential recording\",\n          \"long term potentiation assay\",\n          \"mRNA counts\",\n          \"magnetic resonance angiography\",\n          \"magnetic resonance spectroscopy\",\n          \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n          \"mass spectrometry\",\n          \"massively parallel reporter assay\",\n          \"metabolic screening\",\n          \"methylation array\",\n          \"miRNA array\",\n          \"miRNA-seq\",\n          \"microrheology\",\n          \"Skindex-16\",\n          \"multi-electrode array\",\n          \"nanoparticle tracking analysis\",\n          \"NanoString nCounter Analysis System\",\n          \"n-back task\",\n          \"neuropsychological assessment\",\n          \"next generation targeted sequencing\",\n          \"novelty response behavior assay\",\n          \"open field test\",\n          \"optical tomography\",\n          \"optical coherence tomography\",\n          \"optokinetic reflex assay\",\n          \"oscillatory rheology\",\n          \"oxBS-seq\",\n          \"oxygen consumption assay\",\n          \"pattern electroretinogram\",\n          \"perineurial cell thickness\",\n          \"pharmocokinetic ADME assay\",\n          \"phase-contrast microscopy\",\n          \"photograph\",\n          \"polymerase chain reaction\",\n          \"polysomnography\",\n          \"positron emission tomography\",\n          \"PROMIS Cognitive Function\",\n          \"proximity extension assay\",\n          \"pure tone average\",\n          \"quantitative PCR\",\n          \"questionnaire\",\n          \"reactive oxygen species assay\",\n          \"reporter gene assay\",\n          \"rheometry\",\n          \"ribo-seq\",\n          \"rotarod performance test\",\n          \"sandwich ELISA\",\n          \"scCGI-seq\",\n          \"scale\",\n          \"SaferSeqS\",\n          \"single molecule drug screen assay\",\n          \"single-cell RNA-seq\",\n          \"single cell ATAC-seq\",\n          \"single-nucleus RNA-seq\",\n          \"small molecule library screen\",\n          \"sorbitol dehydrogenase activity level assay\",\n          \"spatial frequency domain imaging\",\n          \"spatial transcriptomics\",\n          \"static histomorphometry\",\n          \"static light scattering\",\n          \"survival\",\n          \"targeted exome sequencing\",\n          \"traction force microscopy\",\n          \"transcranial doppler ultrasonography\",\n          \"twin spot assay\",\n          \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n          \"western blot\",\n          \"whole exome sequencing\",\n          \"whole genome sequencing\",\n          \"whole-cell patch clamp\",\n          \"word recognition score\",\n          \"STR profile\"\n        ],\n        \"type\": \"string\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn4939890\n\n##Exploring the Plexiform Neurofibroma Interactome\n**Initiative:** Open\n&nbsp;\n**Name:** Jianqiang Wu\n**Contact Email:** Jianqiang.wu@cchmc.org\n**Name:** Kakajan Komurov\n**Contact Email:** kakajan.komurov@cchmc.org\n**Dates:** 5-15-13 to 11-14-15\n**Tumor Focus:** Plexiform Neurofibroma\n**Application:** Biomarkers, Omics\n&nbsp;\n**Background:** \n\nAdults with neurofibromas can be disfigured by thousands of neurofibromas and 25-50% of children with NF1 develop plexiform neurofibromas that can cause severe disfigurement and serious morbidity-- and death when they compress vital organs. Therefore, we focus on identification of therapeutic targets for plexiform neurofibromas.  \n\nNF1 mutations in Schwann cells (SCs) drive neurofibroma formation; thus the primary neoplastic cell type in neurofibromas is derived from the SC lineage.  The SC genes that are deregulated in mouse and human neurofibromas have not been fully identified. Many cell types are present in neurofibromas besides SCs.  These include fibroblasts, mast cells, macrophages, and endothelial cells that are NF1 wild type (as in solitary neurofibroma or in somatic mosaic patients) or NF1 heterozygous (as in many NF1 patients and some mouse models).  But how these cells and the intercellular communications contribute to plexiform neurofibroma growth is unknown. It has been recently identified that macrophage is a major cell type in neurofibromas. Macrophages shift gene expression and function in response to the environment, including after nerve injury. Macrophages show anti- tumor effects by secreting free-radicals and recruiting the adaptive immune system (primarily T-cells). However as tumors progress, macrophages stimulate tumor growth and blood vessel formation. Injury-associated inflammation facilitates neurofibroma development by recruiting macrophages in mouse models. How these inter- and intra-cellular interactions contribute to neurofibroma formation has not been studied yet.\n&nbsp;\n**Goals of Project:** \n1.  to characterize gene expression profiles of Schwann cells and macrophages in mouse nerves and neurofibromas\n2.  to identify cytokine/chemokine pathways that slow or promote tumor growth\n3. to identify molecular networks that mediate intra- and inter-cellular signaling in controlling neurofibroma growth.  \n&nbsp;\n**Impact:** \nSchwann cell lineage cells are the cells of origin for neurofibroma formation. Macrophages are abundant in neurofibromas and play important roles in neurofibroma formation. Our findings suggest that SCs and macrophages interact each other within neurofibromas.  Specifically, Nf1-/- SCs promote a chronic inflammatory microenvironment to alter gene expression in both SCs and macrophages. Our analysis also reveals that neurofibroma SCs and macrophages both progressively adapt  to pro-inflammatory states during tumor progression, that is, neurofibroma SCs initiate tumorigenesis, while neurofibroma macrophages may maintain the pro-inflammatory state in the neurofibroma microenvironment and account for prolonged chronic inflammation.  The neurofibroma system described here provides a platform to investigate mechanistic aspects of RAS/Interferon signaling.  Our results suggest that targeting SC-macrophage interactions might provide a potential therapy for neurofibroma patients.\n&nbsp;\n**Publications:** \n* Choi K, Komurov K, Fletcher JS, Jousma E, Cancelas JA, Wu J, Ratner N. An inflammatory gene signature distinguishes neurofibroma Schwann cells and macrophages from cells in the normal peripheral nervous system. **Scientific Reports** 2017 Mar; 7, 43315. DOI:10.1038/srep43315, https://www.readcube.com/articles/10.1038/srep43315\n\n\n&nbsp;\n${buttonlink?text=Back to the NTAP Data Portal&url=https%3A%2F%2Fwww%2Esynapse%2Eorg%2F%23%21Synapse%3Asyn4939478}\n\n## Tables for Curation\n1. ID: syn51915059\nName: Gene expression profiling of Schwann cells and macrophages in mouse nerves and neurofibromas\nSummary:\n- Assays: ?\n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: ?\n- File formats present: ?\n- Funders: ?\n- Contains data created by: Kwangmn Choi\n- Example files present: 1__28_+_30_Schwann_cell_(MoGene-2_0-st).CEL, 1__28_+_30_Schwann_cell_(MoGene-2_0-st).rma-gene-full.chp, 2__193_+_195_Schwann_cell_(MoGene-2_0-st).CEL, 2__193_+_195_Schwann_cell_(MoGene-2_0-st).rma-gene-full.chp, 3__196_+_197_+_198_Schwann_cell_(MoGene-2_0-st).CEL\n\n\n"}]}]}{"system_instruction":{"parts":[{"text":"You are Syndi, a highly competent and helpful data assistant."}]},"contents":[{"parts":[{"text":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Default is the project PI and/or the user who created all files/records.\",\n        \"title\": \"Creator\",\n        \"type\": \"string\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate original data, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"title\": \"Measurement Technique\",\n        \"enum\": [\n          \"2D AlamarBlue absorbance\",\n          \"2D AlamarBlue fluorescence\",\n          \"3D confocal imaging\",\n          \"3D electron microscopy\",\n          \"3D imaging\",\n          \"3D microtissue viability\",\n          \"actigraphy\",\n          \"AlgometRx Nociometer\",\n          \"auditory brainstem response\",\n          \"ATAC-seq\",\n          \"ATPase activity assay\",\n          \"BrdU proliferation assay\",\n          \"CAPP-seq\",\n          \"CUT&RUN\",\n          \"ChIP-seq\",\n          \"Child Behavior Checklist for Ages 1.5-5\",\n          \"Child Behavior Checklist for Ages 6-18\",\n          \"CODEX\",\n          \"confocal microscopy\",\n          \"Corsi blocks\",\n          \"current clamp assay\",\n          \"diffusion MRI\",\n          \"distortion product otoacoustic emissions\",\n          \"DNA optical mapping\",\n          \"ELISA\",\n          \"ERR bisulfite sequencing\",\n          \"EdU proliferation assay\",\n          \"FIA-MSMS\",\n          \"FLIPR high-throughput cellular screening\",\n          \"Fluorescence In Situ Hybridization\",\n          \"Focus group\",\n          \"FTIR spectroscopy\",\n          \"HI-C\",\n          \"HPLC\",\n          \"Interview\",\n          \"ISO-seq\",\n          \"MIB/MS\",\n          \"Matrigel-based tumorigenesis assay\",\n          \"MudPIT\",\n          \"Migration Assay\",\n          \"NIH Toolbox\",\n          \"NOMe-seq\",\n          \"RNA array\",\n          \"RNA-seq\",\n          \"RPPA\",\n          \"Riccardi and Ablon scales\",\n          \"SNP array\",\n          \"SUSHI\",\n          \"Sanger sequencing\",\n          \"Social Responsiveness Scale\",\n          \"Social Responsiveness Scale, Second Edition\",\n          \"T cell receptor repertoire sequencing\",\n          \"TIDE\",\n          \"TMT quantitation\",\n          \"TriKinetics activity monitoring\",\n          \"Von Frey test\",\n          \"active avoidance learning behavior assay\",\n          \"array\",\n          \"atomic force microscopy\",\n          \"autoradiography\",\n          \"bisulfite sequencing\",\n          \"blood chemistry measurement\",\n          \"blue native PAGE\",\n          \"body size trait measurement\",\n          \"bone histomorphometry\",\n          \"brightfield microscopy\",\n          \"cAMP-Glo Max Assay\",\n          \"calcium retention capacity assay\",\n          \"cell competition\",\n          \"cell count\",\n          \"cell painting\",\n          \"cell proliferation\",\n          \"cell viability assay\",\n          \"clinical data\",\n          \"cNF-Skindex\",\n          \"cognitive assessment\",\n          \"combination library screen\",\n          \"combination screen\",\n          \"complex II enzyme activity assay\",\n          \"compound screen\",\n          \"contextual conditioning behavior assay\",\n          \"conventional MRI\",\n          \"Children's Dermatology Life Quality Index Questionnaire\",\n          \"differential scanning calorimetry\",\n          \"dynamic light scattering\",\n          \"electrochemiluminescence\",\n          \"electrophoretic light scattering\",\n          \"elevated plus maze test\",\n          \"FACE-Q Appearance-related Distress\",\n          \"flow cytometry\",\n          \"focus forming assay\",\n          \"functional MRI\",\n          \"gait measurement\",\n          \"gel filtration chromatography\",\n          \"gel permeation chromatography\",\n          \"genotyping\",\n          \"high content screen\",\n          \"high frequency ultrasound\",\n          \"high-performance liquid chromatography/tandem mass spectrometry\",\n          \"immunoassay\",\n          \"immunocytochemistry\",\n          \"immunofluorescence\",\n          \"immunohistochemistry\",\n          \"in silico synthesis\",\n          \"in vitro tumorigenesis\",\n          \"in vivo PDX viability\",\n          \"in vivo bioluminescence\",\n          \"in vivo tumor growth\",\n          \"jumping library\",\n          \"label free mass spectrometry\",\n          \"laser speckle imaging\",\n          \"light scattering assay\",\n          \"liquid chromatography-electrochemical detection\",\n          \"liquid chromatography/mass spectrometry\",\n          \"liquid chromatography/tandem mass spectrometry\",\n          \"lncRNA-seq\",\n          \"local field potential recording\",\n          \"long term potentiation assay\",\n          \"mRNA counts\",\n          \"magnetic resonance angiography\",\n          \"magnetic resonance spectroscopy\",\n          \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n          \"mass spectrometry\",\n          \"massively parallel reporter assay\",\n          \"metabolic screening\",\n          \"methylation array\",\n          \"miRNA array\",\n          \"miRNA-seq\",\n          \"microrheology\",\n          \"Skindex-16\",\n          \"multi-electrode array\",\n          \"nanoparticle tracking analysis\",\n          \"NanoString nCounter Analysis System\",\n          \"n-back task\",\n          \"neuropsychological assessment\",\n          \"next generation targeted sequencing\",\n          \"novelty response behavior assay\",\n          \"open field test\",\n          \"optical tomography\",\n          \"optical coherence tomography\",\n          \"optokinetic reflex assay\",\n          \"oscillatory rheology\",\n          \"oxBS-seq\",\n          \"oxygen consumption assay\",\n          \"pattern electroretinogram\",\n          \"perineurial cell thickness\",\n          \"pharmocokinetic ADME assay\",\n          \"phase-contrast microscopy\",\n          \"photograph\",\n          \"polymerase chain reaction\",\n          \"polysomnography\",\n          \"positron emission tomography\",\n          \"PROMIS Cognitive Function\",\n          \"proximity extension assay\",\n          \"pure tone average\",\n          \"quantitative PCR\",\n          \"questionnaire\",\n          \"reactive oxygen species assay\",\n          \"reporter gene assay\",\n          \"rheometry\",\n          \"ribo-seq\",\n          \"rotarod performance test\",\n          \"sandwich ELISA\",\n          \"scCGI-seq\",\n          \"scale\",\n          \"SaferSeqS\",\n          \"single molecule drug screen assay\",\n          \"single-cell RNA-seq\",\n          \"single cell ATAC-seq\",\n          \"single-nucleus RNA-seq\",\n          \"small molecule library screen\",\n          \"sorbitol dehydrogenase activity level assay\",\n          \"spatial frequency domain imaging\",\n          \"spatial transcriptomics\",\n          \"static histomorphometry\",\n          \"static light scattering\",\n          \"survival\",\n          \"targeted exome sequencing\",\n          \"traction force microscopy\",\n          \"transcranial doppler ultrasonography\",\n          \"twin spot assay\",\n          \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n          \"western blot\",\n          \"whole exome sequencing\",\n          \"whole genome sequencing\",\n          \"whole-cell patch clamp\",\n          \"word recognition score\",\n          \"STR profile\"\n        ],\n        \"type\": \"string\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn7217928\n\n##Plexiform Neurofibroma Model Systems for Preclinical Drug Screening\n\n**Initiative:** Cell Culture\n&nbsp;\n**Name:** Ray Mattingly, Ph.D.\n**Contact Email:** rmatting@med.wayne.edu\n**Dates:** 5-1-13 to 4-30-16\n**Tumor Focus:** Plexiform Neurofibroma\n**Application:** Preclinical Models\n&nbsp;\n**Background & Rationale:**\nUp to half of NF1 patients suffer with plexiform neurofibromas (PNs), for which there is no effective therapeutic approach. PNs are complex tumors that include a driving, deranged Schwann cell (NF1-/-) component plus other haploin sufficent (Nf1+/-) fibroblasts, perineural cells, mast cells and endothelial cells, together with secreted collagens and other matrix proteins. Surgery is the only current option for patients with PNs causing serious disfigurement or loss of function. At a recent NF patient forum in Detroit, it was reported that the high vascularity of these tumors can cause major problems during surgery. Most in vitro drug testing is still performed on cells growing in two dimensions (2D) on plastic dishes. In comparison to 2D cultures, cells growing in a 3-dimensional (3D) matrix that models the (patho) physiological environment typically: 1) adopt a morphology that better recapitulates that in vivo; 2) exhibit slower growth more akin to those in vivo; and 3) demonstrate drug sensitivity and resistance that may better reflect potential therapeutic response.\n&nbsp;\n**Goals of Project:** \nOur goals were to develop and optimize robust 3D co-culture models of NF1 PNs to allow preclinical drug screening that is both much more representative of likely translational effectiveness than provided by testing in 2D mono-culture, and at a much higher throughput than is available in animal models. Further, we predict that programs such as the NF Clinical Trials Consortium are more likely to be successful if they build on data from robust and representative pre-clinical models. Our aims were therefore to: 1. Develop, characterize and optimize 3D co-culture models to include the cell types found in NF1 PNs; and 2. Test potential drugs in the 3D models of NF1 PNs, with a focus on candidates chosen for translational potential.\n&nbsp;\n**Impact:** \n1. We have developed and optimized assays of cell proliferation that can be reproducibly used in 3D PN cultures and co-cultures and that will provide the basis for secondary screening of potential drug treatments. \n2. We have established and optimized what we believe to be the first 3D co-culture models of PN cells with endothelial cells. We suggest that these new models will provide an innovative way to investigate the clinically important aspect of the high vascularity of PNs. \n3. We have made major progress in the investigation of the interactions between the 3D PN co-cultures and their matrix through use of the live-cell collagen degradation assay. Development and refinement of this assay provides the groundwork for further studies on the pre-malignant phenotype of PNs.\n&nbsp;\n**Publications:** \n1. Review article published: Brock EJ, Ji K, Reiners JJ Jr. & Mattingly RR. How to Target Activated Ras Proteins: Direct Inhibition vs. Induced Mislocalization. **Mini Rev Med Chem.** 2016 ; 16(5): 358–369. PMID: 26423696, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4955559/pdf/nihms802301.pdf\n&nbsp;\n${buttonlink?text=Back to the NTAP Data Portal&url=https%3A%2F%2Fwww%2Esynapse%2Eorg%2F%23%21Synapse%3Asyn4939478}\n2. Kraniak JM, Mattingly RR, Sloane BF (2018). Roles of pericellular proteases in tumor angiogenesis: therapeutic implications, ch14, in Extracellular Targeting of Cell Signaling in Cancer: Strategies Directed at MET and RON Receptor Tyrosine Kinase Pathways.  Janetka J (Ed). Wiley, 2018, ISBN: 9781119300212 \n3. Kraniak JM, Chalasani A, Wallace MR, Mattingly RR. Development of 3D Culture Models of Plexiform Neurofibroma and Initial Application for Phenotypic Characterization and Drug Screening.  Exp Neurol. 2018; J299(Pt B):289-298. PMID: 29055717\n\n\n\n## Tables for Curation\n1. ID: syn64954702\nName: Drug screen data\nSummary:\n- Assays: ?\n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: ?\n- File formats present: ?\n- Funders: NTAP\n- Contains data created by: Anh Nguyet Vu\n- Example files present: RFP_97-4Samp3.csv, dapiD1_974_S3_4-15-15.csv, DQ_CS4_1_21_15.csv, dapi_D6_028_S1_4-8-15.csv, DQ_95-6_2lambS1_2-4-15.csv\n\n\n\n2. ID: syn52163155\nName: Drug screens with 3D Plexiform Neurofibroma Model System\nSummary:\n- Assays: ?\n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: ?\n- File formats present: ?\n- Funders: ?\n- Contains data created by: Anh Nguyet Vu\n- Example files present: RFP_97-4Samp3.csv, dapiD1_974_S3_4-15-15.csv, DQ_CS4_1_21_15.csv, dapi_D6_028_S1_4-8-15.csv, DQ_95-6_2lambS1_2-4-15.csv\n\n\n"}]}]}{"system_instruction":{"parts":[{"text":"You are Syndi, a highly competent and helpful data assistant."}]},"contents":[{"parts":[{"text":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Default is the project PI and/or the user who created all files/records.\",\n        \"title\": \"Creator\",\n        \"type\": \"string\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate original data, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"title\": \"Measurement Technique\",\n        \"enum\": [\n          \"2D AlamarBlue absorbance\",\n          \"2D AlamarBlue fluorescence\",\n          \"3D confocal imaging\",\n          \"3D electron microscopy\",\n          \"3D imaging\",\n          \"3D microtissue viability\",\n          \"actigraphy\",\n          \"AlgometRx Nociometer\",\n          \"auditory brainstem response\",\n          \"ATAC-seq\",\n          \"ATPase activity assay\",\n          \"BrdU proliferation assay\",\n          \"CAPP-seq\",\n          \"CUT&RUN\",\n          \"ChIP-seq\",\n          \"Child Behavior Checklist for Ages 1.5-5\",\n          \"Child Behavior Checklist for Ages 6-18\",\n          \"CODEX\",\n          \"confocal microscopy\",\n          \"Corsi blocks\",\n          \"current clamp assay\",\n          \"diffusion MRI\",\n          \"distortion product otoacoustic emissions\",\n          \"DNA optical mapping\",\n          \"ELISA\",\n          \"ERR bisulfite sequencing\",\n          \"EdU proliferation assay\",\n          \"FIA-MSMS\",\n          \"FLIPR high-throughput cellular screening\",\n          \"Fluorescence In Situ Hybridization\",\n          \"Focus group\",\n          \"FTIR spectroscopy\",\n          \"HI-C\",\n          \"HPLC\",\n          \"Interview\",\n          \"ISO-seq\",\n          \"MIB/MS\",\n          \"Matrigel-based tumorigenesis assay\",\n          \"MudPIT\",\n          \"Migration Assay\",\n          \"NIH Toolbox\",\n          \"NOMe-seq\",\n          \"RNA array\",\n          \"RNA-seq\",\n          \"RPPA\",\n          \"Riccardi and Ablon scales\",\n          \"SNP array\",\n          \"SUSHI\",\n          \"Sanger sequencing\",\n          \"Social Responsiveness Scale\",\n          \"Social Responsiveness Scale, Second Edition\",\n          \"T cell receptor repertoire sequencing\",\n          \"TIDE\",\n          \"TMT quantitation\",\n          \"TriKinetics activity monitoring\",\n          \"Von Frey test\",\n          \"active avoidance learning behavior assay\",\n          \"array\",\n          \"atomic force microscopy\",\n          \"autoradiography\",\n          \"bisulfite sequencing\",\n          \"blood chemistry measurement\",\n          \"blue native PAGE\",\n          \"body size trait measurement\",\n          \"bone histomorphometry\",\n          \"brightfield microscopy\",\n          \"cAMP-Glo Max Assay\",\n          \"calcium retention capacity assay\",\n          \"cell competition\",\n          \"cell count\",\n          \"cell painting\",\n          \"cell proliferation\",\n          \"cell viability assay\",\n          \"clinical data\",\n          \"cNF-Skindex\",\n          \"cognitive assessment\",\n          \"combination library screen\",\n          \"combination screen\",\n          \"complex II enzyme activity assay\",\n          \"compound screen\",\n          \"contextual conditioning behavior assay\",\n          \"conventional MRI\",\n          \"Children's Dermatology Life Quality Index Questionnaire\",\n          \"differential scanning calorimetry\",\n          \"dynamic light scattering\",\n          \"electrochemiluminescence\",\n          \"electrophoretic light scattering\",\n          \"elevated plus maze test\",\n          \"FACE-Q Appearance-related Distress\",\n          \"flow cytometry\",\n          \"focus forming assay\",\n          \"functional MRI\",\n          \"gait measurement\",\n          \"gel filtration chromatography\",\n          \"gel permeation chromatography\",\n          \"genotyping\",\n          \"high content screen\",\n          \"high frequency ultrasound\",\n          \"high-performance liquid chromatography/tandem mass spectrometry\",\n          \"immunoassay\",\n          \"immunocytochemistry\",\n          \"immunofluorescence\",\n          \"immunohistochemistry\",\n          \"in silico synthesis\",\n          \"in vitro tumorigenesis\",\n          \"in vivo PDX viability\",\n          \"in vivo bioluminescence\",\n          \"in vivo tumor growth\",\n          \"jumping library\",\n          \"label free mass spectrometry\",\n          \"laser speckle imaging\",\n          \"light scattering assay\",\n          \"liquid chromatography-electrochemical detection\",\n          \"liquid chromatography/mass spectrometry\",\n          \"liquid chromatography/tandem mass spectrometry\",\n          \"lncRNA-seq\",\n          \"local field potential recording\",\n          \"long term potentiation assay\",\n          \"mRNA counts\",\n          \"magnetic resonance angiography\",\n          \"magnetic resonance spectroscopy\",\n          \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n          \"mass spectrometry\",\n          \"massively parallel reporter assay\",\n          \"metabolic screening\",\n          \"methylation array\",\n          \"miRNA array\",\n          \"miRNA-seq\",\n          \"microrheology\",\n          \"Skindex-16\",\n          \"multi-electrode array\",\n          \"nanoparticle tracking analysis\",\n          \"NanoString nCounter Analysis System\",\n          \"n-back task\",\n          \"neuropsychological assessment\",\n          \"next generation targeted sequencing\",\n          \"novelty response behavior assay\",\n          \"open field test\",\n          \"optical tomography\",\n          \"optical coherence tomography\",\n          \"optokinetic reflex assay\",\n          \"oscillatory rheology\",\n          \"oxBS-seq\",\n          \"oxygen consumption assay\",\n          \"pattern electroretinogram\",\n          \"perineurial cell thickness\",\n          \"pharmocokinetic ADME assay\",\n          \"phase-contrast microscopy\",\n          \"photograph\",\n          \"polymerase chain reaction\",\n          \"polysomnography\",\n          \"positron emission tomography\",\n          \"PROMIS Cognitive Function\",\n          \"proximity extension assay\",\n          \"pure tone average\",\n          \"quantitative PCR\",\n          \"questionnaire\",\n          \"reactive oxygen species assay\",\n          \"reporter gene assay\",\n          \"rheometry\",\n          \"ribo-seq\",\n          \"rotarod performance test\",\n          \"sandwich ELISA\",\n          \"scCGI-seq\",\n          \"scale\",\n          \"SaferSeqS\",\n          \"single molecule drug screen assay\",\n          \"single-cell RNA-seq\",\n          \"single cell ATAC-seq\",\n          \"single-nucleus RNA-seq\",\n          \"small molecule library screen\",\n          \"sorbitol dehydrogenase activity level assay\",\n          \"spatial frequency domain imaging\",\n          \"spatial transcriptomics\",\n          \"static histomorphometry\",\n          \"static light scattering\",\n          \"survival\",\n          \"targeted exome sequencing\",\n          \"traction force microscopy\",\n          \"transcranial doppler ultrasonography\",\n          \"twin spot assay\",\n          \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n          \"western blot\",\n          \"whole exome sequencing\",\n          \"whole genome sequencing\",\n          \"whole-cell patch clamp\",\n          \"word recognition score\",\n          \"STR profile\"\n        ],\n        \"type\": \"string\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn61696875\n\n# Supplementing The Children's Tumor Foundation-Neurofibromatosis Registry with Electronic Health Record Dataset from Mayo Clinic Rochester\n## CTF - Contract Award\n### Principal Investigator: Mayowa Osundiji\n### Project Lead / Data Coordinator: Mayowa Osundiji, Marlene Girardo\n### Institution: Mayo Clinic Arizona\n### Project Description:\nThe development of disease registries is a topical issue. Registries are robust resources that hold great promise for improving our understanding of disease processes, therapeutic responses and for enhancing the recruitment of patient populations into clinical trials. The Children’s Tumor Foundation (CTF) Neurofibromatosis (NF) [CTF-NF] registry provides a unique opportunity to study and improve NF clinical care. The CTF-NF registry utilizes web-based approaches for gathering patient reported clinical history. Although robust, the CTF-NF registry in its current form may potentially be limited by patient recollections and understanding of pertinent details of their clinical history. In the studies proposed herewith, we will complement the CTF-NF registry by extracting de-identified NF clinical data directly from electronic health records (EHRs) at Mayo Clinic to improve the CTF-NF registry. Individuals with NF have an increased risk of developing some types of cancers, and many other health concerns. Considering the health risks that can accompany NF, regular clinical surveillance is critical in the overall care of NF patients. A wealth of dataset is continuously generated during NF clinical surveillance. We will extract de-identified forms of the most relevant NF dataset at Mayo Clinic Rochester (estimated patients number is > 1000) into CTF-NF registry. The proposed preliminary studies will help pave the way for multi-institutional EHR driven enhancement of the current CTF-NF registry. The studies will help develop a protocol that may also be used for batch collection and importation of NF data from EHRs in other institutions onto the CTF-NF registry. Expanding the current CTF-NF registry to a multi-institutional EHR driven NF registry holds great potential for improving our current understanding of NF disease processes and for refining clinical management strategies. The proposed studies hold great promise for improving the accuracy of CTF-NF registry and providing novel insights into NF clinical management in line with the CTF's mission to drive research, expand knowledge and advance care.\n\n## Tables for Curation\n1. ID: syn64954927\nName: Mayo Clinic cohort REDCap database of de-identified phenotype and genotype information\nSummary:\n- Assays: genotyping\n- Species: Homo sapiens\n- Individual count: 1\n- Specimen count: ?\n- Diagnoses present: Neurofibromatosis type 1\n- Tumor types present: Malignant Peripheral Nerve Sheath Tumor\n- Data types: clinical, AggregatedData\n- File formats present: excel, doc\n- Funders: CTF\n- Contains data created by: Mayowa Osundiji\n- Example files present: Osundiji_data_de_30DEC24.xlsx, Clinical_data_30DEC24.doc\n\n\n"}]}]}{"system_instruction":{"parts":[{"text":"You are Syndi, a highly competent and helpful data assistant."}]},"contents":[{"parts":[{"text":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Default is the project PI and/or the user who created all files/records.\",\n        \"title\": \"Creator\",\n        \"type\": \"string\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate original data, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"title\": \"Measurement Technique\",\n        \"enum\": [\n          \"2D AlamarBlue absorbance\",\n          \"2D AlamarBlue fluorescence\",\n          \"3D confocal imaging\",\n          \"3D electron microscopy\",\n          \"3D imaging\",\n          \"3D microtissue viability\",\n          \"actigraphy\",\n          \"AlgometRx Nociometer\",\n          \"auditory brainstem response\",\n          \"ATAC-seq\",\n          \"ATPase activity assay\",\n          \"BrdU proliferation assay\",\n          \"CAPP-seq\",\n          \"CUT&RUN\",\n          \"ChIP-seq\",\n          \"Child Behavior Checklist for Ages 1.5-5\",\n          \"Child Behavior Checklist for Ages 6-18\",\n          \"CODEX\",\n          \"confocal microscopy\",\n          \"Corsi blocks\",\n          \"current clamp assay\",\n          \"diffusion MRI\",\n          \"distortion product otoacoustic emissions\",\n          \"DNA optical mapping\",\n          \"ELISA\",\n          \"ERR bisulfite sequencing\",\n          \"EdU proliferation assay\",\n          \"FIA-MSMS\",\n          \"FLIPR high-throughput cellular screening\",\n          \"Fluorescence In Situ Hybridization\",\n          \"Focus group\",\n          \"FTIR spectroscopy\",\n          \"HI-C\",\n          \"HPLC\",\n          \"Interview\",\n          \"ISO-seq\",\n          \"MIB/MS\",\n          \"Matrigel-based tumorigenesis assay\",\n          \"MudPIT\",\n          \"Migration Assay\",\n          \"NIH Toolbox\",\n          \"NOMe-seq\",\n          \"RNA array\",\n          \"RNA-seq\",\n          \"RPPA\",\n          \"Riccardi and Ablon scales\",\n          \"SNP array\",\n          \"SUSHI\",\n          \"Sanger sequencing\",\n          \"Social Responsiveness Scale\",\n          \"Social Responsiveness Scale, Second Edition\",\n          \"T cell receptor repertoire sequencing\",\n          \"TIDE\",\n          \"TMT quantitation\",\n          \"TriKinetics activity monitoring\",\n          \"Von Frey test\",\n          \"active avoidance learning behavior assay\",\n          \"array\",\n          \"atomic force microscopy\",\n          \"autoradiography\",\n          \"bisulfite sequencing\",\n          \"blood chemistry measurement\",\n          \"blue native PAGE\",\n          \"body size trait measurement\",\n          \"bone histomorphometry\",\n          \"brightfield microscopy\",\n          \"cAMP-Glo Max Assay\",\n          \"calcium retention capacity assay\",\n          \"cell competition\",\n          \"cell count\",\n          \"cell painting\",\n          \"cell proliferation\",\n          \"cell viability assay\",\n          \"clinical data\",\n          \"cNF-Skindex\",\n          \"cognitive assessment\",\n          \"combination library screen\",\n          \"combination screen\",\n          \"complex II enzyme activity assay\",\n          \"compound screen\",\n          \"contextual conditioning behavior assay\",\n          \"conventional MRI\",\n          \"Children's Dermatology Life Quality Index Questionnaire\",\n          \"differential scanning calorimetry\",\n          \"dynamic light scattering\",\n          \"electrochemiluminescence\",\n          \"electrophoretic light scattering\",\n          \"elevated plus maze test\",\n          \"FACE-Q Appearance-related Distress\",\n          \"flow cytometry\",\n          \"focus forming assay\",\n          \"functional MRI\",\n          \"gait measurement\",\n          \"gel filtration chromatography\",\n          \"gel permeation chromatography\",\n          \"genotyping\",\n          \"high content screen\",\n          \"high frequency ultrasound\",\n          \"high-performance liquid chromatography/tandem mass spectrometry\",\n          \"immunoassay\",\n          \"immunocytochemistry\",\n          \"immunofluorescence\",\n          \"immunohistochemistry\",\n          \"in silico synthesis\",\n          \"in vitro tumorigenesis\",\n          \"in vivo PDX viability\",\n          \"in vivo bioluminescence\",\n          \"in vivo tumor growth\",\n          \"jumping library\",\n          \"label free mass spectrometry\",\n          \"laser speckle imaging\",\n          \"light scattering assay\",\n          \"liquid chromatography-electrochemical detection\",\n          \"liquid chromatography/mass spectrometry\",\n          \"liquid chromatography/tandem mass spectrometry\",\n          \"lncRNA-seq\",\n          \"local field potential recording\",\n          \"long term potentiation assay\",\n          \"mRNA counts\",\n          \"magnetic resonance angiography\",\n          \"magnetic resonance spectroscopy\",\n          \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n          \"mass spectrometry\",\n          \"massively parallel reporter assay\",\n          \"metabolic screening\",\n          \"methylation array\",\n          \"miRNA array\",\n          \"miRNA-seq\",\n          \"microrheology\",\n          \"Skindex-16\",\n          \"multi-electrode array\",\n          \"nanoparticle tracking analysis\",\n          \"NanoString nCounter Analysis System\",\n          \"n-back task\",\n          \"neuropsychological assessment\",\n          \"next generation targeted sequencing\",\n          \"novelty response behavior assay\",\n          \"open field test\",\n          \"optical tomography\",\n          \"optical coherence tomography\",\n          \"optokinetic reflex assay\",\n          \"oscillatory rheology\",\n          \"oxBS-seq\",\n          \"oxygen consumption assay\",\n          \"pattern electroretinogram\",\n          \"perineurial cell thickness\",\n          \"pharmocokinetic ADME assay\",\n          \"phase-contrast microscopy\",\n          \"photograph\",\n          \"polymerase chain reaction\",\n          \"polysomnography\",\n          \"positron emission tomography\",\n          \"PROMIS Cognitive Function\",\n          \"proximity extension assay\",\n          \"pure tone average\",\n          \"quantitative PCR\",\n          \"questionnaire\",\n          \"reactive oxygen species assay\",\n          \"reporter gene assay\",\n          \"rheometry\",\n          \"ribo-seq\",\n          \"rotarod performance test\",\n          \"sandwich ELISA\",\n          \"scCGI-seq\",\n          \"scale\",\n          \"SaferSeqS\",\n          \"single molecule drug screen assay\",\n          \"single-cell RNA-seq\",\n          \"single cell ATAC-seq\",\n          \"single-nucleus RNA-seq\",\n          \"small molecule library screen\",\n          \"sorbitol dehydrogenase activity level assay\",\n          \"spatial frequency domain imaging\",\n          \"spatial transcriptomics\",\n          \"static histomorphometry\",\n          \"static light scattering\",\n          \"survival\",\n          \"targeted exome sequencing\",\n          \"traction force microscopy\",\n          \"transcranial doppler ultrasonography\",\n          \"twin spot assay\",\n          \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n          \"western blot\",\n          \"whole exome sequencing\",\n          \"whole genome sequencing\",\n          \"whole-cell patch clamp\",\n          \"word recognition score\",\n          \"STR profile\"\n        ],\n        \"type\": \"string\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn2343195\n\n${image?fileName=CTF Synodos Data Site Headers4%2Ejpg&align=Center&scale=100&responsive=true}\n#### ->*Creating tools and treatment paradigms for NF2-associated meningioma and schwannoma*<-\n---\n### ->**Check out the the [2019 data release](https://www.synapse.org/#!Synapse:syn2343195/wiki/400095)!**<-\n\n${image?fileName=Screen Shot 2016%2D06%2D13 at 11%2E52%2E29 AM%2Epng&align=Center&responsive=true&scale=60}\n\nSynodos for NF2 is a first-of-its-kind Neurofibromatosis research collaboration dedicated to defeating the rare genetic disorder neurofibromatosis type 2 (NF2). This unique consortium brings together a multidisciplinary team of scientists from twelve world-class labs at academic and medical centers of excellence, who have pledged to work closely together – sharing information, datasets, results and more – at every step in research development, with the goal of speeding up the drug discovery process. The end goal of this effort is to find new approaches to the diagnosis and treatment of two primary NF2-related tumors:  schwannoma and meningioma. The expectation is to take the work from discovery to pre-clinical development, resulting in the development of an Investigational New Drug (IND) for NF2. _The consortium is funded by [Children's Tumor Foundation](http://www.ctf.org/)(CTF)_\n\n----\n->${buttonlink?highlight=true&text=NF2 Data Summary&url=https://www.synapse.org/#!Synapse:syn2343195/wiki/499423}<- \n->${buttonlink?highlight=true&text=NF2 Public Data&url=https://www.synapse.org/#!Synapse:syn6133098}<-\n${buttonlink?text=Back to CTF Data Portal&url=https://nf%2Esynapse%2Eorg/Organizations/DetailsPage%3Fabbreviation%3DCTF&highlight=true&align=Center}\n\n----\n\nThe Synodos NF2 project has generated several types of ‘omic and drug screening data from NF2 tumor models of schwannoma and meningioma, including: \n* Low throughput drug screening data: A panel of rationally-selected small molecules and drugs such as mTOR and HDAC inhibitors were tested against human and mouse cell line models of meningioma and schwannoma. \n* Single-agent and combination high throughput drug screening data: A panel of 1912 drugs and drug-like molecules (the MIPE 4.0 library from NCATS) was screened in 6 cell line models of meningioma and schwannoma with NF2 wildtype or NF2 deficient status. In addition, 4 of these cell lines were screened with 6x6 and 10x10 point combination dose-response assays with this panel of drugs. Both raw and processed data are available. \n* Genomic variant data (structural rearrangement): Jumping library sequencing facilitates detection of chromosomal abnormalities such as pathogenic breakpoints. There are processed data (bam files) from 11 human and mouse cell line models of meningioma and schwannoma with NF2 wildtype or NF2 deficient status. \n* Gene expression: Raw (fastq files) and processed (bam, count, and differential expression files) RNAseq data were generated from an Nf2fl/fl mouse model dorsal root ganglion tissue and cell line models of meningioma and schwannoma. In addition, data were generated from cell line models of meningioma and schwannoma with vehicle control, or 12 different single agent or combinations of small molecule inhibitors. Data from the 2017 release and the 2019 release are both now available for exploration.\n* Kinomics: Processed data are available from NF2 mouse model dorsal root ganglion tissue several cell line models of meningioma and schwannoma after treatment with a vehicle control or one of seven small molecules. Data from the 2017 release and the 2019 release are both now available for exploration.\n\n\n## Tables for Curation\n1. ID: syn64954668\nName: 2017 Release - Jumping Library Seq\nSummary:\n- Assays: jumping library\n- Species: Homo sapiens, Mus musculus, \n- Individual count: 11\n- Specimen count: 12\n- Diagnoses present: , Neurofibromatosis type 2\n- Tumor types present: Meningioma, Schwannoma, \n- Data types: genomicVariants\n- File formats present: bam, bai, doc\n- Funders: CTF\n- Contains data created by: Robert Allaway\n- Example files present: Syn1_i14.mkdup.coordsort.bam, Syn2_i2.mkdup.coordsort.bam, Syn5_i6.mkdup.coordsort.bam, Syn5_i5.mkdup.coordsort.bam, NF2_i7.mkdup.coordsort.bam\n\n\n\n2. ID: syn64954669\nName: 2017 Release - Proteomics_Kinome\nSummary:\n- Assays: MIB/MS\n- Species: Homo sapiens, Mus musculus, Homo sapiens,Mus musculus\n- Individual count: 11\n- Specimen count: 9\n- Diagnoses present: Neurofibromatosis type 2, \n- Tumor types present: [\"Schwannoma\"], [\"Meningioma\"], [\"Schwannoma\", \"Meningioma\"]\n- Data types: kinomics\n- File formats present: excel, txt, csv, tsv\n- Funders: CTF\n- Contains data created by: Abhishek Pratap\n- Example files present: HS01_run1_CUDC_and_Pano_kinome.xlsx, HS01_run1_CUDC_and_Pano_kinome_peptides.txt, HS01_run1_GSK458_kinome.xlsx, HS01_run1_GSK458_kinome_peptides.txt, HS01_run2_CUDC_and_Pano_kinome.xlsx\n\n\n\n3. ID: syn64954671\nName: 2019 Release - Animal Studies\nSummary:\n- Assays: in vivo bioluminescence\n- Species: Mus musculus, Homo sapiens\n- Individual count: ?\n- Specimen count: 2\n- Diagnoses present: Neurofibromatosis type 2\n- Tumor types present: Meningioma\n- Data types: volume\n- File formats present: csv, excel\n- Funders: CTF\n- Contains data created by: Robert Allaway\n- Example files present: GSK458_mouse_data_standardized.csv, GSK458_Panobinostat_CUDC907TreatmentData.xlsx, MK2206andBrigatinibAloneAndCombinationINTheBenMen1Model.xlsx, MK2206andBrigatinibCombinationAndBrigatinibAlonePostTxAndReTx.xlsx\n\n\n\n4. ID: syn64954672\nName: 2019 Release - High-Throughput Drug Screens\nSummary:\n- Assays: cell viability assay\n- Species: Homo sapiens, Mus musculus\n- Individual count: 7\n- Specimen count: 15\n- Diagnoses present: Neurofibromatosis type 2\n- Tumor types present: [\"Schwannoma\"], [\"Meningioma\"], [\"Schwannoma\", \"Meningioma\"]\n- Data types: drugScreen\n- File formats present: csv, txt, excel\n- Funders: CTF\n- Contains data created by: Robert Allaway\n- Example files present: HS01_CCG_20hours_calc_set1.csv, HS01_CCG_20hours_calc_set2.csv, HS01_CCG_20hours_metadata_set1.csv, HS01_CCG_20hours_metadata_set2.csv, HS01_CCG_20hours_responses_set1.csv\n\n\n\n5. ID: syn64954673\nName: 2019 Release - Proteomics_Kinome\nSummary:\n- Assays: MIB/MS, sandwich ELISA\n- Species: Homo sapiens, Homo sapiens,Mus musculus, Mus musculus\n- Individual count: 3\n- Specimen count: 2\n- Diagnoses present: Neurofibromatosis type 2\n- Tumor types present: , Meningioma, Schwannoma\n- Data types: kinomics, immunoassay\n- File formats present: pzf, excel, powerpoint, doc, pdf, xlsx\n- Funders: CTF\n- Contains data created by: Robert Allaway\n- Example files present: 170919-Syn1-Syn5-MK2206-Brig.pzf, 170925-PCA plot-allLFQ.pzf, Syn1Syn5-MK2206-Brigatinib-Combo.xlsx, 170927-HS11-HS01-Brig-Das-Sim-replicate1summary.pptx, 170927-PCA plot-allLFQ.pzf\n\n\n\n6. ID: syn64954674\nName: 2019 Release - RNASeq\nSummary:\n- Assays: RNA-seq, \n- Species: Homo sapiens, Mus musculus, \n- Individual count: 8\n- Specimen count: 109\n- Diagnoses present: Neurofibromatosis type 2, \n- Tumor types present: Meningioma, Schwannoma, \n- Data types: geneExpression, \n- File formats present: bam, fastq, log, R script, tsv\n- Funders: CTF\n- Contains data created by: Serkan Erdin, Robert Allaway\n- Example files present: Syn1_1.Aligned.out.bam, Syn1_10.Aligned.out.bam, Syn1_11.Aligned.out.bam, Syn1_12.Aligned.out.bam, Syn1_13.Aligned.out.bam\n\n\n\n7. ID: syn64954675\nName: 2021 - Raw Blot Images\nSummary:\n- Assays: ?\n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: ?\n- File formats present: ?\n- Funders: CTF\n- Contains data created by: Abbi Smith\n- Example files present: S1_raw_images.pdf\n\n\n\n8. ID: syn55203921\nName: Gene Expression Quantification from RNA-seq\nSummary:\n- Assays: \n- Species: \n- Individual count: 2\n- Specimen count: ?\n- Diagnoses present: Neurofibromatosis type 2, \n- Tumor types present: Schwannoma\n- Data types: geneExpression\n- File formats present: sf\n- Funders: CTF\n- Contains data created by: Robert Allaway\n- Example files present: quant.genes.sf, quant.genes.sf, quant.sf, quant.sf, quant.sf\n\n\n\n9. ID: syn64954676\nName: NF-OSI RNASeq Reprocessing\nSummary:\n- Assays: RNA-seq\n- Species: Homo sapiens\n- Individual count: 75\n- Specimen count: 84\n- Diagnoses present: Neurofibromatosis type 2, \n- Tumor types present: , Meningioma\n- Data types: geneExpression\n- File formats present: sf\n- Funders: CTF\n- Contains data created by: Sara Gosline\n- Example files present: HS01_1_quant.sf, HS01_10_quant.sf, HS01_11_quant.sf, HS01_12_quant.sf, HS01_13_quant.sf\n\n\n\n10. ID: syn51914478\nName: Synodos NF2 Drug Screen - 2017 Release\nSummary:\n- Assays: ?\n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: ?\n- File formats present: ?\n- Funders: ?\n- Contains data created by: Abhishek Pratap\n- Example files present: Synodos_DrugScreen_processed_data.tsv, Synodos_DrugScreen_combined_rawData.tsv\n\n\n\n11. ID: syn51914129\nName: Synodos NF2 Processed RNA-seq - 2017 Release\nSummary:\n- Assays: ?\n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: ?\n- File formats present: ?\n- Funders: ?\n- Contains data created by: Robert Allaway\n- Example files present: schwannoma_reseq_raw_counts_bedtoolsHtseq.txt, Synodos_mouseSchwannoma_RNASeq_diffExp_genes.tsv, meningioma_differential_expression.txt, schwannoma_differential_expression.txt, meningioma_raw_counts.txt\n\n\n\n12. ID: syn64954670\nName: Synodos NF2 RNA-seq Raw Data - 2017 Release\nSummary:\n- Assays: RNA-seq, \n- Species: Homo sapiens, , Mus musculus\n- Individual count: 47\n- Specimen count: 205\n- Diagnoses present: Neurofibromatosis type 2, \n- Tumor types present: Schwannoma, , Meningioma\n- Data types: geneExpression, \n- File formats present: fastq, txt, bam, tsv, bai, html, zip, bat\n- Funders: CTF\n- Contains data created by: Steven Angus, Robert Allaway\n- Example files present: HS01_CUDC907_Run1_S2_R1_001.fastq, HS01_CUDC907_Run2_S2_R1_001.fastq, HS01_CUDC907_Run3_S2_R1_001.fastq, HS01_DMSO_Run1_S1_R1_001.fastq, HS01_DMSO_Run2_S1_R1_001.fastq\n\n\n"}]}]}{"system_instruction":{"parts":[{"text":"You are Syndi, a highly competent and helpful data assistant."}]},"contents":[{"parts":[{"text":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Default is the project PI and/or the user who created all files/records.\",\n        \"title\": \"Creator\",\n        \"type\": \"string\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate original data, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"title\": \"Measurement Technique\",\n        \"enum\": [\n          \"2D AlamarBlue absorbance\",\n          \"2D AlamarBlue fluorescence\",\n          \"3D confocal imaging\",\n          \"3D electron microscopy\",\n          \"3D imaging\",\n          \"3D microtissue viability\",\n          \"actigraphy\",\n          \"AlgometRx Nociometer\",\n          \"auditory brainstem response\",\n          \"ATAC-seq\",\n          \"ATPase activity assay\",\n          \"BrdU proliferation assay\",\n          \"CAPP-seq\",\n          \"CUT&RUN\",\n          \"ChIP-seq\",\n          \"Child Behavior Checklist for Ages 1.5-5\",\n          \"Child Behavior Checklist for Ages 6-18\",\n          \"CODEX\",\n          \"confocal microscopy\",\n          \"Corsi blocks\",\n          \"current clamp assay\",\n          \"diffusion MRI\",\n          \"distortion product otoacoustic emissions\",\n          \"DNA optical mapping\",\n          \"ELISA\",\n          \"ERR bisulfite sequencing\",\n          \"EdU proliferation assay\",\n          \"FIA-MSMS\",\n          \"FLIPR high-throughput cellular screening\",\n          \"Fluorescence In Situ Hybridization\",\n          \"Focus group\",\n          \"FTIR spectroscopy\",\n          \"HI-C\",\n          \"HPLC\",\n          \"Interview\",\n          \"ISO-seq\",\n          \"MIB/MS\",\n          \"Matrigel-based tumorigenesis assay\",\n          \"MudPIT\",\n          \"Migration Assay\",\n          \"NIH Toolbox\",\n          \"NOMe-seq\",\n          \"RNA array\",\n          \"RNA-seq\",\n          \"RPPA\",\n          \"Riccardi and Ablon scales\",\n          \"SNP array\",\n          \"SUSHI\",\n          \"Sanger sequencing\",\n          \"Social Responsiveness Scale\",\n          \"Social Responsiveness Scale, Second Edition\",\n          \"T cell receptor repertoire sequencing\",\n          \"TIDE\",\n          \"TMT quantitation\",\n          \"TriKinetics activity monitoring\",\n          \"Von Frey test\",\n          \"active avoidance learning behavior assay\",\n          \"array\",\n          \"atomic force microscopy\",\n          \"autoradiography\",\n          \"bisulfite sequencing\",\n          \"blood chemistry measurement\",\n          \"blue native PAGE\",\n          \"body size trait measurement\",\n          \"bone histomorphometry\",\n          \"brightfield microscopy\",\n          \"cAMP-Glo Max Assay\",\n          \"calcium retention capacity assay\",\n          \"cell competition\",\n          \"cell count\",\n          \"cell painting\",\n          \"cell proliferation\",\n          \"cell viability assay\",\n          \"clinical data\",\n          \"cNF-Skindex\",\n          \"cognitive assessment\",\n          \"combination library screen\",\n          \"combination screen\",\n          \"complex II enzyme activity assay\",\n          \"compound screen\",\n          \"contextual conditioning behavior assay\",\n          \"conventional MRI\",\n          \"Children's Dermatology Life Quality Index Questionnaire\",\n          \"differential scanning calorimetry\",\n          \"dynamic light scattering\",\n          \"electrochemiluminescence\",\n          \"electrophoretic light scattering\",\n          \"elevated plus maze test\",\n          \"FACE-Q Appearance-related Distress\",\n          \"flow cytometry\",\n          \"focus forming assay\",\n          \"functional MRI\",\n          \"gait measurement\",\n          \"gel filtration chromatography\",\n          \"gel permeation chromatography\",\n          \"genotyping\",\n          \"high content screen\",\n          \"high frequency ultrasound\",\n          \"high-performance liquid chromatography/tandem mass spectrometry\",\n          \"immunoassay\",\n          \"immunocytochemistry\",\n          \"immunofluorescence\",\n          \"immunohistochemistry\",\n          \"in silico synthesis\",\n          \"in vitro tumorigenesis\",\n          \"in vivo PDX viability\",\n          \"in vivo bioluminescence\",\n          \"in vivo tumor growth\",\n          \"jumping library\",\n          \"label free mass spectrometry\",\n          \"laser speckle imaging\",\n          \"light scattering assay\",\n          \"liquid chromatography-electrochemical detection\",\n          \"liquid chromatography/mass spectrometry\",\n          \"liquid chromatography/tandem mass spectrometry\",\n          \"lncRNA-seq\",\n          \"local field potential recording\",\n          \"long term potentiation assay\",\n          \"mRNA counts\",\n          \"magnetic resonance angiography\",\n          \"magnetic resonance spectroscopy\",\n          \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n          \"mass spectrometry\",\n          \"massively parallel reporter assay\",\n          \"metabolic screening\",\n          \"methylation array\",\n          \"miRNA array\",\n          \"miRNA-seq\",\n          \"microrheology\",\n          \"Skindex-16\",\n          \"multi-electrode array\",\n          \"nanoparticle tracking analysis\",\n          \"NanoString nCounter Analysis System\",\n          \"n-back task\",\n          \"neuropsychological assessment\",\n          \"next generation targeted sequencing\",\n          \"novelty response behavior assay\",\n          \"open field test\",\n          \"optical tomography\",\n          \"optical coherence tomography\",\n          \"optokinetic reflex assay\",\n          \"oscillatory rheology\",\n          \"oxBS-seq\",\n          \"oxygen consumption assay\",\n          \"pattern electroretinogram\",\n          \"perineurial cell thickness\",\n          \"pharmocokinetic ADME assay\",\n          \"phase-contrast microscopy\",\n          \"photograph\",\n          \"polymerase chain reaction\",\n          \"polysomnography\",\n          \"positron emission tomography\",\n          \"PROMIS Cognitive Function\",\n          \"proximity extension assay\",\n          \"pure tone average\",\n          \"quantitative PCR\",\n          \"questionnaire\",\n          \"reactive oxygen species assay\",\n          \"reporter gene assay\",\n          \"rheometry\",\n          \"ribo-seq\",\n          \"rotarod performance test\",\n          \"sandwich ELISA\",\n          \"scCGI-seq\",\n          \"scale\",\n          \"SaferSeqS\",\n          \"single molecule drug screen assay\",\n          \"single-cell RNA-seq\",\n          \"single cell ATAC-seq\",\n          \"single-nucleus RNA-seq\",\n          \"small molecule library screen\",\n          \"sorbitol dehydrogenase activity level assay\",\n          \"spatial frequency domain imaging\",\n          \"spatial transcriptomics\",\n          \"static histomorphometry\",\n          \"static light scattering\",\n          \"survival\",\n          \"targeted exome sequencing\",\n          \"traction force microscopy\",\n          \"transcranial doppler ultrasonography\",\n          \"twin spot assay\",\n          \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n          \"western blot\",\n          \"whole exome sequencing\",\n          \"whole genome sequencing\",\n          \"whole-cell patch clamp\",\n          \"word recognition score\",\n          \"STR profile\"\n        ],\n        \"type\": \"string\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn11374349\n\n###Modeling NF with human Schwann cells via tunable and reversible control of NF1 protein\n&nbsp;\n\n#####**PI:**  Gabsang Lee, Ph.D.\n**Johns Hopkins University**\n\n&nbsp;\n\n######**Study Design:**  \n\nWe will combine the human Schwann cell specification system and temporal ‘SMASh’ control of NF1 protein to develop a humanized cNF model with hESCs (**Figure**). First, we will modify the NF1 locus by ‘knocking-out’ one allele of NF1 and ‘knocking-in’ the SMASh tag and Puro-selection cassette (as a donor vector) into the other allele. The Lee and Kim labs have been working on genetic editing in human pluripotent stem cells for over three years and have generated many ‘knock-in’ and ‘knock-out’ lines. After verification of the gene targeting and pluripotency of the selected clones, established NF1-/SMASh hESC clones will be subjected to our Schwann cell specification protocol. We will treat cells with the asunaprevir (ASv) chemical compound at different time points to assess any cellular and molecular changes, either in intact cells or isolated populations (SOX10::GFP+ neural crest cells, CD49d+ Schwann cell precursors and EGFR+ Schwann cells).\n\n&nbsp;\n\n${image?fileName=lee%2Epng&align=Center&scale=100&responsive=true}\n\n&nbsp;\n\n######**Deliverables:**\n1. NF1-/SMASh SOX10::GFP hESC clones,\n2. Frozen stocks of SOX10::GFP+ neural crest cells, CD49d+ Schwann cell precursors and EGFR+ Schwann cells upon NF1 loss (at least three vials for each cells, ~20,000 cells per vial), and\n3. Cellular and molecular profiling of each cell type.\n\n&nbsp;\n\n######**Expected Outcomes:**\n\nThe goal of this project is to generate a viable human Schwann cell model for cNF and identify differences in susceptibility to NF1 loss in different stages of Schwann cell development. In addition, we will provide the tunable and reversible method of control of NF1 expression (culminated in NF1-/SMASh hESCs) to the general neurofibroma and neurofibromatosis research community.\n\n&nbsp;\n\n${buttonlink?text=Back to the NTAP Data Portal&url=https%3A%2F%2Fwww%2Esynapse%2Eorg%2F%23%21Synapse%3Asyn4939478}\n\n\n\n## Tables for Curation\n1. ID: syn64954749\nName: 12 month deliverables\nSummary:\n- Assays: , immunohistochemistry, quantitative PCR, flow cytometry\n- Species: , Homo sapiens\n- Individual count: 1\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: , image, geneExpression\n- File formats present: doc, pdf\n- Funders: NTAP\n- Contains data created by: gabsang lee\n- Example files present: 1. Cell cycle data.docx, 2. qRT-PCR data.docx, 3. Karyotyping data.docx, 4. Staining data.docx, 20X-2-20-DAPI(B).tif\n\n\n\n2. ID: syn64954750\nName: 18 month deliverables\nSummary:\n- Assays: western blot, flow cytometry, quantitative PCR, immunohistochemistry, immunofluorescence\n- Species: Homo sapiens\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: image\n- File formats present: doc, png, excel, tif\n- Funders: NTAP\n- Contains data created by: gabsang lee\n- Example files present: 1. western blot data.docx, 2. Annexin V-PI staining data.docx, 3. qRT-PCR.docx, 4. Immunostainig and FACS data.docx, wetern blot.png\n\n\n\n3. ID: syn64954751\nName: 24 month deliverables\nSummary:\n- Assays: western blot, quantitative PCR, immunofluorescence, immunocytochemistry, \n- Species: ?\n- Individual count: ?\n- Specimen count: 1\n- Diagnoses present: , \n- Tumor types present: , \n- Data types: geneExpression, immunoassay, \n- File formats present: ?\n- Funders: NTAP\n- Contains data created by: gabsang lee\n- Example files present: 2. western blot data.docx, 3. qRT-PCR data.docx, 4. FACS analysis data.docx, 1. immunostaining data.docx, 3. qRT-PCR.png\n\n\n\n4. ID: syn64954752\nName: 30 month deliverables\nSummary:\n- Assays: immunocytochemistry, atomic force microscopy, immunofluorescence, RNA-seq, quantitative PCR, \n- Species: ?\n- Individual count: ?\n- Specimen count: 1\n- Diagnoses present: , \n- Tumor types present: , \n- Data types: immunoassay, image, geneExpression, \n- File formats present: ?\n- Funders: NTAP\n- Contains data created by: gabsang lee\n- Example files present: 3. MBP staining data.docx, 4. TEM data.docx, 1. FACS sorting data.docx, 2. RNA-seq data.docx, 1. FACS sorting - CD49+ SCP cells.png\n\n\n\n5. ID: syn64954753\nName: 36 month deliverables\nSummary:\n- Assays: cell viability assay, quantitative PCR, atomic force microscopy, RNA-seq, immunofluorescence, \n- Species: , Homo sapiens\n- Individual count: ?\n- Specimen count: 16\n- Diagnoses present: ?\n- Tumor types present: , Not Applicable\n- Data types: cellularPhysiology, geneExpression, image, immunoassay, \n- File formats present: ?\n- Funders: NTAP\n- Contains data created by: gabsang lee, NF Service\n- Example files present: 3. Cell proliferation assay.docx, 4. qRT-PCR assay.docx, 5. TEM imaging.docx, 1. RNA-seq data.docx, 2. Cell cycle analysis data.docx\n\n\n\n6. ID: syn64954754\nName: 6 month deliverables\nSummary:\n- Assays: , Sanger sequencing\n- Species: , Homo sapiens\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: , genomicVariants\n- File formats present: doc, pdf\n- Funders: NTAP\n- Contains data created by: gabsang lee\n- Example files present: 1. Construction of Donor vector.docx, 2. Transfection data.docx, 3. Sequencing data.docx, 4. Expansion data.docx, 180723 NF1-SMASh Summary .docx\n\n\n\n7. ID: syn51930817\nName: Gene Expression Quantification from RNA-seq\nSummary:\n- Assays: RNA-seq\n- Species: Homo sapiens\n- Individual count: ?\n- Specimen count: 16\n- Diagnoses present: ?\n- Tumor types present: Not Applicable\n- Data types: geneExpression\n- File formats present: sf\n- Funders: ?\n- Contains data created by: NF Service\n- Example files present: quant.genes.sf, quant.sf, quant.genes.sf, quant.sf, quant.sf\n\n\n\n8. ID: syn51199006\nName: NFOSI-RNASeq-To-Process-2023-14-03\nSummary:\n- Assays: RNA-seq\n- Species: Homo sapiens\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: Not Applicable\n- Data types: geneExpression\n- File formats present: ?\n- Funders: NTAP\n- Contains data created by: gabsang lee\n- Example files present: ES-SSEA4-A1_R1.fastq.gz, ES-SSEA4-A1_R2.fastq.gz, ES-SSEA4-A2_R1.fastq.gz, ES-SSEA4-A2_R2.fastq.gz, ES-SSEA4-D1_R1.fastq.gz\n\n\n"}]}]}{"system_instruction":{"parts":[{"text":"You are Syndi, a highly competent and helpful data assistant."}]},"contents":[{"parts":[{"text":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Default is the project PI and/or the user who created all files/records.\",\n        \"title\": \"Creator\",\n        \"type\": \"string\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate original data, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"title\": \"Measurement Technique\",\n        \"enum\": [\n          \"2D AlamarBlue absorbance\",\n          \"2D AlamarBlue fluorescence\",\n          \"3D confocal imaging\",\n          \"3D electron microscopy\",\n          \"3D imaging\",\n          \"3D microtissue viability\",\n          \"actigraphy\",\n          \"AlgometRx Nociometer\",\n          \"auditory brainstem response\",\n          \"ATAC-seq\",\n          \"ATPase activity assay\",\n          \"BrdU proliferation assay\",\n          \"CAPP-seq\",\n          \"CUT&RUN\",\n          \"ChIP-seq\",\n          \"Child Behavior Checklist for Ages 1.5-5\",\n          \"Child Behavior Checklist for Ages 6-18\",\n          \"CODEX\",\n          \"confocal microscopy\",\n          \"Corsi blocks\",\n          \"current clamp assay\",\n          \"diffusion MRI\",\n          \"distortion product otoacoustic emissions\",\n          \"DNA optical mapping\",\n          \"ELISA\",\n          \"ERR bisulfite sequencing\",\n          \"EdU proliferation assay\",\n          \"FIA-MSMS\",\n          \"FLIPR high-throughput cellular screening\",\n          \"Fluorescence In Situ Hybridization\",\n          \"Focus group\",\n          \"FTIR spectroscopy\",\n          \"HI-C\",\n          \"HPLC\",\n          \"Interview\",\n          \"ISO-seq\",\n          \"MIB/MS\",\n          \"Matrigel-based tumorigenesis assay\",\n          \"MudPIT\",\n          \"Migration Assay\",\n          \"NIH Toolbox\",\n          \"NOMe-seq\",\n          \"RNA array\",\n          \"RNA-seq\",\n          \"RPPA\",\n          \"Riccardi and Ablon scales\",\n          \"SNP array\",\n          \"SUSHI\",\n          \"Sanger sequencing\",\n          \"Social Responsiveness Scale\",\n          \"Social Responsiveness Scale, Second Edition\",\n          \"T cell receptor repertoire sequencing\",\n          \"TIDE\",\n          \"TMT quantitation\",\n          \"TriKinetics activity monitoring\",\n          \"Von Frey test\",\n          \"active avoidance learning behavior assay\",\n          \"array\",\n          \"atomic force microscopy\",\n          \"autoradiography\",\n          \"bisulfite sequencing\",\n          \"blood chemistry measurement\",\n          \"blue native PAGE\",\n          \"body size trait measurement\",\n          \"bone histomorphometry\",\n          \"brightfield microscopy\",\n          \"cAMP-Glo Max Assay\",\n          \"calcium retention capacity assay\",\n          \"cell competition\",\n          \"cell count\",\n          \"cell painting\",\n          \"cell proliferation\",\n          \"cell viability assay\",\n          \"clinical data\",\n          \"cNF-Skindex\",\n          \"cognitive assessment\",\n          \"combination library screen\",\n          \"combination screen\",\n          \"complex II enzyme activity assay\",\n          \"compound screen\",\n          \"contextual conditioning behavior assay\",\n          \"conventional MRI\",\n          \"Children's Dermatology Life Quality Index Questionnaire\",\n          \"differential scanning calorimetry\",\n          \"dynamic light scattering\",\n          \"electrochemiluminescence\",\n          \"electrophoretic light scattering\",\n          \"elevated plus maze test\",\n          \"FACE-Q Appearance-related Distress\",\n          \"flow cytometry\",\n          \"focus forming assay\",\n          \"functional MRI\",\n          \"gait measurement\",\n          \"gel filtration chromatography\",\n          \"gel permeation chromatography\",\n          \"genotyping\",\n          \"high content screen\",\n          \"high frequency ultrasound\",\n          \"high-performance liquid chromatography/tandem mass spectrometry\",\n          \"immunoassay\",\n          \"immunocytochemistry\",\n          \"immunofluorescence\",\n          \"immunohistochemistry\",\n          \"in silico synthesis\",\n          \"in vitro tumorigenesis\",\n          \"in vivo PDX viability\",\n          \"in vivo bioluminescence\",\n          \"in vivo tumor growth\",\n          \"jumping library\",\n          \"label free mass spectrometry\",\n          \"laser speckle imaging\",\n          \"light scattering assay\",\n          \"liquid chromatography-electrochemical detection\",\n          \"liquid chromatography/mass spectrometry\",\n          \"liquid chromatography/tandem mass spectrometry\",\n          \"lncRNA-seq\",\n          \"local field potential recording\",\n          \"long term potentiation assay\",\n          \"mRNA counts\",\n          \"magnetic resonance angiography\",\n          \"magnetic resonance spectroscopy\",\n          \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n          \"mass spectrometry\",\n          \"massively parallel reporter assay\",\n          \"metabolic screening\",\n          \"methylation array\",\n          \"miRNA array\",\n          \"miRNA-seq\",\n          \"microrheology\",\n          \"Skindex-16\",\n          \"multi-electrode array\",\n          \"nanoparticle tracking analysis\",\n          \"NanoString nCounter Analysis System\",\n          \"n-back task\",\n          \"neuropsychological assessment\",\n          \"next generation targeted sequencing\",\n          \"novelty response behavior assay\",\n          \"open field test\",\n          \"optical tomography\",\n          \"optical coherence tomography\",\n          \"optokinetic reflex assay\",\n          \"oscillatory rheology\",\n          \"oxBS-seq\",\n          \"oxygen consumption assay\",\n          \"pattern electroretinogram\",\n          \"perineurial cell thickness\",\n          \"pharmocokinetic ADME assay\",\n          \"phase-contrast microscopy\",\n          \"photograph\",\n          \"polymerase chain reaction\",\n          \"polysomnography\",\n          \"positron emission tomography\",\n          \"PROMIS Cognitive Function\",\n          \"proximity extension assay\",\n          \"pure tone average\",\n          \"quantitative PCR\",\n          \"questionnaire\",\n          \"reactive oxygen species assay\",\n          \"reporter gene assay\",\n          \"rheometry\",\n          \"ribo-seq\",\n          \"rotarod performance test\",\n          \"sandwich ELISA\",\n          \"scCGI-seq\",\n          \"scale\",\n          \"SaferSeqS\",\n          \"single molecule drug screen assay\",\n          \"single-cell RNA-seq\",\n          \"single cell ATAC-seq\",\n          \"single-nucleus RNA-seq\",\n          \"small molecule library screen\",\n          \"sorbitol dehydrogenase activity level assay\",\n          \"spatial frequency domain imaging\",\n          \"spatial transcriptomics\",\n          \"static histomorphometry\",\n          \"static light scattering\",\n          \"survival\",\n          \"targeted exome sequencing\",\n          \"traction force microscopy\",\n          \"transcranial doppler ultrasonography\",\n          \"twin spot assay\",\n          \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n          \"western blot\",\n          \"whole exome sequencing\",\n          \"whole genome sequencing\",\n          \"whole-cell patch clamp\",\n          \"word recognition score\",\n          \"STR profile\"\n        ],\n        \"type\": \"string\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn5698493\n\n${image?fileName=CTF Synodos Data Site Headers3%2Ejpg&align=Center&scale=100&responsive=true}\n###**Welcome to the Synodos for NF1- Low Grade Glioma Site**\n\nThis site is the central place for all data related to the CTF-funded Synodos for NF1 - Low Grade Glioma project.  The wiki area and specific folders can be accessed by all members of the group from the menu on the left. \n\n###Data Generation Update\nTo access the data, please follow [these instructions](https://www.synapse.org/#!Synapse:syn5698493/wiki/617779). \n${plot?query=SELECT tumorType,assay,count(distinct individualID) as number FROM syn11614205 group by assay,tumorType&title=Tumors collected by data type&xaxis=tumorType&yaxis=Number of patients &type=BAR&barmode=GROUP&fill=assay&horizontal=TRUE}\n\nThe counts for these files can be found below:\n${plot?query=SELECT tumorType,assay,count(distinct id) as number FROM syn11614205 group by assay,tumorType&title=Files collected by data type&xaxis=tumorType&yaxis=Number of files &type=BAR&barmode=GROUP&fill=assay&horizontal=TRUE}\n\n->${buttonlink?text=Back to CTF Data Portal&url=http%3A%2F%2Fwww%2Esynapse%2Eorg%2Fctf}<-\n\n## Tables for Curation\n1. ID: syn30865300\nName: Synodos LGG Methylation Arrays\nSummary:\n- Assays: methylation array\n- Species: Homo sapiens\n- Individual count: 43\n- Specimen count: 43\n- Diagnoses present: Neurofibromatosis type 1\n- Tumor types present: Pilocytic Astrocytoma, Unknown, Low-Grade Glioma NOS, Pilomyxoid Astrocytoma, Diffuse Astrocytoma, Atypical Pilocytic Astrocytoma, Glioblastoma Multiforme, Anaplastic Astrocytoma, Pleomorphic Xanthoastrocytoma\n- Data types: chromatinActivity\n- File formats present: idat\n- Funders: CTF\n- Contains data created by: ?\n- Example files present: 201194000076_R07C01_Grn.idat, 201194000076_R07C01_Red.idat, 201194000076_R08C01_Grn.idat, 201194000076_R08C01_Red.idat, 201194000077_R01C01_Grn.idat\n\n\n\n2. ID: syn30865196\nName: Synodos LGG RNAseq\nSummary:\n- Assays: RNA-seq, 3D microtissue viability\n- Species: Homo sapiens\n- Individual count: 23\n- Specimen count: 23\n- Diagnoses present: Neurofibromatosis type 1\n- Tumor types present: Pilocytic Astrocytoma, Unknown, Low-Grade Glioma NOS, Pleomorphic Xanthoastrocytoma, Diffuse Astrocytoma, Pilomyxoid Astrocytoma\n- Data types: geneExpression\n- File formats present: fastq\n- Funders: CTF\n- Contains data created by: ?\n- Example files present: AS-167591-LR-25156_R1.fastq.gz, AS-167591-LR-25156_R2.fastq.gz, AS-167592-LR-25156_R1.fastq.gz, AS-167592-LR-25156_R2.fastq.gz, AS-167593-LR-25156_R1.fastq.gz\n\n\n\n3. ID: syn30865247\nName: Synodos LGG Whole Genome Sequencing (bam)\nSummary:\n- Assays: whole genome sequencing\n- Species: Homo sapiens\n- Individual count: 22\n- Specimen count: 44\n- Diagnoses present: Neurofibromatosis type 1\n- Tumor types present: Pilocytic Astrocytoma, Unknown, Low-Grade Glioma NOS, Pilomyxoid Astrocytoma, Diffuse Astrocytoma, Atypical Pilocytic Astrocytoma, Not Applicable\n- Data types: genomicVariants\n- File formats present: bam\n- Funders: CTF\n- Contains data created by: ?\n- Example files present: tumor_XI065_SYN_NF_004_merged.mdup.bam, tumor_XI065_SYN_NF_006_merged.mdup.bam, tumor_XI065_SYN_NF_007_merged.mdup.bam, tumor_XI065_SYN_NF_009_merged.mdup.bam, tumor_XI065_SYN_NF_010_merged.mdup.bam\n\n\n"}]}]}{"system_instruction":{"parts":[{"text":"You are Syndi, a highly competent and helpful data assistant."}]},"contents":[{"parts":[{"text":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Default is the project PI and/or the user who created all files/records.\",\n        \"title\": \"Creator\",\n        \"type\": \"string\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate original data, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"title\": \"Measurement Technique\",\n        \"enum\": [\n          \"2D AlamarBlue absorbance\",\n          \"2D AlamarBlue fluorescence\",\n          \"3D confocal imaging\",\n          \"3D electron microscopy\",\n          \"3D imaging\",\n          \"3D microtissue viability\",\n          \"actigraphy\",\n          \"AlgometRx Nociometer\",\n          \"auditory brainstem response\",\n          \"ATAC-seq\",\n          \"ATPase activity assay\",\n          \"BrdU proliferation assay\",\n          \"CAPP-seq\",\n          \"CUT&RUN\",\n          \"ChIP-seq\",\n          \"Child Behavior Checklist for Ages 1.5-5\",\n          \"Child Behavior Checklist for Ages 6-18\",\n          \"CODEX\",\n          \"confocal microscopy\",\n          \"Corsi blocks\",\n          \"current clamp assay\",\n          \"diffusion MRI\",\n          \"distortion product otoacoustic emissions\",\n          \"DNA optical mapping\",\n          \"ELISA\",\n          \"ERR bisulfite sequencing\",\n          \"EdU proliferation assay\",\n          \"FIA-MSMS\",\n          \"FLIPR high-throughput cellular screening\",\n          \"Fluorescence In Situ Hybridization\",\n          \"Focus group\",\n          \"FTIR spectroscopy\",\n          \"HI-C\",\n          \"HPLC\",\n          \"Interview\",\n          \"ISO-seq\",\n          \"MIB/MS\",\n          \"Matrigel-based tumorigenesis assay\",\n          \"MudPIT\",\n          \"Migration Assay\",\n          \"NIH Toolbox\",\n          \"NOMe-seq\",\n          \"RNA array\",\n          \"RNA-seq\",\n          \"RPPA\",\n          \"Riccardi and Ablon scales\",\n          \"SNP array\",\n          \"SUSHI\",\n          \"Sanger sequencing\",\n          \"Social Responsiveness Scale\",\n          \"Social Responsiveness Scale, Second Edition\",\n          \"T cell receptor repertoire sequencing\",\n          \"TIDE\",\n          \"TMT quantitation\",\n          \"TriKinetics activity monitoring\",\n          \"Von Frey test\",\n          \"active avoidance learning behavior assay\",\n          \"array\",\n          \"atomic force microscopy\",\n          \"autoradiography\",\n          \"bisulfite sequencing\",\n          \"blood chemistry measurement\",\n          \"blue native PAGE\",\n          \"body size trait measurement\",\n          \"bone histomorphometry\",\n          \"brightfield microscopy\",\n          \"cAMP-Glo Max Assay\",\n          \"calcium retention capacity assay\",\n          \"cell competition\",\n          \"cell count\",\n          \"cell painting\",\n          \"cell proliferation\",\n          \"cell viability assay\",\n          \"clinical data\",\n          \"cNF-Skindex\",\n          \"cognitive assessment\",\n          \"combination library screen\",\n          \"combination screen\",\n          \"complex II enzyme activity assay\",\n          \"compound screen\",\n          \"contextual conditioning behavior assay\",\n          \"conventional MRI\",\n          \"Children's Dermatology Life Quality Index Questionnaire\",\n          \"differential scanning calorimetry\",\n          \"dynamic light scattering\",\n          \"electrochemiluminescence\",\n          \"electrophoretic light scattering\",\n          \"elevated plus maze test\",\n          \"FACE-Q Appearance-related Distress\",\n          \"flow cytometry\",\n          \"focus forming assay\",\n          \"functional MRI\",\n          \"gait measurement\",\n          \"gel filtration chromatography\",\n          \"gel permeation chromatography\",\n          \"genotyping\",\n          \"high content screen\",\n          \"high frequency ultrasound\",\n          \"high-performance liquid chromatography/tandem mass spectrometry\",\n          \"immunoassay\",\n          \"immunocytochemistry\",\n          \"immunofluorescence\",\n          \"immunohistochemistry\",\n          \"in silico synthesis\",\n          \"in vitro tumorigenesis\",\n          \"in vivo PDX viability\",\n          \"in vivo bioluminescence\",\n          \"in vivo tumor growth\",\n          \"jumping library\",\n          \"label free mass spectrometry\",\n          \"laser speckle imaging\",\n          \"light scattering assay\",\n          \"liquid chromatography-electrochemical detection\",\n          \"liquid chromatography/mass spectrometry\",\n          \"liquid chromatography/tandem mass spectrometry\",\n          \"lncRNA-seq\",\n          \"local field potential recording\",\n          \"long term potentiation assay\",\n          \"mRNA counts\",\n          \"magnetic resonance angiography\",\n          \"magnetic resonance spectroscopy\",\n          \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n          \"mass spectrometry\",\n          \"massively parallel reporter assay\",\n          \"metabolic screening\",\n          \"methylation array\",\n          \"miRNA array\",\n          \"miRNA-seq\",\n          \"microrheology\",\n          \"Skindex-16\",\n          \"multi-electrode array\",\n          \"nanoparticle tracking analysis\",\n          \"NanoString nCounter Analysis System\",\n          \"n-back task\",\n          \"neuropsychological assessment\",\n          \"next generation targeted sequencing\",\n          \"novelty response behavior assay\",\n          \"open field test\",\n          \"optical tomography\",\n          \"optical coherence tomography\",\n          \"optokinetic reflex assay\",\n          \"oscillatory rheology\",\n          \"oxBS-seq\",\n          \"oxygen consumption assay\",\n          \"pattern electroretinogram\",\n          \"perineurial cell thickness\",\n          \"pharmocokinetic ADME assay\",\n          \"phase-contrast microscopy\",\n          \"photograph\",\n          \"polymerase chain reaction\",\n          \"polysomnography\",\n          \"positron emission tomography\",\n          \"PROMIS Cognitive Function\",\n          \"proximity extension assay\",\n          \"pure tone average\",\n          \"quantitative PCR\",\n          \"questionnaire\",\n          \"reactive oxygen species assay\",\n          \"reporter gene assay\",\n          \"rheometry\",\n          \"ribo-seq\",\n          \"rotarod performance test\",\n          \"sandwich ELISA\",\n          \"scCGI-seq\",\n          \"scale\",\n          \"SaferSeqS\",\n          \"single molecule drug screen assay\",\n          \"single-cell RNA-seq\",\n          \"single cell ATAC-seq\",\n          \"single-nucleus RNA-seq\",\n          \"small molecule library screen\",\n          \"sorbitol dehydrogenase activity level assay\",\n          \"spatial frequency domain imaging\",\n          \"spatial transcriptomics\",\n          \"static histomorphometry\",\n          \"static light scattering\",\n          \"survival\",\n          \"targeted exome sequencing\",\n          \"traction force microscopy\",\n          \"transcranial doppler ultrasonography\",\n          \"twin spot assay\",\n          \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n          \"western blot\",\n          \"whole exome sequencing\",\n          \"whole genome sequencing\",\n          \"whole-cell patch clamp\",\n          \"word recognition score\",\n          \"STR profile\"\n        ],\n        \"type\": \"string\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn21984813\n\n##Predictive Modeling Utilizing a Preclinical NF1-MPNST Platform Suitable for Precision Oncology\nPIs: Angela Hirbe, David Largaespada\n\n### Rationale\nNF1 is one of the most prevalent cancer predisposition syndromes, affecting 1 in 2500 individuals worldwide. Approximately 10-13% of affected individuals will develop an aggressive sarcoma, the malignant peripheral nerve sheath tumor (MPNST). One of the major barriers to the improving outcomes for these patients is the lack of preclinical models that accurately represent the genetic heterogeneity of these cancers. In this regard, no effective therapies have emerged from recent clinical trials, which likely reflects the use of a single mouse MPNST model system (Nf1+/-;Trp53+/- mice) and a paucity of human tumor xenografts. To address this critical problem, our laboratories have successfully generated a series of patient-derived MPNST xenografts that more accurately reflect the genetic heterogeneity seen in the human condition. To date, we have generated 15 NF1-MPNST patient-derived xenograft (PDX) lines propagated in immunocompromised mice.  We have demonstrated that these lines harbor the spectrum of genomic alterations that we see in patients with NF1, including germline and somatic NF1 mutations, and subsets with loss of CDKN2A, TP53 mutations, EED/SUZ12 mutations, and numerous copy number changes. We plan to use collagen microtissues generated from the PDX lines in vitro to perform high throughput drug screening, to accelerate identification of efficacious therapeutic combinations.  We will then proceed with in vivo testing of the promising combinations. This proposal brings together four institutions with deep expertise in NF1 research and a non-profit, collaborative research institute, Sage Bionetworks, to develop a truly integrated effort to explore the therapeutic potential of a set of well-vetted drugs for MPNST. \n\n### Specific Scientific Aims\n#### Aim 1: Continue development and characterization of NF1-MPNST PDX lines to maintain the platform for pre-clinical testing.  Our goal is to generate a total of at least 20 unique PDX lines available for use in Aims 2 and 3.\n#### Aim 2: Determine the in vitro response to cytotoxic chemotherapy or targeted therapy based on molecular phenotype and computational modeling.  Our goal is to screen all PDX for responses to a set of well vetted candidate drugs and drug combinations using a novel high throughput 3-dimensional tissue culture platform.\n#### Aim 3: Determine the in vivo response to cytotoxic chemotherapy or targeted therapy or their combination and identify molecular signatures that are associated with this response.\n\n### Funding\n\nIn addition to funding from the Neurofibromatosis Research Initiative, this project was also supported in part through NCI 3U54CA224083-02S1 award to Ramaswamy Govindan, Li Ding, and Shunqiang Li for the Washington University PDX Development and Trial Center.\n\n### Citation\n\nWang J, Calizo A, Zhang L, Pino JC, Lyu Y, Pollard K, Zhang X, Larsson AT, Conniff E, Llosa NJ, Wood DK, Largaespada DA, Moody SE, Gosline SJ, Hirbe AC, Pratilas CA. CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors. Sci Adv. 2023 Nov 24;9(47):eadg8876. doi: 10.1126/sciadv.adg8876. Epub 2023 Nov 24. PMID: 38000020; PMCID: PMC10672174.\n\nLarsson AT, Bhatia H, Calizo A, Pollard K, Zhang X, Conniff E, Tibbitts JF, Rono E, Cummins K, Osum SH, Williams KB, Crampton AL, Jubenville T, Schefer D, Yang K, Lyu Y, Pino JC, Bade J, Gross JM, Lisok A, Dehner CA, Chrisinger JSA, He K, Gosline SJC, Pratilas CA, Largaespada DA, Wood DK, Hirbe AC. Ex vivo to in vivo model of malignant peripheral nerve sheath tumors for precision oncology. Neuro Oncol. 2023 Nov 2;25(11):2044-2057. doi: 10.1093/neuonc/noad097. PMID: 37246765; PMCID: PMC10628938.\n\n## Tables for Curation\n1. ID: syn64954847\nName: Animal Tumor Growth Studies\nSummary:\n- Assays: in vivo tumor growth, \n- Species: Homo sapiens, \n- Individual count: 9\n- Specimen count: ?\n- Diagnoses present: Neurofibromatosis type 1, \n- Tumor types present: Malignant Peripheral Nerve Sheath Tumor, \n- Data types: drugScreen, \n- File formats present: csv, xlsx, \n- Funders: NFRI,NIH-NCI\n- Contains data created by: Ana Calizo, himanshi bhatia, Daniel Schefer\n- Example files present: JHU Animal Tumor Growth JH-2-031 tram_tno_ribo.csv, JHU Animal Tumor Growth WU-225 tram_tno_ribo.csv, JHU Animal Tumor Growth WU-386 tram_tno_ribo.csv, JHU Animal Tumor Growth WU-545 tram_tno_ribo.csv, MN2 InVivo.xlsx\n\n\n\n2. ID: syn43094628\nName: Batch 1 RNA-seq (Drug Treated Cell Lines)\nSummary:\n- Assays: ?\n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: ?\n- File formats present: ?\n- Funders: ?\n- Contains data created by: ?\n- Example files present: ?\n\n\n\n3. ID: syn64954848\nName: Cell_growth_data_annotation_files\nSummary:\n- Assays: ?\n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: ?\n- File formats present: ?\n- Funders: NFRI,NIH-NCI\n- Contains data created by: Yang Lyu\n- Example files present: syn25791480_annotation.csv, syn25791505_annotation.csv, syn25837063_annotation.csv, syn25837094_annotation.csv, syn25837122_annotation.csv\n\n\n\n4. ID: syn64954849\nName: Drug Combo Incucyte\nSummary:\n- Assays: ?\n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: ?\n- File formats present: ?\n- Funders: NFRI,NIH-NCI\n- Contains data created by: Sara Gosline\n- Example files present: Compile of incucyte data.xlsx\n\n\n\n5. ID: syn64954851\nName: Hirbe_s5180_MGI0731_Batch2_RNAseq\nSummary:\n- Assays: ?\n- Species: Homo sapiens, \n- Individual count: 8\n- Specimen count: 16\n- Diagnoses present: Neurofibromatosis type 1, \n- Tumor types present: ?\n- Data types: geneExpression, \n- File formats present: fastq, \n- Funders: NFRI,NIH-NCI\n- Contains data created by: Kuangying Yang, Yang Lyu\n- Example files present: 2-079_pdx.CCTTCACCAT-ACGACGCTCC.HM3CHDSXY_CCTTCACCAT-ACGACGCTCC_L004_R1.fastq.gz, WU-536_pt.AGCTCGCTAT-ACGCAGAATC.HNJG2DSXY_AGCTCGCTAT-ACGCAGAATC_L001_R2.fastq.gz, mn3_pt.TTCCTGTTAT-ACAGTATCTT.HM3CHDSXY_TTCCTGTTAT-ACAGTATCTT_L004_R2.fastq.gz, mn2_pdx.GTGTCGGAAT-ACGCTTGCGC.HNJG2DSXY_GTGTCGGAAT-ACGCTTGCGC_L001_R1.fastq.gz, 2-055_pt_rna.ACTCGTGTAT-ACATTGGAAC.HM3CHDSXY_ACTCGTGTAT-ACATTGGAAC_L004_R1.fastq.gz\n\n\n\n6. ID: syn64954852\nName: Incucyte Drug Response Data\nSummary:\n- Assays: cell viability assay\n- Species: Homo sapiens, \n- Individual count: 4\n- Specimen count: ?\n- Diagnoses present: Neurofibromatosis type 1\n- Tumor types present: Malignant Peripheral Nerve Sheath Tumor\n- Data types: drugScreen\n- File formats present: xlsx\n- Funders: NFRI,NIH-NCI\n- Contains data created by: Ana Calizo\n- Example files present: Incucyte_JH-2-002_trametinib+trabectedin.xlsx, Incucyte_JH-2-002_mirdametinib+trabectedin.xlsx, Incucyte_JH-2-002_selumetinib+trabectedin.xlsx, Incucyte_JH-2-079_mirdametinib+trabectedin.xlsx, Incucyte_JH-2-079_selumetinib+trabectedin.xlsx\n\n\n\n7. ID: syn64954853\nName: JH_Samples_WEX_MAF\nSummary:\n- Assays: whole exome sequencing, \n- Species: Homo sapiens, \n- Individual count: 6\n- Specimen count: 6\n- Diagnoses present: Unknown, \n- Tumor types present: ?\n- Data types: genomicVariants, \n- File formats present: ?\n- Funders: NFRI,NIH-NCI\n- Contains data created by: Yang Lyu\n- Example files present: JH-2-009_Tumor_filtered_somatic_variants.maf, JH-2-079_Tumor_filtered_somatic_variants.maf, JH-2-055_Tumor_filtered_somatic_variants.maf, JH-2-002_Tumor_filtered_somatic_variants.maf, JH-2-023_Tumor_filtered_somatic_variants.maf\n\n\n\n8. ID: syn64954854\nName: MGI_DT-2862929_Batch2_WEX\nSummary:\n- Assays: whole exome sequencing, \n- Species: Homo sapiens, \n- Individual count: 8\n- Specimen count: 21\n- Diagnoses present: , high grade metastatic MPNST, high grade MPNST, Atypical Neurofibroma, NA\n- Tumor types present: Not Applicable, Malignant Peripheral Nerve Sheath Tumor, Recurrent MPNST, Atypical Neurofibroma, Atypical MPNST, \n- Data types: genomicVariants, \n- File formats present: fastq, \n- Funders: NFRI,NIH-NCI\n- Contains data created by: Yang Lyu\n- Example files present: gccactta-ctctactc_s69_l001_r1_001.fastq.gz, gccactta-ctctactc_s69_l001_r2_001.fastq.gz, hlvwkdsxy_acttagatcg-gccaacatta_l001_r1.fastq.gz, hlvwkdsxy_acttagatcg-gccaacatta_l001_r2.fastq.gz, hlvwkdsxy_agaggcacga-ctcgttgtcg_l001_r1.fastq.gz\n\n\n\n9. ID: syn64954855\nName: MGI_DT-2862929_Batch2_WEX_BAM\nSummary:\n- Assays: whole exome sequencing, \n- Species: Homo sapiens, \n- Individual count: 8\n- Specimen count: 14\n- Diagnoses present: ?\n- Tumor types present: normal, Malignant Peripheral Nerve Sheath Tumor, Atypical Neurofibroma, \n- Data types: genomicVariants, \n- File formats present: bam, \n- Funders: NFRI,NIH-NCI\n- Contains data created by: Yang Lyu\n- Example files present: jh-2-055_normal_trimmed_mk_dup_after_bqsr.bai, jh-2-055_normal_trimmed_mk_dup_after_bqsr.bam, jh-2-055_pdx_trimmed_mk_dup_after_bqsr.bai, jh-2-055_pdx_trimmed_mk_dup_after_bqsr.bam, jh-2-055_tumor_trimmed_merged_mkdup_after_bqsr.bai\n\n\n\n10. ID: syn64954856\nName: MGI_DT-2862930_Batch2_WGS\nSummary:\n- Assays: whole genome sequencing, \n- Species: Homo sapiens, \n- Individual count: 8\n- Specimen count: 22\n- Diagnoses present: NA, high grade MPNST, high grade metastatic MPNST, Atypical Neurofibroma, high grade MPNST with divergent differentiation, \n- Tumor types present: Not Applicable, Atypical MPNST, Recurrent MPNST, Malignant Peripheral Nerve Sheath Tumor, Atypical Neurofibroma, \n- Data types: genomicVariants, \n- File formats present: fastq, \n- Funders: NFRI,NIH-NCI\n- Contains data created by: Yang Lyu\n- Example files present: HLGL7DSXY_CACATGCCAG-GCACAGTGTG_L001_R1.fastq.gz, HLGL7DSXY_CACATGCCAG-GCACAGTGTG_L001_R2.fastq.gz, HLGL7DSXY_CAGTTGGAGG-ACGACAATGA_L001_R1.fastq.gz, HLGL7DSXY_CAGTTGGAGG-ACGACAATGA_L001_R2.fastq.gz, HLMY5DSXY_AACACGCCAC-ACACCAGCTG_L002_R1.fastq.gz\n\n\n\n11. ID: syn64954857\nName: MGI_DT_2862930_Batch2_WGS_BAM\nSummary:\n- Assays: whole genome sequencing, \n- Species: Homo sapiens, \n- Individual count: 8\n- Specimen count: ?\n- Diagnoses present: nan, \n- Tumor types present: ?\n- Data types: genomicVariants, \n- File formats present: bam, bai, \n- Funders: NFRI,NIH-NCI\n- Contains data created by: Yang Lyu\n- Example files present: JH-2-009_PDX_trimmed_mk_dup_after_BQSR.bam, JH-2-009_Normal_trimmed_mk_dup_after_BQSR.bam, JH-2-009_Tumor_trimmed_mk_dup_after_BQSR.bam, WU-487_PDX_trimmed_mk_dup_after_BQSR.bam, WU-487_Normal_trimmed_merged_mkdup_after_BQSR.bam\n\n\n\n12. ID: syn64954858\nName: MGI_WEX_2020_Batch1_BAM\nSummary:\n- Assays: whole exome sequencing, \n- Species: Homo sapiens, \n- Individual count: 8\n- Specimen count: 27\n- Diagnoses present: ?\n- Tumor types present: normal, Malignant Peripheral Nerve Sheath Tumor, \n- Data types: genomicVariants, \n- File formats present: bam, \n- Funders: NFRI,NIH-NCI\n- Contains data created by: Yang Lyu\n- Example files present: JH-2-002_Normal_trimmed_mk_dup_after_BQSR.bam, JH-2-002_Normal_trimmed_mk_dup_after_BQSR.bai, JH-2-002_PDX_trimmed_merged_mkdup_after_BQSR.bam, JH-2-002_PDX_trimmed_merged_mkdup_after_BQSR.bai, JH-2-002_Tumor_trimmed_merged_mkdup_after_BQSR.bam\n\n\n\n13. ID: syn50924729\nName: NF-OSI_processing_01242023\nSummary:\n- Assays: ?\n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: ?\n- File formats present: ?\n- Funders: ?\n- Contains data created by: Yang Lyu\n- Example files present: gerald_HN7F3BBXX_2_ATTACTCG-GGCTCTGA.bam, gerald_HN7F3BBXX_2_ATTCAGAA-GGCTCTGA.bam, gerald_HN7F3BBXX_2_CGCTCATT-GGCTCTGA.bam, gerald_HN7F3BBXX_2_CGGCTATG-GGCTCTGA.bam, gerald_HN7F3BBXX_2_CTGAAGCT-GGCTCTGA.bam\n\n\n\n14. ID: syn50207753\nName: NFOSI-processing_12192022\nSummary:\n- Assays: ?\n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: ?\n- File formats present: ?\n- Funders: ?\n- Contains data created by: Yang Lyu\n- Example files present: gerald_HN7F3BBXX_2_ATTACTCG-GGCTCTGA.bam, gerald_HN7F3BBXX_2_ATTCAGAA-GGCTCTGA.bam, gerald_HN7F3BBXX_2_CGCTCATT-GGCTCTGA.bam, gerald_HN7F3BBXX_2_CGGCTATG-GGCTCTGA.bam, gerald_HN7F3BBXX_2_CTGAAGCT-GGCTCTGA.bam\n\n\n\n15. ID: syn64954859\nName: Proteomics\nSummary:\n- Assays: ?\n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: ?\n- File formats present: ?\n- Funders: NFRI,NIH-NCI\n- Contains data created by: Sara Gosline, Camilo Posso\n- Example files present: 4008 Phospho crosstab.txt, 4007 Global crosstab.txt, FISH_metadata.xlsx, 4007 Phospho crosstab.txt, 4008 Global crosstab.txt\n\n\n\n16. ID: syn64954861\nName: Sample_annotation\nSummary:\n- Assays: ?\n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: ?\n- File formats present: ?\n- Funders: NFRI,NIH-NCI\n- Contains data created by: Yang Lyu\n- Example files present: WU_PDX_batch1_2_WU_samples.xlsx\n\n\n\n17. ID: syn64954862\nName: Somatic_Varaint_Calls_WEX_2020\nSummary:\n- Assays: whole exome sequencing\n- Species: ?\n- Individual count: 8\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: genomicVariants\n- File formats present: maf\n- Funders: NFRI,NIH-NCI\n- Contains data created by: Yang Lyu\n- Example files present: WU-436_PDX_filtered_somatic_variants.maf, WU-368_PDX_filtered_somatic_variants.maf, WU-225_PDX_filtered_somatic_variants.maf, WU-356_PDX_filtered_somatic_variants.maf, WU-386_PDX_filtered_somatic_variants.maf\n\n\n\n18. ID: syn64954863\nName: Updated Somatic Variant Calls\nSummary:\n- Assays: whole exome sequencing\n- Species: Homo sapiens\n- Individual count: 7\n- Specimen count: 14\n- Diagnoses present: high grade metastatic MPNST, high grade MPNST, high grade MPNST with divergent differentiation, , Atypical Neurofibroma\n- Tumor types present: Atypical MPNST, Malignant Peripheral Nerve Sheath Tumor, Recurrent MPNST, Atypical Neurofibroma\n- Data types: genomicVariants\n- File formats present: maf\n- Funders: NFRI,NIH-NCI\n- Contains data created by: Yang Lyu\n- Example files present: JH-2-055_PDX_filtered_somatic_variants.maf, JH-2-055_Tumor_plus_PDX_VCF_review_somatic.maf, JH-2-079_PDX_filtered_somatic_variants.maf, JH-2-079_Tumor_plus_PDX_VCF_review_somatic.maf, MN2_PDX_filtered_somatic_variants.maf\n\n\n\n19. ID: syn64954864\nName: WGS_CNVKIT_MGI2020_2862930\nSummary:\n- Assays: ?\n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: ?\n- File formats present: ?\n- Funders: NFRI,NIH-NCI\n- Contains data created by: Yang Lyu\n- Example files present: MN2_PDX_trimmed_mk_dup_after_BQSR.targetcoverage.cnn, MN3_PDX_trimmed_mk_dup_after_BQSR.targetcoverage.cnn, WU-225_PDX_trimmed_mk_dup_after_BQSR.targetcoverage.cnn, WU-356_PDX_trimmed_mk_dup_after_BQSR.targetcoverage.cnn, WU-368_PDX_trimmed_mk_dup_after_BQSR.targetcoverage.cnn\n\n\n"}]}]}{"system_instruction":{"parts":[{"text":"You are Syndi, a highly competent and helpful data assistant."}]},"contents":[{"parts":[{"text":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Default is the project PI and/or the user who created all files/records.\",\n        \"title\": \"Creator\",\n        \"type\": \"string\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate original data, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"title\": \"Measurement Technique\",\n        \"enum\": [\n          \"2D AlamarBlue absorbance\",\n          \"2D AlamarBlue fluorescence\",\n          \"3D confocal imaging\",\n          \"3D electron microscopy\",\n          \"3D imaging\",\n          \"3D microtissue viability\",\n          \"actigraphy\",\n          \"AlgometRx Nociometer\",\n          \"auditory brainstem response\",\n          \"ATAC-seq\",\n          \"ATPase activity assay\",\n          \"BrdU proliferation assay\",\n          \"CAPP-seq\",\n          \"CUT&RUN\",\n          \"ChIP-seq\",\n          \"Child Behavior Checklist for Ages 1.5-5\",\n          \"Child Behavior Checklist for Ages 6-18\",\n          \"CODEX\",\n          \"confocal microscopy\",\n          \"Corsi blocks\",\n          \"current clamp assay\",\n          \"diffusion MRI\",\n          \"distortion product otoacoustic emissions\",\n          \"DNA optical mapping\",\n          \"ELISA\",\n          \"ERR bisulfite sequencing\",\n          \"EdU proliferation assay\",\n          \"FIA-MSMS\",\n          \"FLIPR high-throughput cellular screening\",\n          \"Fluorescence In Situ Hybridization\",\n          \"Focus group\",\n          \"FTIR spectroscopy\",\n          \"HI-C\",\n          \"HPLC\",\n          \"Interview\",\n          \"ISO-seq\",\n          \"MIB/MS\",\n          \"Matrigel-based tumorigenesis assay\",\n          \"MudPIT\",\n          \"Migration Assay\",\n          \"NIH Toolbox\",\n          \"NOMe-seq\",\n          \"RNA array\",\n          \"RNA-seq\",\n          \"RPPA\",\n          \"Riccardi and Ablon scales\",\n          \"SNP array\",\n          \"SUSHI\",\n          \"Sanger sequencing\",\n          \"Social Responsiveness Scale\",\n          \"Social Responsiveness Scale, Second Edition\",\n          \"T cell receptor repertoire sequencing\",\n          \"TIDE\",\n          \"TMT quantitation\",\n          \"TriKinetics activity monitoring\",\n          \"Von Frey test\",\n          \"active avoidance learning behavior assay\",\n          \"array\",\n          \"atomic force microscopy\",\n          \"autoradiography\",\n          \"bisulfite sequencing\",\n          \"blood chemistry measurement\",\n          \"blue native PAGE\",\n          \"body size trait measurement\",\n          \"bone histomorphometry\",\n          \"brightfield microscopy\",\n          \"cAMP-Glo Max Assay\",\n          \"calcium retention capacity assay\",\n          \"cell competition\",\n          \"cell count\",\n          \"cell painting\",\n          \"cell proliferation\",\n          \"cell viability assay\",\n          \"clinical data\",\n          \"cNF-Skindex\",\n          \"cognitive assessment\",\n          \"combination library screen\",\n          \"combination screen\",\n          \"complex II enzyme activity assay\",\n          \"compound screen\",\n          \"contextual conditioning behavior assay\",\n          \"conventional MRI\",\n          \"Children's Dermatology Life Quality Index Questionnaire\",\n          \"differential scanning calorimetry\",\n          \"dynamic light scattering\",\n          \"electrochemiluminescence\",\n          \"electrophoretic light scattering\",\n          \"elevated plus maze test\",\n          \"FACE-Q Appearance-related Distress\",\n          \"flow cytometry\",\n          \"focus forming assay\",\n          \"functional MRI\",\n          \"gait measurement\",\n          \"gel filtration chromatography\",\n          \"gel permeation chromatography\",\n          \"genotyping\",\n          \"high content screen\",\n          \"high frequency ultrasound\",\n          \"high-performance liquid chromatography/tandem mass spectrometry\",\n          \"immunoassay\",\n          \"immunocytochemistry\",\n          \"immunofluorescence\",\n          \"immunohistochemistry\",\n          \"in silico synthesis\",\n          \"in vitro tumorigenesis\",\n          \"in vivo PDX viability\",\n          \"in vivo bioluminescence\",\n          \"in vivo tumor growth\",\n          \"jumping library\",\n          \"label free mass spectrometry\",\n          \"laser speckle imaging\",\n          \"light scattering assay\",\n          \"liquid chromatography-electrochemical detection\",\n          \"liquid chromatography/mass spectrometry\",\n          \"liquid chromatography/tandem mass spectrometry\",\n          \"lncRNA-seq\",\n          \"local field potential recording\",\n          \"long term potentiation assay\",\n          \"mRNA counts\",\n          \"magnetic resonance angiography\",\n          \"magnetic resonance spectroscopy\",\n          \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n          \"mass spectrometry\",\n          \"massively parallel reporter assay\",\n          \"metabolic screening\",\n          \"methylation array\",\n          \"miRNA array\",\n          \"miRNA-seq\",\n          \"microrheology\",\n          \"Skindex-16\",\n          \"multi-electrode array\",\n          \"nanoparticle tracking analysis\",\n          \"NanoString nCounter Analysis System\",\n          \"n-back task\",\n          \"neuropsychological assessment\",\n          \"next generation targeted sequencing\",\n          \"novelty response behavior assay\",\n          \"open field test\",\n          \"optical tomography\",\n          \"optical coherence tomography\",\n          \"optokinetic reflex assay\",\n          \"oscillatory rheology\",\n          \"oxBS-seq\",\n          \"oxygen consumption assay\",\n          \"pattern electroretinogram\",\n          \"perineurial cell thickness\",\n          \"pharmocokinetic ADME assay\",\n          \"phase-contrast microscopy\",\n          \"photograph\",\n          \"polymerase chain reaction\",\n          \"polysomnography\",\n          \"positron emission tomography\",\n          \"PROMIS Cognitive Function\",\n          \"proximity extension assay\",\n          \"pure tone average\",\n          \"quantitative PCR\",\n          \"questionnaire\",\n          \"reactive oxygen species assay\",\n          \"reporter gene assay\",\n          \"rheometry\",\n          \"ribo-seq\",\n          \"rotarod performance test\",\n          \"sandwich ELISA\",\n          \"scCGI-seq\",\n          \"scale\",\n          \"SaferSeqS\",\n          \"single molecule drug screen assay\",\n          \"single-cell RNA-seq\",\n          \"single cell ATAC-seq\",\n          \"single-nucleus RNA-seq\",\n          \"small molecule library screen\",\n          \"sorbitol dehydrogenase activity level assay\",\n          \"spatial frequency domain imaging\",\n          \"spatial transcriptomics\",\n          \"static histomorphometry\",\n          \"static light scattering\",\n          \"survival\",\n          \"targeted exome sequencing\",\n          \"traction force microscopy\",\n          \"transcranial doppler ultrasonography\",\n          \"twin spot assay\",\n          \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n          \"western blot\",\n          \"whole exome sequencing\",\n          \"whole genome sequencing\",\n          \"whole-cell patch clamp\",\n          \"word recognition score\",\n          \"STR profile\"\n        ],\n        \"type\": \"string\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn5562324\n\n\n### Phenotypic screening of anti-NF2 drug candidates as a single agent or in combination using high content assays in merlin-deficient and normal mouse schwann cells\n\nThis project was an industry-academia collaboration between Cenix Bioscience and the University of Central Florida. MS01 and MS11 mouse Schwann cells (NF2-/- and NF2 wild-type) were screened with 95 different drugs and vehicle conditions for 48 hours in an 8-point dose response format. The screen also included a 30 minute incubation wih 10uM EdU to assess DNA replication in all conditions. At the end of the incubation period, phenotypic measurements were performed with an automated microscope (Image Express) and analyzed with the Definiens automated image analysis software. A variety of nuclear phenotypes were assessed for all conditions, including EDU-positive nuclei, number of nuclei, oversized nuclei, mitotic nuclei, undersized nuclei, non-ellipsoid nuclei, and condensed nuclei. MS11 were Mouse Schwann cells purchased from ScienCell (#M1700). MS01 were derived from Schwann cells from the sciatic nerves of adult Nf2flox2/flox2 mice that underwent Nf2 exon 2 deletion by in vitro infection with a Cre-expressing adenovirus (Ad-Cre).\n\n### Data\nAvailable [here.](syn5562327)\n\n#### Contributors: \n1. Children's Tumor Foundation \n2. Dr. Cristina Fernandez-Valle (UCF)\n3. Cenix Bioscience\n\n## Tables for Curation\n1. ID: syn51916091\nName: CTF-UCF-Cenix Complete Compound Drug Screen\nSummary:\n- Assays: ?\n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: ?\n- File formats present: ?\n- Funders: ?\n- Contains data created by: Abhishek Pratap\n- Example files present: CTF-UCF-Cenix-CompleteCompoundData-all passes in one tab_ to release_FINAL.xlsx\n\n\n"}]}]}{"system_instruction":{"parts":[{"text":"You are Syndi, a highly competent and helpful data assistant."}]},"contents":[{"parts":[{"text":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Default is the project PI and/or the user who created all files/records.\",\n        \"title\": \"Creator\",\n        \"type\": \"string\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate original data, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"title\": \"Measurement Technique\",\n        \"enum\": [\n          \"2D AlamarBlue absorbance\",\n          \"2D AlamarBlue fluorescence\",\n          \"3D confocal imaging\",\n          \"3D electron microscopy\",\n          \"3D imaging\",\n          \"3D microtissue viability\",\n          \"actigraphy\",\n          \"AlgometRx Nociometer\",\n          \"auditory brainstem response\",\n          \"ATAC-seq\",\n          \"ATPase activity assay\",\n          \"BrdU proliferation assay\",\n          \"CAPP-seq\",\n          \"CUT&RUN\",\n          \"ChIP-seq\",\n          \"Child Behavior Checklist for Ages 1.5-5\",\n          \"Child Behavior Checklist for Ages 6-18\",\n          \"CODEX\",\n          \"confocal microscopy\",\n          \"Corsi blocks\",\n          \"current clamp assay\",\n          \"diffusion MRI\",\n          \"distortion product otoacoustic emissions\",\n          \"DNA optical mapping\",\n          \"ELISA\",\n          \"ERR bisulfite sequencing\",\n          \"EdU proliferation assay\",\n          \"FIA-MSMS\",\n          \"FLIPR high-throughput cellular screening\",\n          \"Fluorescence In Situ Hybridization\",\n          \"Focus group\",\n          \"FTIR spectroscopy\",\n          \"HI-C\",\n          \"HPLC\",\n          \"Interview\",\n          \"ISO-seq\",\n          \"MIB/MS\",\n          \"Matrigel-based tumorigenesis assay\",\n          \"MudPIT\",\n          \"Migration Assay\",\n          \"NIH Toolbox\",\n          \"NOMe-seq\",\n          \"RNA array\",\n          \"RNA-seq\",\n          \"RPPA\",\n          \"Riccardi and Ablon scales\",\n          \"SNP array\",\n          \"SUSHI\",\n          \"Sanger sequencing\",\n          \"Social Responsiveness Scale\",\n          \"Social Responsiveness Scale, Second Edition\",\n          \"T cell receptor repertoire sequencing\",\n          \"TIDE\",\n          \"TMT quantitation\",\n          \"TriKinetics activity monitoring\",\n          \"Von Frey test\",\n          \"active avoidance learning behavior assay\",\n          \"array\",\n          \"atomic force microscopy\",\n          \"autoradiography\",\n          \"bisulfite sequencing\",\n          \"blood chemistry measurement\",\n          \"blue native PAGE\",\n          \"body size trait measurement\",\n          \"bone histomorphometry\",\n          \"brightfield microscopy\",\n          \"cAMP-Glo Max Assay\",\n          \"calcium retention capacity assay\",\n          \"cell competition\",\n          \"cell count\",\n          \"cell painting\",\n          \"cell proliferation\",\n          \"cell viability assay\",\n          \"clinical data\",\n          \"cNF-Skindex\",\n          \"cognitive assessment\",\n          \"combination library screen\",\n          \"combination screen\",\n          \"complex II enzyme activity assay\",\n          \"compound screen\",\n          \"contextual conditioning behavior assay\",\n          \"conventional MRI\",\n          \"Children's Dermatology Life Quality Index Questionnaire\",\n          \"differential scanning calorimetry\",\n          \"dynamic light scattering\",\n          \"electrochemiluminescence\",\n          \"electrophoretic light scattering\",\n          \"elevated plus maze test\",\n          \"FACE-Q Appearance-related Distress\",\n          \"flow cytometry\",\n          \"focus forming assay\",\n          \"functional MRI\",\n          \"gait measurement\",\n          \"gel filtration chromatography\",\n          \"gel permeation chromatography\",\n          \"genotyping\",\n          \"high content screen\",\n          \"high frequency ultrasound\",\n          \"high-performance liquid chromatography/tandem mass spectrometry\",\n          \"immunoassay\",\n          \"immunocytochemistry\",\n          \"immunofluorescence\",\n          \"immunohistochemistry\",\n          \"in silico synthesis\",\n          \"in vitro tumorigenesis\",\n          \"in vivo PDX viability\",\n          \"in vivo bioluminescence\",\n          \"in vivo tumor growth\",\n          \"jumping library\",\n          \"label free mass spectrometry\",\n          \"laser speckle imaging\",\n          \"light scattering assay\",\n          \"liquid chromatography-electrochemical detection\",\n          \"liquid chromatography/mass spectrometry\",\n          \"liquid chromatography/tandem mass spectrometry\",\n          \"lncRNA-seq\",\n          \"local field potential recording\",\n          \"long term potentiation assay\",\n          \"mRNA counts\",\n          \"magnetic resonance angiography\",\n          \"magnetic resonance spectroscopy\",\n          \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n          \"mass spectrometry\",\n          \"massively parallel reporter assay\",\n          \"metabolic screening\",\n          \"methylation array\",\n          \"miRNA array\",\n          \"miRNA-seq\",\n          \"microrheology\",\n          \"Skindex-16\",\n          \"multi-electrode array\",\n          \"nanoparticle tracking analysis\",\n          \"NanoString nCounter Analysis System\",\n          \"n-back task\",\n          \"neuropsychological assessment\",\n          \"next generation targeted sequencing\",\n          \"novelty response behavior assay\",\n          \"open field test\",\n          \"optical tomography\",\n          \"optical coherence tomography\",\n          \"optokinetic reflex assay\",\n          \"oscillatory rheology\",\n          \"oxBS-seq\",\n          \"oxygen consumption assay\",\n          \"pattern electroretinogram\",\n          \"perineurial cell thickness\",\n          \"pharmocokinetic ADME assay\",\n          \"phase-contrast microscopy\",\n          \"photograph\",\n          \"polymerase chain reaction\",\n          \"polysomnography\",\n          \"positron emission tomography\",\n          \"PROMIS Cognitive Function\",\n          \"proximity extension assay\",\n          \"pure tone average\",\n          \"quantitative PCR\",\n          \"questionnaire\",\n          \"reactive oxygen species assay\",\n          \"reporter gene assay\",\n          \"rheometry\",\n          \"ribo-seq\",\n          \"rotarod performance test\",\n          \"sandwich ELISA\",\n          \"scCGI-seq\",\n          \"scale\",\n          \"SaferSeqS\",\n          \"single molecule drug screen assay\",\n          \"single-cell RNA-seq\",\n          \"single cell ATAC-seq\",\n          \"single-nucleus RNA-seq\",\n          \"small molecule library screen\",\n          \"sorbitol dehydrogenase activity level assay\",\n          \"spatial frequency domain imaging\",\n          \"spatial transcriptomics\",\n          \"static histomorphometry\",\n          \"static light scattering\",\n          \"survival\",\n          \"targeted exome sequencing\",\n          \"traction force microscopy\",\n          \"transcranial doppler ultrasonography\",\n          \"twin spot assay\",\n          \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n          \"western blot\",\n          \"whole exome sequencing\",\n          \"whole genome sequencing\",\n          \"whole-cell patch clamp\",\n          \"word recognition score\",\n          \"STR profile\"\n        ],\n        \"type\": \"string\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn22392179\n\n## Description\n\nEstablished cell lines have been extensively used in Malignant Peripheral Nerve Sheath Tumors (MPNST) research and are a vital tool for basic and preclinical works. However, the most widely used MPNST cell lines had not been exhaustively described and characterized at the genomic and epigenomic level, and for some of them, even the mutational status of critical genes for MPNST-genesis was missing. \n\nIn this project by the [Hereditary Cancer Laboratory](https://www.germanstrias.org/en/research/cancer/10/hereditary-cancer), at the [Germans Trias i Pujol Research Institute (IGTP)](http://www.igtp.cat) in Spain, we performed a deep genomic characterization of 8 of the most widely used MPNST cell lines to provide a solid foundation for MPNST basic and preclinical research. However, along the way, we found that some of the cell lines labeled as MPNST seemed to be derived from other tumor types. We found genomic evidence of this potential misdiagnosis and it perfectly matched with the potential misdiagnoses identified by a methylation-based sarcoma classifier.\n\nThis project was published in a paper titled \"[Deep genomic analysis of malignant peripheral nerve sheath tumor cell lines challenges current malignant peripheral nerve sheath tumor diagnosis](https://www.cell.com/iscience/fulltext/S2589-0042(23)00173-6)\" in iScience in 2023 with DOI [10.1016/j.isci.2023.106096](10.1016/j.isci.2023.106096) and previously in a BioRxiv preprint at [https://www.biorxiv.org/content/10.1101/2022.05.07.491026v1](https://www.biorxiv.org/content/10.1101/2022.05.07.491026v1).\n\nThis page contains all data generated in the project, including the raw data from the different genomic experiments (WGS, WES, SNP-array and Methylation arrays) as well as access to the summary information sheets we have generated for each cell line.\n\n### Citation\n\nIf you are using the data contained here you should cite Magallón-Lorenz _et. al._, 2023 at DOI [10.1016/j.isci.2023.106096](10.1016/j.isci.2023.106096)\n\n### Samples Summary\n\n${image?fileName=summary%5Ftable%2Epng&align=Center&scale=100&responsive=true&altText=Summary table with the genomic findings about the 8 MPNST cell lines}\n\n### Summary information sheets\n\nFor each of the cell lines analysed we created a summary information sheet summarizing the global genomic profile, the mutational status of MPNST-related genes, the STR profile, the methylome-based classification, ploidy analysis by flow cytometry, cell culture images and any additional information and mutations. \n\n${image?fileName=ST88%2D14%5FCellInfoSheet%5Fedited%2E2%2Epdf%2Epng&align=Center&scale=100&responsive=true&altText=}\n\n${buttonlink?text=ST88%2D14&url=https://www%2Esynapse%2Eorg/Portal/filehandleassociation%3FassociatedObjectId%3Dsyn51607061%26associatedObjectType%3DFileEntity%26fileHandleId%3D125171894&highlight=true&align=None}&nbsp;${buttonlink?text=S462&url=https://www%2Esynapse%2Eorg/Portal/filehandleassociation%3FassociatedObjectId%3Dsyn51607063%26associatedObjectType%3DFileEntity%26fileHandleId%3D125171898&highlight=true&align=None}&nbsp;${buttonlink?text=sNF96%2E2&url=https://www%2Esynapse%2Eorg/Portal/filehandleassociation%3FassociatedObjectId%3Dsyn51607062%26associatedObjectType%3DFileEntity%26fileHandleId%3D125171897&highlight=true&align=None}&nbsp;${buttonlink?text=NF90%2D8&url=https://www%2Esynapse%2Eorg/Portal/filehandleassociation%3FassociatedObjectId%3Dsyn51607069%26associatedObjectType%3DFileEntity%26fileHandleId%3D125171909&highlight=true&align=None}&nbsp;${buttonlink?text=NMS%2D2&url=https://www%2Esynapse%2Eorg/Portal/filehandleassociation%3FassociatedObjectId%3Dsyn51607065%26associatedObjectType%3DFileEntity%26fileHandleId%3D125171899&highlight=true&align=None}&nbsp;${buttonlink?text=STS%2D26T&url=https://www%2Esynapse%2Eorg/Portal/filehandleassociation%3FassociatedObjectId%3Dsyn51607068%26associatedObjectType%3DFileEntity%26fileHandleId%3D125171907&highlight=true&align=None}&nbsp;${buttonlink?text=HS%2DPSS&url=https://www%2Esynapse%2Eorg/Portal/filehandleassociation%3FassociatedObjectId%3Dsyn51607067%26associatedObjectType%3DFileEntity%26fileHandleId%3D125171904&highlight=true&align=None}&nbsp;${buttonlink?text=HS%2DSch%2D2&url=https://www%2Esynapse%2Eorg/Portal/filehandleassociation%3FassociatedObjectId%3Dsyn51607066%26associatedObjectType%3DFileEntity%26fileHandleId%3D125171901&highlight=true&align=None}\n\n## Access Restrictions\n\nThe data deposited here is freely available and has no access restrictions. \n\n## Access to raw data\n\nIn the Files tab, you can find the raw data for [SNP-array](https://www.synapse.org/#!Synapse:syn30058753), [WES](https://www.synapse.org/#!Synapse:syn30091998) and [WGS](https://www.synapse.org/#!Synapse:syn30093085) analysis.\n\n\n\n\n\n## Tables for Curation\n1. ID: syn51586253\nName: MPNST Cell Line Methylation Arrays\nSummary:\n- Assays: methylation array\n- Species: Homo sapiens, \n- Individual count: 8\n- Specimen count: 8\n- Diagnoses present: Neurofibromatosis type 1, Not Applicable, \n- Tumor types present: Malignant Peripheral Nerve Sheath Tumor, Melanoma, Sarcoma, \n- Data types: chromatinActivity\n- File formats present: idat, \n- Funders: Fundación Proyecto Neurofibromatosis\n- Contains data created by: ?\n- Example files present: 205023290165_R06C01_Grn.idat, 205023290165_R06C01_Red.idat, 205023290165_R07C01_Grn.idat, 205023290165_R07C01_Red.idat, 205049780004_R06C01_Grn.idat\n\n\n\n2. ID: syn30613372\nName: MPNST Cell Line SNP Arrays\nSummary:\n- Assays: SNP array\n- Species: Homo sapiens\n- Individual count: 8\n- Specimen count: 8\n- Diagnoses present: Neurofibromatosis type 1, Not Applicable\n- Tumor types present: Malignant Peripheral Nerve Sheath Tumor, Melanoma, Sarcoma\n- Data types: genomicVariants\n- File formats present: txt\n- Funders: Fundación Proyecto Neurofibromatosis\n- Contains data created by: ?\n- Example files present: NF90-8.txt, HS-Sch-2.txt, sNF96.2.txt, HS-PSS.txt, STS-26T.txt\n\n\n\n3. ID: syn51585807\nName: MPNST Cell Line Whole Exome Sequencing\nSummary:\n- Assays: whole exome sequencing\n- Species: Homo sapiens\n- Individual count: 8\n- Specimen count: 8\n- Diagnoses present: Neurofibromatosis type 1, Not Applicable\n- Tumor types present: Malignant Peripheral Nerve Sheath Tumor, Sarcoma, Melanoma\n- Data types: genomicVariants\n- File formats present: fastq\n- Funders: Fundación Proyecto Neurofibromatosis\n- Contains data created by: ?\n- Example files present: S462_2.fastq.gz, HS_PSS_2.fastq.gz, STS-26T_2.fastq.gz, HS-Sch-2_1.fastq.gz, sNF96.2_2.fastq.gz\n\n\n\n4. ID: syn51585677\nName: MPNST Cell Line Whole Genome Sequencing\nSummary:\n- Assays: whole genome sequencing\n- Species: Homo sapiens\n- Individual count: 8\n- Specimen count: 8\n- Diagnoses present: Neurofibromatosis type 1, Not Applicable\n- Tumor types present: Malignant Peripheral Nerve Sheath Tumor, Melanoma, Sarcoma\n- Data types: genomicVariants\n- File formats present: fastq\n- Funders: Fundación Proyecto Neurofibromatosis\n- Contains data created by: ?\n- Example files present: S462_2.fastq.gz, STS-26T_2.fastq.gz, HS-PSS_2.fastq.gz, HS-Sch-2_1.fastq.gz, sNF96.2_2.fastq.gz\n\n\n\n5. ID: syn64954877\nName: Methylation\nSummary:\n- Assays: methylation array, \n- Species: Homo sapiens, \n- Individual count: 8\n- Specimen count: 8\n- Diagnoses present: Neurofibromatosis type 1, Not Applicable, \n- Tumor types present: Malignant Peripheral Nerve Sheath Tumor, Melanoma, Sarcoma, \n- Data types: chromatinActivity, \n- File formats present: idat, \n- Funders: Fundación Proyecto Neurofibromatosis\n- Contains data created by: Bernat Gel Moreno, Robert Allaway\n- Example files present: 205023290165_R06C01_Grn.idat, 205023290165_R06C01_Red.idat, 205023290165_R07C01_Grn.idat, 205023290165_R07C01_Red.idat, 205049780004_R06C01_Grn.idat\n\n\n\n6. ID: syn64954878\nName: SNP_array\nSummary:\n- Assays: SNP array, \n- Species: Homo sapiens, \n- Individual count: 8\n- Specimen count: 8\n- Diagnoses present: Neurofibromatosis type 1, Not Applicable, \n- Tumor types present: Malignant Peripheral Nerve Sheath Tumor, Melanoma, Sarcoma, \n- Data types: genomicVariants, \n- File formats present: txt, \n- Funders: Fundación Proyecto Neurofibromatosis\n- Contains data created by: Bernat Gel Moreno, Robert Allaway\n- Example files present: NF90-8.txt, HS-Sch-2.txt, sNF96.2.txt, HS-PSS.txt, STS-26T.txt\n\n\n\n7. ID: syn64954879\nName: WES\nSummary:\n- Assays: whole exome sequencing, \n- Species: Homo sapiens, \n- Individual count: 8\n- Specimen count: 8\n- Diagnoses present: Neurofibromatosis type 1, Not Applicable, \n- Tumor types present: Malignant Peripheral Nerve Sheath Tumor, Sarcoma, Melanoma, \n- Data types: genomicVariants, \n- File formats present: fastq, \n- Funders: Fundación Proyecto Neurofibromatosis\n- Contains data created by: Bernat Gel Moreno, Robert Allaway\n- Example files present: S462_2.fastq.gz, HS_PSS_2.fastq.gz, STS-26T_2.fastq.gz, HS-Sch-2_1.fastq.gz, sNF96.2_2.fastq.gz\n\n\n\n8. ID: syn64954882\nName: WGS\nSummary:\n- Assays: whole genome sequencing, \n- Species: Homo sapiens, \n- Individual count: 8\n- Specimen count: 8\n- Diagnoses present: Neurofibromatosis type 1, Not Applicable, \n- Tumor types present: Malignant Peripheral Nerve Sheath Tumor, Melanoma, Sarcoma, \n- Data types: genomicVariants, \n- File formats present: fastq, \n- Funders: Fundación Proyecto Neurofibromatosis\n- Contains data created by: Bernat Gel Moreno, Robert Allaway\n- Example files present: S462_2.fastq.gz, STS-26T_2.fastq.gz, HS-PSS_2.fastq.gz, HS-Sch-2_1.fastq.gz, sNF96.2_2.fastq.gz\n\n\n"}]}]}{"system_instruction":{"parts":[{"text":"You are Syndi, a highly competent and helpful data assistant."}]},"contents":[{"parts":[{"text":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Default is the project PI and/or the user who created all files/records.\",\n        \"title\": \"Creator\",\n        \"type\": \"string\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate original data, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"title\": \"Measurement Technique\",\n        \"enum\": [\n          \"2D AlamarBlue absorbance\",\n          \"2D AlamarBlue fluorescence\",\n          \"3D confocal imaging\",\n          \"3D electron microscopy\",\n          \"3D imaging\",\n          \"3D microtissue viability\",\n          \"actigraphy\",\n          \"AlgometRx Nociometer\",\n          \"auditory brainstem response\",\n          \"ATAC-seq\",\n          \"ATPase activity assay\",\n          \"BrdU proliferation assay\",\n          \"CAPP-seq\",\n          \"CUT&RUN\",\n          \"ChIP-seq\",\n          \"Child Behavior Checklist for Ages 1.5-5\",\n          \"Child Behavior Checklist for Ages 6-18\",\n          \"CODEX\",\n          \"confocal microscopy\",\n          \"Corsi blocks\",\n          \"current clamp assay\",\n          \"diffusion MRI\",\n          \"distortion product otoacoustic emissions\",\n          \"DNA optical mapping\",\n          \"ELISA\",\n          \"ERR bisulfite sequencing\",\n          \"EdU proliferation assay\",\n          \"FIA-MSMS\",\n          \"FLIPR high-throughput cellular screening\",\n          \"Fluorescence In Situ Hybridization\",\n          \"Focus group\",\n          \"FTIR spectroscopy\",\n          \"HI-C\",\n          \"HPLC\",\n          \"Interview\",\n          \"ISO-seq\",\n          \"MIB/MS\",\n          \"Matrigel-based tumorigenesis assay\",\n          \"MudPIT\",\n          \"Migration Assay\",\n          \"NIH Toolbox\",\n          \"NOMe-seq\",\n          \"RNA array\",\n          \"RNA-seq\",\n          \"RPPA\",\n          \"Riccardi and Ablon scales\",\n          \"SNP array\",\n          \"SUSHI\",\n          \"Sanger sequencing\",\n          \"Social Responsiveness Scale\",\n          \"Social Responsiveness Scale, Second Edition\",\n          \"T cell receptor repertoire sequencing\",\n          \"TIDE\",\n          \"TMT quantitation\",\n          \"TriKinetics activity monitoring\",\n          \"Von Frey test\",\n          \"active avoidance learning behavior assay\",\n          \"array\",\n          \"atomic force microscopy\",\n          \"autoradiography\",\n          \"bisulfite sequencing\",\n          \"blood chemistry measurement\",\n          \"blue native PAGE\",\n          \"body size trait measurement\",\n          \"bone histomorphometry\",\n          \"brightfield microscopy\",\n          \"cAMP-Glo Max Assay\",\n          \"calcium retention capacity assay\",\n          \"cell competition\",\n          \"cell count\",\n          \"cell painting\",\n          \"cell proliferation\",\n          \"cell viability assay\",\n          \"clinical data\",\n          \"cNF-Skindex\",\n          \"cognitive assessment\",\n          \"combination library screen\",\n          \"combination screen\",\n          \"complex II enzyme activity assay\",\n          \"compound screen\",\n          \"contextual conditioning behavior assay\",\n          \"conventional MRI\",\n          \"Children's Dermatology Life Quality Index Questionnaire\",\n          \"differential scanning calorimetry\",\n          \"dynamic light scattering\",\n          \"electrochemiluminescence\",\n          \"electrophoretic light scattering\",\n          \"elevated plus maze test\",\n          \"FACE-Q Appearance-related Distress\",\n          \"flow cytometry\",\n          \"focus forming assay\",\n          \"functional MRI\",\n          \"gait measurement\",\n          \"gel filtration chromatography\",\n          \"gel permeation chromatography\",\n          \"genotyping\",\n          \"high content screen\",\n          \"high frequency ultrasound\",\n          \"high-performance liquid chromatography/tandem mass spectrometry\",\n          \"immunoassay\",\n          \"immunocytochemistry\",\n          \"immunofluorescence\",\n          \"immunohistochemistry\",\n          \"in silico synthesis\",\n          \"in vitro tumorigenesis\",\n          \"in vivo PDX viability\",\n          \"in vivo bioluminescence\",\n          \"in vivo tumor growth\",\n          \"jumping library\",\n          \"label free mass spectrometry\",\n          \"laser speckle imaging\",\n          \"light scattering assay\",\n          \"liquid chromatography-electrochemical detection\",\n          \"liquid chromatography/mass spectrometry\",\n          \"liquid chromatography/tandem mass spectrometry\",\n          \"lncRNA-seq\",\n          \"local field potential recording\",\n          \"long term potentiation assay\",\n          \"mRNA counts\",\n          \"magnetic resonance angiography\",\n          \"magnetic resonance spectroscopy\",\n          \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n          \"mass spectrometry\",\n          \"massively parallel reporter assay\",\n          \"metabolic screening\",\n          \"methylation array\",\n          \"miRNA array\",\n          \"miRNA-seq\",\n          \"microrheology\",\n          \"Skindex-16\",\n          \"multi-electrode array\",\n          \"nanoparticle tracking analysis\",\n          \"NanoString nCounter Analysis System\",\n          \"n-back task\",\n          \"neuropsychological assessment\",\n          \"next generation targeted sequencing\",\n          \"novelty response behavior assay\",\n          \"open field test\",\n          \"optical tomography\",\n          \"optical coherence tomography\",\n          \"optokinetic reflex assay\",\n          \"oscillatory rheology\",\n          \"oxBS-seq\",\n          \"oxygen consumption assay\",\n          \"pattern electroretinogram\",\n          \"perineurial cell thickness\",\n          \"pharmocokinetic ADME assay\",\n          \"phase-contrast microscopy\",\n          \"photograph\",\n          \"polymerase chain reaction\",\n          \"polysomnography\",\n          \"positron emission tomography\",\n          \"PROMIS Cognitive Function\",\n          \"proximity extension assay\",\n          \"pure tone average\",\n          \"quantitative PCR\",\n          \"questionnaire\",\n          \"reactive oxygen species assay\",\n          \"reporter gene assay\",\n          \"rheometry\",\n          \"ribo-seq\",\n          \"rotarod performance test\",\n          \"sandwich ELISA\",\n          \"scCGI-seq\",\n          \"scale\",\n          \"SaferSeqS\",\n          \"single molecule drug screen assay\",\n          \"single-cell RNA-seq\",\n          \"single cell ATAC-seq\",\n          \"single-nucleus RNA-seq\",\n          \"small molecule library screen\",\n          \"sorbitol dehydrogenase activity level assay\",\n          \"spatial frequency domain imaging\",\n          \"spatial transcriptomics\",\n          \"static histomorphometry\",\n          \"static light scattering\",\n          \"survival\",\n          \"targeted exome sequencing\",\n          \"traction force microscopy\",\n          \"transcranial doppler ultrasonography\",\n          \"twin spot assay\",\n          \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n          \"western blot\",\n          \"whole exome sequencing\",\n          \"whole genome sequencing\",\n          \"whole-cell patch clamp\",\n          \"word recognition score\",\n          \"STR profile\"\n        ],\n        \"type\": \"string\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn11672851\n\n### Project Summary\n${image?fileName=Screen Shot 2018%2D02%2D19 at 4%2E46%2E36 PM%2Epng&align=Right&scale=50&responsive=true}\n\nPhenotypic high-throughput screens are often utilized in modern oncology drug discovery pipelines. Such screens are conducted with an array of molecules (panels of oncology drugs, drugs for other indications, and compounds with possibly unknown bioactivity), ultimately measuring a biological change within a disease model. While these screens can yield valuable hits, they also present the challenge of identifying the target(s) that mediate the effect seen in the screen for several reasons. For example, many drugs have a polypharmacologic target profile making it hard to identify which targets are biologically relevant for a given drug. Furthermore, some libraries contain molecules for which drug-target studies have never been conducted. \n&nbsp;\nTo address these challenges, we developed an application that enables exploration of the chemical-biological interaction space. Drug-target interaction data from [ChEMBL](https://www.ebi.ac.uk/chembl/) (CC BY-SA 3.0), [ChemicalProbes.org](www.chemicalprobes.org) (CC BY-SA 3.0), [DGIdb](http://www.dgidb.org/) (open), [DrugBank](https://www.drugbank.ca/) (CC BY-NC 4.0, used with approval), and [Klaeger, et al, 2017](http://science.sciencemag.org/content/358/6367/eaan4368) was collected for over 280,000 molecules. In addition, when quantitative data were obtained, pChEMBL values were calculated. Each molecule was annotated with a name and chemical structure, and every target was annotated with protein & gene identifiers. An interactive web interface was developed using the R Shiny platform and cheminformatics R packages. The app enables the end user with a specific query molecule to search a database of experimentally-derived drug-target interactions. The database can be queried using drug names or structures. A similarity parameter allows the user to expand their search to other structurally related molecules. The structure of the query molecule is compared to every database molecule, and structurally similar molecules and targets are presented in interactive tabular and network-based forms for in-depth exploration. \n&nbsp;\n\nThe app also performs enrichment analysis on the target lists, and allows the user to evaluate structure-activity relationships for drug response data using publicly-available in vitro datasets. Finally, if a user has a target of interest, they can search for molecules that bind that target and explore the resulting data interactively. This app provides a multifunctional platform for exploring chemical space as it relates to biological targets, and may be useful at several steps along the oncology drug development pipeline including target discovery, structure-activity relationship, and lead identification studies.\n\n## 2021 update:\n\nWow, it's been a while since this project was first released. Some updates: \n- I recently created an R package with functions that allow you to build a database locally. This might be of interest if you have some proprietary drug-target information that you'd like to aggregate alongside public data. Documentation is a work in progress, but please reach out if you'd like help: https://github.com/nf-osi/dtexbuilder\n- I've updated to v4 of the database. This database now contains content from ChEMBL v24.1, ChemicalProbes (07-02-2018), DGIdb 3.0.2, DrugBank 5.1.0 to ChEMBL v28, ChemicalProbes.org (03-10-2021), DGIdb 4.2.0, DrugBank 5.1.8.\n-this updates deprecates the concept of \"internal_id's\", and instead relies on the InChIKey to describe unique molecules. There is a small, but nonzero, chance that there are colliding hashed InChIs causing multiple molecules to be mis-aggregated together. However, this is unlikely considering the size of this database (e.g. the molecules in the database are restricted to \"real\" molecules and of those, only those that have been tested for activity against human targets). More reading on this issue here: https://depth-first.com/articles/2009/04/24/the-first-inchikey-collision/\n\nI've also made some updates to the front end app to make it compatible with the v4 database. I've also tackled some old bugs:\n- CIR search no longer works reliably, replaced with PUG-REST pubchem API query\n- enrichr data structure had a breaking change that resulted in the gene set enrichment analysis module no longer working. replaced Z-scores (which no longer exist) with combined scores.\n\n&nbsp;\n${buttonlink?text=Drug Target Explorer&url=https%3A%2F%2Fshiny%2Esynapse%2Eorg%2Fusers%2Frallaway%2Fpolypharmacology%2Ddb%2F}  \n&nbsp;\n${buttonlink?text=Drug Target Explorer Database v4&url=https://www.synapse.org/#!Synapse:syn25388367}\n&nbsp;\n\nThis app is licensed under the Apache 2.0 software license, and the [source code is available on Github](https://github.com/Sage-Bionetworks/polypharmacology-db).\n&nbsp;\nAs a requirement of the source database license agreements, this dataset is licensed under the [CC BY-SA 4.0](https://creativecommons.org/licenses/by-sa/4.0/) license. \n\n&nbsp;\n[${image?fileName=CC%5FBY%2DSA%5F3%2E0%2Epng&align=Left&scale=15&responsive=true}](https://creativecommons.org/licenses/by-sa/4.0/legalcode)\n\n\n\n\n## Tables for Curation\n1. ID: syn51927498\nName: Drug-Target Explorer\nSummary:\n- Assays: ?\n- Species: ?\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: ?\n- Tumor types present: ?\n- Data types: ?\n- File formats present: ?\n- Funders: ?\n- Contains data created by: Robert Allaway\n- Example files present: compound_target_associations_v4.rds, compound_target_associations_v4.csv, distinct_compound_names_v4.rds, distinct_compound_names_v4.csv, distinct_compound_synonyms_v4.csv\n\n\n"}]}]}{"system_instruction":{"parts":[{"text":"You are Syndi, a highly competent and helpful data assistant."}]},"contents":[{"parts":[{"text":"You are given this curation assignment as one of our top-performing data assistants:\n\nA project has one or more table(s) within the project, where each table represents a dataset.\nYour goal is to create high-quality dataset metadata for these tables that conform to the JSON schema below.\nAlso below is pre-summarized information from the project and tables that can be used for forming accurate and useful metadata.\n\n# JSON Schema\n```\n{\n  \"additionalProperties\": false,\n  \"description\": \"Description of one or more datasets.\",\n  \"type\": \"array\",\n  \"items\":  {\n    \"type\": \"object\",\n    \"title\": \"PortalDataset\",\n    \"properties\": {\n      \"accessType\": {\n        \"description\": \"Access type for the dataset.\",\n        \"title\": \"Access Type\",\n        \"enum\": [\n          \"Public Access\",\n          \"Open Access\",\n          \"Controlled Access\",\n          \"Private Access\"\n        ],\n        \"type\": \"string\"\n      },\n      \"alternateName\": {\n        \"description\": \"An altername name that can be used for search and discovery improvement.\",\n        \"title\": \"Alternate Name\",\n        \"type\": \"string\"\n      },\n      \"conditionsOfAccess\": {\n        \"description\": \"Additional requirements a user may need outside of Data Use Modifiers. This could include additional registration, updating profile information, joining a Synapse Team, or using specific authentication methods like 2FA or RAS. Omit property if not applicable/unknown.\",\n        \"title\": \"User Specific Restriction\",\n        \"type\": \"string\"\n      },\n      \"contributor\": {\n        \"description\": \"Properly formatted name of organization(s) or person(s) that contributed to the dataset.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Contributor(s)\",\n        \"type\": \"array\"\n      },\n      \"countryOfOrigin\": {\n        \"description\": \"Origin of individuals from which data were generated. Omit if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Country of Origin\",\n        \"type\": \"array\"\n      },\n      \"creator\": {\n        \"description\": \"Properly formatted name of the organization or person that is creator of the dataset (e.g. \\\"NF-OSI\\\" or \\\"Robert Allaway\\\"), not an id. Default is the project PI and/or the user who created all files/records.\",\n        \"title\": \"Creator\",\n        \"type\": \"string\"\n      },\n      \"dataType\": {\n        \"description\": \"Reflects the data types within the dataset.\",\n        \"items\": {\n          \"description\": \"What the data (file) contains.\",\n          \"enum\": [\n            \"immunoassay\",\n            \"behavior process\",\n            \"clinical\",\n            \"demographics\",\n            \"particle characterization\",\n            \"drugCombinationScreen\",\n            \"isoformExpression\",\n            \"proteomics\",\n            \"surveyData\",\n            \"kinomics\",\n            \"SomaticVariants\",\n            \"Volume\",\n            \"characteristic\",\n            \"drugScreen\",\n            \"geneExpression\",\n            \"AlignedReads\",\n            \"genomicFeatures\",\n            \"genomicVariants\",\n            \"raw counts\",\n            \"RawIntensities\",\n            \"NormalizedIntensities\",\n            \"Pharmacokinetic Study\",\n            \"mask image\",\n            \"chromatinActivity\",\n            \"StructuralVariants\",\n            \"GermlineVariants\",\n            \"CopyNumberVariants\",\n            \"image\",\n            \"network\",\n            \"cellularPhysiology\",\n            \"metabolomics\",\n            \"AnnotatedSomaticVariants\",\n            \"AnnotatedGermlineVariants\",\n            \"Weight\",\n            \"electrophysiology\",\n            \"audio transcript\",\n            \"dataIndex\",\n            \"AggregatedData\"\n          ],\n          \"title\": \"Data\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Type\",\n        \"type\": \"array\"\n      },\n      \"dataUseModifiers\": {\n        \"description\": \"List of data use ontology (DUO) terms that are true for dataset, which describes the allowable scope and terms for data use. Most datasets allow \\\"General Research Use\\\" unless otherwise specified.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Clinical Care Use\",\n            \"Collaboration Required\",\n            \"Disease Specific Research\",\n            \"Ethics Approval Required\",\n            \"General Research Use\",\n            \"Genetic Studies Only\",\n            \"Geographical Restriction\",\n            \"Health or Medical or Biomedical Research\",\n            \"Institution Specific Restriction\",\n            \"No General Methods Research\",\n            \"No Restriction\",\n            \"Not-for-Profit Non-Commercial Use Only\",\n            \"Non-Commercial Use Only\",\n            \"Not-for-Profit Organisation Use Only\",\n            \"Population Origins or Ancestry Research Only\",\n            \"Population Origins or Ancestry Research Prohibited\",\n            \"Project Specific Restriction\",\n            \"Publication Moratorium\",\n            \"Publication Required\",\n            \"Research Specific Restrictions\",\n            \"Return to Database or Resource\",\n            \"Time Limit on Use\",\n            \"User Specific Restriction\"\n          ],\n          \"title\": \"Data Use Modifiers\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Data Use Modifiers\",\n        \"type\": \"array\"\n      },\n      \"datePublished\": {\n        \"description\": \"Date data were published/available on Synapse.\",\n        \"title\": \"Date Published\",\n        \"type\": \"integer\"\n      },\n      \"description\": {\n        \"description\": \"Blurb for the dataset, which is highly desirable; should be no more than 500 characters.\",\n        \"title\": \"Description\",\n        \"type\": \"string\"\n      },\n      \"diseaseFocus\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Neurofibromatosis type 1\",\n            \"NF2-related schwannomatosis\",\n            \"SMARCB1-related schwannomatosis\",\n            \"LZTR1-related schwannomatosis\",\n            \"22q-related schwannomatosis\",\n            \"Schwannomatosis-NOS\",\n            \"Schwannomatosis-NEC\",\n            \"Multiple\"\n          ],\n          \"title\": \"Disease Focus\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Disease Focus\",\n        \"type\": \"array\"\n      },\n      \"funder\": {\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"CTF\",\n            \"GFF\",\n            \"NTAP\",\n            \"NIH-NCI\",\n            \"Independent\",\n            \"Other\"\n          ],\n          \"title\": \"FundingAgencyEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Funder\",\n        \"type\": \"array\"\n      },\n      \"includedInDataCatalog\": {\n        \"description\": \"Link(s) to known data catalog(s) the dataset is included in.\",\n        \"title\": \"Included In Data Catalog\",\n        \"enum\": [\n          \"https://www.synapse.org/DataCatalog:0\"\n        ],\n        \"type\": \"string\"\n      },\n      \"individualCount\": {\n        \"description\": \"Number of unique individuals included in the dataset (whether as individual-level or as aggregate data). Omit if not applicable/unknown.\",\n        \"title\": \"Individual Count\",\n        \"type\": \"integer\"\n      },\n      \"keywords\": {\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Keywords\",\n        \"type\": \"array\"\n      },\n      \"license\": {\n        \"description\": \"Unless information for license is clear, this should default to UNKNOWN.\",\n        \"title\": \"License\",\n        \"enum\": [\n          \"UNKNOWN\",\n          \"Public Domain\",\n          \"CC-0\",\n          \"ODC-PDDL\",\n          \"CC-BY\",\n          \"ODC-BY\",\n          \"ODC-ODbL\",\n          \"CC BY-SA\",\n          \"CC BY-NC\",\n          \"CC BY-ND\",\n          \"CC BY-NC-SA\",\n          \"CC BY-NC-ND\"\n        ],\n        \"type\": \"string\"\n      },\n      \"manifestation\": {\n        \"description\": \"Refers to the phenotype(s) studied in the dataset. Omit if not applicable.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Aneurysmal Bone Cyst (ANNUBP)\",\n            \"Atypical Neurofibroma\",\n            \"Behavioral\",\n            \"Breast Cancer\",\n            \"Cognition\",\n            \"Cutaneous Neurofibroma\",\n            \"Glioma\",\n            \"High-Grade Glioma\",\n            \"Juvenile Myelomonocytic Leukemia (JMML)\",\n            \"Low-Grade Glioma\",\n            \"Meningioma\",\n            \"Memory\",\n            \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n            \"Pain\",\n            \"Plexiform Neurofibroma\",\n            \"Quality of Life\",\n            \"Schwannoma\",\n            \"Spinal Meningioma (SMN)\",\n            \"Vision Loss\"\n          ],\n          \"title\": \"ManifestationEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Manifestation(s)\",\n        \"type\": \"array\"\n      },\n      \"measurementTechnique\": {\n        \"description\": \"What's used to generate original data, typically referring to the assay. Omit if not applicable (e.g. for curated dataset such as a list compounds from a database or text extracted from Wikipedia).\",\n        \"title\": \"Measurement Technique\",\n        \"enum\": [\n          \"2D AlamarBlue absorbance\",\n          \"2D AlamarBlue fluorescence\",\n          \"3D confocal imaging\",\n          \"3D electron microscopy\",\n          \"3D imaging\",\n          \"3D microtissue viability\",\n          \"actigraphy\",\n          \"AlgometRx Nociometer\",\n          \"auditory brainstem response\",\n          \"ATAC-seq\",\n          \"ATPase activity assay\",\n          \"BrdU proliferation assay\",\n          \"CAPP-seq\",\n          \"CUT&RUN\",\n          \"ChIP-seq\",\n          \"Child Behavior Checklist for Ages 1.5-5\",\n          \"Child Behavior Checklist for Ages 6-18\",\n          \"CODEX\",\n          \"confocal microscopy\",\n          \"Corsi blocks\",\n          \"current clamp assay\",\n          \"diffusion MRI\",\n          \"distortion product otoacoustic emissions\",\n          \"DNA optical mapping\",\n          \"ELISA\",\n          \"ERR bisulfite sequencing\",\n          \"EdU proliferation assay\",\n          \"FIA-MSMS\",\n          \"FLIPR high-throughput cellular screening\",\n          \"Fluorescence In Situ Hybridization\",\n          \"Focus group\",\n          \"FTIR spectroscopy\",\n          \"HI-C\",\n          \"HPLC\",\n          \"Interview\",\n          \"ISO-seq\",\n          \"MIB/MS\",\n          \"Matrigel-based tumorigenesis assay\",\n          \"MudPIT\",\n          \"Migration Assay\",\n          \"NIH Toolbox\",\n          \"NOMe-seq\",\n          \"RNA array\",\n          \"RNA-seq\",\n          \"RPPA\",\n          \"Riccardi and Ablon scales\",\n          \"SNP array\",\n          \"SUSHI\",\n          \"Sanger sequencing\",\n          \"Social Responsiveness Scale\",\n          \"Social Responsiveness Scale, Second Edition\",\n          \"T cell receptor repertoire sequencing\",\n          \"TIDE\",\n          \"TMT quantitation\",\n          \"TriKinetics activity monitoring\",\n          \"Von Frey test\",\n          \"active avoidance learning behavior assay\",\n          \"array\",\n          \"atomic force microscopy\",\n          \"autoradiography\",\n          \"bisulfite sequencing\",\n          \"blood chemistry measurement\",\n          \"blue native PAGE\",\n          \"body size trait measurement\",\n          \"bone histomorphometry\",\n          \"brightfield microscopy\",\n          \"cAMP-Glo Max Assay\",\n          \"calcium retention capacity assay\",\n          \"cell competition\",\n          \"cell count\",\n          \"cell painting\",\n          \"cell proliferation\",\n          \"cell viability assay\",\n          \"clinical data\",\n          \"cNF-Skindex\",\n          \"cognitive assessment\",\n          \"combination library screen\",\n          \"combination screen\",\n          \"complex II enzyme activity assay\",\n          \"compound screen\",\n          \"contextual conditioning behavior assay\",\n          \"conventional MRI\",\n          \"Children's Dermatology Life Quality Index Questionnaire\",\n          \"differential scanning calorimetry\",\n          \"dynamic light scattering\",\n          \"electrochemiluminescence\",\n          \"electrophoretic light scattering\",\n          \"elevated plus maze test\",\n          \"FACE-Q Appearance-related Distress\",\n          \"flow cytometry\",\n          \"focus forming assay\",\n          \"functional MRI\",\n          \"gait measurement\",\n          \"gel filtration chromatography\",\n          \"gel permeation chromatography\",\n          \"genotyping\",\n          \"high content screen\",\n          \"high frequency ultrasound\",\n          \"high-performance liquid chromatography/tandem mass spectrometry\",\n          \"immunoassay\",\n          \"immunocytochemistry\",\n          \"immunofluorescence\",\n          \"immunohistochemistry\",\n          \"in silico synthesis\",\n          \"in vitro tumorigenesis\",\n          \"in vivo PDX viability\",\n          \"in vivo bioluminescence\",\n          \"in vivo tumor growth\",\n          \"jumping library\",\n          \"label free mass spectrometry\",\n          \"laser speckle imaging\",\n          \"light scattering assay\",\n          \"liquid chromatography-electrochemical detection\",\n          \"liquid chromatography/mass spectrometry\",\n          \"liquid chromatography/tandem mass spectrometry\",\n          \"lncRNA-seq\",\n          \"local field potential recording\",\n          \"long term potentiation assay\",\n          \"mRNA counts\",\n          \"magnetic resonance angiography\",\n          \"magnetic resonance spectroscopy\",\n          \"Magnetization-Prepared Rapid Gradient Echo MRI\",\n          \"mass spectrometry\",\n          \"massively parallel reporter assay\",\n          \"metabolic screening\",\n          \"methylation array\",\n          \"miRNA array\",\n          \"miRNA-seq\",\n          \"microrheology\",\n          \"Skindex-16\",\n          \"multi-electrode array\",\n          \"nanoparticle tracking analysis\",\n          \"NanoString nCounter Analysis System\",\n          \"n-back task\",\n          \"neuropsychological assessment\",\n          \"next generation targeted sequencing\",\n          \"novelty response behavior assay\",\n          \"open field test\",\n          \"optical tomography\",\n          \"optical coherence tomography\",\n          \"optokinetic reflex assay\",\n          \"oscillatory rheology\",\n          \"oxBS-seq\",\n          \"oxygen consumption assay\",\n          \"pattern electroretinogram\",\n          \"perineurial cell thickness\",\n          \"pharmocokinetic ADME assay\",\n          \"phase-contrast microscopy\",\n          \"photograph\",\n          \"polymerase chain reaction\",\n          \"polysomnography\",\n          \"positron emission tomography\",\n          \"PROMIS Cognitive Function\",\n          \"proximity extension assay\",\n          \"pure tone average\",\n          \"quantitative PCR\",\n          \"questionnaire\",\n          \"reactive oxygen species assay\",\n          \"reporter gene assay\",\n          \"rheometry\",\n          \"ribo-seq\",\n          \"rotarod performance test\",\n          \"sandwich ELISA\",\n          \"scCGI-seq\",\n          \"scale\",\n          \"SaferSeqS\",\n          \"single molecule drug screen assay\",\n          \"single-cell RNA-seq\",\n          \"single cell ATAC-seq\",\n          \"single-nucleus RNA-seq\",\n          \"small molecule library screen\",\n          \"sorbitol dehydrogenase activity level assay\",\n          \"spatial frequency domain imaging\",\n          \"spatial transcriptomics\",\n          \"static histomorphometry\",\n          \"static light scattering\",\n          \"survival\",\n          \"targeted exome sequencing\",\n          \"traction force microscopy\",\n          \"transcranial doppler ultrasonography\",\n          \"twin spot assay\",\n          \"ultra high-performance liquid chromatography/tandem mass spectrometry\",\n          \"western blot\",\n          \"whole exome sequencing\",\n          \"whole genome sequencing\",\n          \"whole-cell patch clamp\",\n          \"word recognition score\",\n          \"STR profile\"\n        ],\n        \"type\": \"string\"\n      },\n      \"series\": {\n        \"description\": \"Datasets may belong to a curated series. Should be assigned by staff only; omit property if not applicable/unknown.\",\n        \"title\": \"Data Series\",\n        \"enum\": [\n          \"NF-OSI Processed Data\"\n        ],\n        \"type\": \"string\"\n      },\n      \"species\": {\n        \"description\": \"Species of the organism(s) from which the data were generated. Omit property if not applicable, such as for data like compounds or other non-biological data.\",\n        \"items\": {\n          \"description\": \"\",\n          \"enum\": [\n            \"Rattus norvegicus\",\n            \"Gallus gallus\",\n            \"Pan troglodytes\",\n            \"Mus musculus (humanized)\",\n            \"Homo sapiens\",\n            \"Danio rerio\",\n            \"Drosophila melanogaster\",\n            \"Rhesus macaque\",\n            \"Sus scrofa\",\n            \"Oryctolagus cuniculus\",\n            \"Mus musculus\"\n          ],\n          \"title\": \"SpeciesEnum\",\n          \"type\": \"string\"\n        },\n        \"title\": \"Species\",\n        \"type\": \"array\"\n      },\n      \"specimenCount\": {\n        \"description\": \"Number of unique specimens included in the dataset. Omit if not applicable/unknown.\",\n        \"title\": \"Specimen Count\",\n        \"type\": \"integer\"\n      },\n      \"studyId\": {\n        \"description\": \"Identifier for the study (project) from which the dataset was derived.\",\n        \"title\": \"Study ID\",\n        \"type\": \"string\"\n      },\n      \"subject\": {\n        \"description\": \"Applicable subject term(s) for dataset cataloging; use the Library of Congress Subject Headings (LCSH) scheme.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Subject\",\n        \"type\": \"array\"\n      },\n      \"title\": {\n        \"title\": \"Title\",\n        \"type\": \"string\"\n      },\n      \"visualizeDataOn\": {\n        \"description\": \"Link(s) to where data may be visualized in a separate application. Omit property if not applicable/unknown.\",\n        \"items\": {\n          \"type\": \"string\"\n        },\n        \"title\": \"Visualize Data On\",\n        \"type\": \"array\"\n      },\n      \"yearProcessed\": {\n        \"description\": \"Year data were processed. Only for processed dataset type and when data series is \\\"NF-OSI Processed Data\\\"; omit if not applicable/unknown.\",\n        \"title\": \"Year Processed\",\n        \"type\": \"integer\"\n      }\n    },\n    \"required\": [\n      \"title\",\n      \"creator\",\n      \"accessType\",\n      \"license\",\n      \"keywords\",\n      \"dataType\",\n      \"studyId\",\n      \"diseaseFocus\",\n      \"funder\"\n    ]\n  }\n}\n\n```\n\n# Project ID: syn37861830\n\n# From cold to hot - Reprogramming tumor microenvironment to target NF1 malignancies\n## CTF - Young Investigator Award\n### Principal Investigator: Bandarigoda Nipunika Somatilaka\n### Project Lead / Data Coordinator: Bandarigoda Nipunika Somatilaka\n### Institution: University of Texas Southwestern Medical Center\n### Project Description:\nNeurofibromatosis type 1 (NF1) affects about 1 in 3000 people worldwide. Patients with NF1 often develop benign tumors on the skin and along the nerves in the spinal cord and brain, and about 8-13% of those become cancerous over time. These cancerous tumors are called Malignant Peripheral Nerve Sheath Tumors (MPNST). The only method of curing MPNST is surgical removal, however, these tumors can be large and located close to complex nerve networks, making complete removal difficult. As a result, tumors tend to reappear after surgery or tumor cells migrate to different sites like lung or bone. When complete removal cannot be achieved, radiotherapy and chemotherapy are recommended to manage the tumor. Unfortunately, MPNST respond poorly to both these therapies. With this lack of treatment options, survival of patients with MPNST is low. \r NF1 is caused by a mutation of the NF1 gene, which encodes a protein called neurofibromin. Neurofibromin acts as an off-switch for downstream signaling pathways. Therefore, inactivating mutations of the NF1 gene produce non-functional neurofibromin resulting in constant signaling of these pathways. Researchers have tried to target these pathways with various drugs to treat MPNST, however clinical trials testing these drugs against MPNST were not successful. Therefore, finding a druggable target for MPNST has been challenging. Given the difficulty of surgical and clinical management, identifying an effective treatment strategy for MPNST is a desperate need. \r A recent approach to treating inoperable, undruggable cancer has been to use Immune Checkpoint Blockers (ICB). The role of immune checkpoints is to prevent the persistence of normal immune responses to avoid possible collateral tissue damage. Cancer cells hijack this mechanism and express immune checkpoint proteins to avoid detection by a patient’s immune cells. ICB disrupts this process, thus enhancing antitumor immunity. ICB has revolutionized the treatments of many cancers. However, for this approach to work, T cells and other types of immune cells must be present in the vicinity and within the tumor. Unfortunately, MPNST are “cold tumors” meaning they do not have many immune cells near and/or within the tumor. This makes using ICB against MPNST challenging. \r We hypothesize that turning MPNST into a “hot” tumor, i.e. increasing immune cell infiltration into the tumor, will make it susceptible to targeting with ICB. In this proposal, we will use a strategy to increase the number of T cells and other immune cells near and/or within the tumor: we will activate the cGAS-STING-IFN pathway, which enhances antitumor immunity through the production of a variety of small molecules capable of tumor cell destruction. We will treat MPNST-bearing mice with different small-molecule drugs to activate the STING pathway, thus turning the MPNST into “hot” tumors. We will then test various combinations of STING-activating drugs and immune checkpoint blockers to determine if they are effective in shrinking MPNST. If successful, this will represent a novel treatment strategy for MPNST, an aggressive and malignant tumor for which no molecular therapy currently exists.\n\n## Tables for Curation\n1. ID: syn64954925\nName: IHC Quantification\nSummary:\n- Assays: immunohistochemistry\n- Species: Mus musculus\n- Individual count: ?\n- Specimen count: ?\n- Diagnoses present: Neurofibromatosis type 1\n- Tumor types present: Malignant Peripheral Nerve Sheath Tumor\n- Data types: raw counts\n- File formats present: excel\n- Funders: CTF\n- Contains data created by: Anh Nguyet Vu\n- Example files present: JCI176748.sdval.xlsx\n\n\n"}]}]}